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ABSTRACT 
We have synthesized a new class of photoaffinity analogs, 
2 ' ,3'-o-(2,4,6-trinitrophenyl)-8-azido-ATP, -ADP and -AMP (TNP-
8N3ATP, -ADP and -AMP), and their radiolabeled derivatives, and 
characterized their interaction with the sarcoplasmic reticulum 
ca2+_ATPase. · The TNP-8N3-nucleotides were synthesized from ATP 
in three steps involving bromination in the 8-position of the 
adenine ring followed by displacement with an azido group and 
then trinitrophenylation of the resulting 8N3-nucleotide with 
TNBS. Inclusion of the oxidizing agent, DTNB, in the final 
reaction was found to be necessary to prevent reduction of the 
azido group by the released sulfite anion and also elevated the 
yield of trinitrophenylation to about 80%. Purity was 
determined spectrophotometrically, as well as by anion exchange 
TLC and reversed phase HPLC. In the dark, the compounds were 
found to display most of the features of the parent TNP-
nucleotides and interacted with the ca2+_ATPase in a similar way. 
When activated by illumination, the probes were specifically 
incorporated into SR vesicles with high efficiency at alkaline 
pH. The site of labeling was identified as being on the A1 
tryptic fragment. 
High affinity binding of all three analogs to SR vesicles 
was determined by three different methods. Direct binding to 
intact vesicles was measured by incubation with TNP-8N3-[s-14c]-
nucleot~des under equilibrium conditions followed by filtration. 
High affinity binding (ko = 0.1, 0.2 and 0.2 µM for the mono-, 
di- and triphosphate, respectively) to the extent of about 4 
nmoles/mg protein was followed by a nonsaturable increase at 
higher nucleotide concentrations and probably represents 
nonspecific binding to the membrane. Specific binding to the 
catalytic site was measured by following the inhibition by TNP-
8N3-nucleotides of active site crosslinking by glutaraldehyde on 
polyacrylamide gels (ko = 0.04, 0.3 and 0.4 µM for the mono-, di-
iii 
and triphosphate, respectively). Finally, we utilized the 
fluorescent properties of the TNP group to measure binding to two 
types of nucleotide site. Binding of TNP-8N3-nucleotides to SR 
vesicles in the absence of ATP and/or _ca2+ and presence of EDTA 
resulted in a small increase in fluorescence, which saturated as 
the concentration was increased. Inclusion of Mg2+, under the 
same conditions, resulted in additional binding which was not 
seen with TNP-ATP. Again, this probably represents partitioning 
of the more hydrophobic, chelated TNP-8N3-nucleotides into the SR 
membrane. In the presence of catalytic amounts of both ATP and 
ca2+, the TNP-8N3-nucleotides undergo a large increase in 
fluorescence, which also saturates as the fluorophore 
concentration is raised. 
TNP-ATP has been found to bind with high affinity (in the 
micromolar range)to a regulatory site and to accelerate enzyme 
activity similarly to that observed with higher concentrations of 
ATP. Consistently, ATPase activity was stimulated 1 .0, 1 .4, and 
1.5 fold respectively by micromolar concentrations of TNP-8N3 
AMP, TNP-8N3ADP, and TNP-8N3ATP. At higher concentrations, TNP-
8N3-nucleotides inhibited ATPase activity, suggesting competition 
at the catalytic site. The large increase in fluorescence seen 
upon binding of TNP-8N3-nucleotides under conditions producing 
acceleration of activity suggested that the high fluorescent site 
is a regulatory site. 
Irradiation of SR vesicles with TNP-8N3-nucleotides under 
equilibrium conditions resulted in covalent incorporation of the 
nucleotide to the SR vesicles. The incorporation of TNP-8N3-
nucleotides was pH dependent, increasing at alkaline pH and 
exhibiting a pK of 7.4. Inhibition of ATPase activity as a 
result of covalent incorporation showed the same pH dependence. 
Thus while labeling at pH 6.0 had little effect on ATPase 
activity, labeling at pH 9.0 resulted in an inhibition of ATPase 
activity stoichiometric with levels of incorporation. TNP-8N3-
nucleotide was covalently incorporated both under conditions of 
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equilibrium binding to the catalytic site, as well as to 
fluorescent/regulatory site under turnover conditions in 
presence of ATP. The pH dependence of incorporation was 
same irrespective of labeling conditions, consistent 
labeling a single locus. Higher levels of labeling 
obtained, however, when illumination was carried out 








site or a more efficient labeling process, perhaps as a result of 
an increase in hydrophobicity of the site. At optimal 
concentrations of TNP-8N3-nucleotide and ATP, specific covalent 
incorporation to the turning over enzyme was obtained to the 
extent of 80% per irradiation period. An increase in labeling 
is also obtained by reirradiating labeled vesicles in the 
presence of fresh TNP-8N3-nucleotide. The covalently 
incorporated TNP-8N3-nucleotide, both under turnover and 
nonturnover conditions, inhibited active site crosslinking with 
glutaraldehyde suggesting that both catalytic and regulatory 
nucleotides are located at the catalytic site. 
The fluorescence properties of the covalently incorporated 
TNP-8N3-nucleotide were measured following removal of the free 
nucleotide with ion exchange resin. A large fluorescence 
increase was observed when SR vesicles covalently labeled with 
TNP-8N3-nucleotide were incubated with AcP + ca2+ or with Pi + 
Me2SO, but not with ATP+ ca2+. Possibly, ATP is sterically 
prevented from entering the nucleotide site by the covalently 
incorporated TNP-8N3-nucleotide, while AcP and Pi are still able 
to induce phosphorylation. A similar phenomenon is seen after 
modification of the enzyme with FITC and so the two probes are 
probably situated close together. The fluorescence enhancement 
upon induction of turnover was the same irrespective of whether 
the TNP-8N3-nucleotide was incorporated into the low fluorescence 
site under nonturnover conditions, or to the high fluorescent 
site under turnover conditions. These latter conditions were 
identical to those in which binding of TNP-8N3ATP and TNP-8N3 
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ADP stimulated ATPase activity. The crosslinking results again 
indicated that covalent incorporation of nucleotide during enzyme 
turnover is more efficient than under nonturnover conditions. 
The covalently incorporated TNP-8N3-nucleotide was localized 
on the A1 tryptic fragment both under turnover and nonturnover 
conditions and thus this part of the molecule must form a fold of 
the nucleotide binding site in addition to the B fragment. 
Preliminary peptide mapping results indicated a single peptide 
carrying most of the radioactive label. Significantly, both the 
nonturnover and turnover labeled peptides eluted in the same 
place during reversed phase HPLC and is consistent with a model 
in which the catalytic, regulatory and high fluorescence sites 
all share the same locus. The pH dependence of labeling 
indicates that an ionizable group with pK of about 7.4 is 
involved and is preferentially labeled when ionized. The most 
likely candidate is a sulfhydryl group with pK of 7.5, but 
another amino acid like Tyr (pK = 10) may be the site of labeling 
as the pK is dependent on the protein environment. 
The probes described here may be useful in labeling a number 
of other ATP binding enzymes particularly those, including 
myosin, (Na++ K+)-ATPase and F1-ATPase, which interact with TNP-
ATP. The fluorescent properties, high affinity binding, and 
potential for nucleotide site discrimination displayed by the 
TNP-8N3-nucleotides with the ca2+_ATPase, are favorable 










































E.coli elongation factor 
ethylene glycol bis(8-aminoethyl ether)-
N,N,N' ,N'-tetraacetic acid 
electron paramagnetic resonance 
phosphoenzyme 
ADP-sensitive ca2+_ATPase phosphoenzyme 
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1 . 1 General Properties of Ion Pumps 
Ion pumps or cation-linked ATPases are one of three 
categories of enzymes catalyzing reactions involving phosphate 
monoesters (Knowles, 1980). This category they share with the 
kinases and mutases which transfer y-phosphate groups to 
molecules other than water, the final acceptor of the phosphatase 
catalyzed y-phosphate cleavage. 
Ion transport systems can be divided into four categories 
(Tanford, 1983; Pedersen and Carafoli, 1987a, b): a) ATP driven 
pumps with phosphoryl enzyme intermediates, or P-type ATPases; 
b) multisubunit ATP-linked proton transport systems without 
phosphoryl protein intermediates or F-type ATPases; 
driven proton pumps (Bacteriorhodopsin) and d) 
exchange transport systems. Another group, called 





associated with membrane bound organelles other than the 
mitochondrion, endoplasmic reticulum or SR. Recently, a further 
group distinct from those above has been identified, comprising 
the proton translocating ATP synthases from archaebacteria (Danon 
and Stoeckenius, 1974; Denda et al., 1988). 
The P-type or aspartophosphoryl cation motive ATPases, 
sometimes referred to as E1E2 ATPases, catalyze reactions of the 
type illustrated below (Kyte, 1981). 
2ca2+i + MgATPi .::......- MgADPi + Pi + 2ca2+ 0 ----:, 
2K+ + 3Na+, + MgATPi .::......- MgADPi + P· + 3Na+0 + 2K+. 0 1 ----:, 1 1 
nK+ + nH+. + MgATPi .::......- MgADPi + P· + nH+ + nK+. 0 1 ----:, 1 0 1 
They include calcium pumps (of which the ca2+_ATPase of SR is an 
example), sodium pumps, proton pumps and bacterial potassium 
pumps, and all contain an aspartic acid residue, which is 
phosphorylated during the catalytic cycle (Degani and Boyer, 
1973; Post and Kume, 1973; Nishigaki et al., 1974; Dame and 
Scarborough, 1981). In addition, they are all inhibited by 
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vanadate (Macara, 1980), and have a reaction cycle characterized 
by two major conformational states, E1 and E2. K+ appears to 
have a common role in the P-type ATPases (Green et al., 1988). 
I t acts as a counterion in the sodium and proton pumps and has a 
s i milar function in the bacterial pump where it is required for 
dephosphorylation. K+ also activates dephosphorylation in the 
ca2+ and fungal H+ pumps. 
The F-type ATPases are large multisubunit complexes that 
predominantly function in ATP synthesis coupled to proton flux 
down an electrochemical gradient (Senior and Wise, 1983; Amzel 
and Pedersen, 1983; Vignais and Satre, 1984; Pedersen and 
Carafoli, 1987a, b; McCarty and Hammes, 1987). The enzymes 
found in bacteria, chloroplasts and mitochondria consist of a 
hydrophilic F1 section, containing the nucleotide binding sites, 
and an ionophoric F0 part responsible for cation flux through the 
membrane. The major differences between individual species lies 
in the F0 section, while the F1 sections are very similar. The 
F1 section is made up of five different subunits usually in a 
stoichiometric ratio of a3B3y6E (at least for MF1 and CF1). 
Considerable sequence homology exists among the a-, B- and y-
subunits of all species examined with B- subunit showing as much 
as 70% homology between species (Walker et al., 1982, 1985). 
a - and B- subunits themselves show significant sequence 
homology. The F1 moeity appears to contain six nucleotide 
b i nding sites located on a- and 8- subunits only (Cross and 
Nalin, 1982; Gromet-Elhanan and Khananshvili, 1984; 
Khananshvili and Gromet-Elhanan, 1985). The F-type ATPases do 
not form phosphoprotein intermediates, but do contain tightly 
bound nucleotides, which may play an analogous role. They are 
also inhibited by a number of agents, although the pattern of 
inhibition may vary between enzymes from different sources. 
Except for a small region round the phosphorylation site, no 
sequence homology with the P-type ATPases exists (Modyanov et 
al., 1985; Ernster et al., 1986). 
The V-type ATPases are probably the largest group of 
ATPases, and they comprise those enzymes associated with membrane 
bound organelles, other than the mitochondrion and the 
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endoplasmic or sarcoplasmic reticulums (Sze, 1985; Bowman and 
Bowman, 1986; Mellman et al., 1986; Rudnick, 1986; Pedersen 
and Carafoli, 1987a, b). They all translocate protons, do not 
form phosphoryl enzyme intermediates, and are composed of 
multiple subunits . There are two major polypeptide components 
of 60-65 kDa and 70-89 kDa as well as a number of smaller 
peptides. The v-type ATPases have a particular pattern of 
inhibitor sensitivity. Many V-type ATPases appear to 
participate in the uptake of biogenic amines or amino acids and 
they have also been implicated in receptor recycling. It 
appears likely that there are still a number of physiological 
roles in which they will be found to play a part. There is, at 
present, no sequence information available for any V-type ATPase. 
The more recently characterized archaebacterial H+-ATPases 
cross-react immunologically with the F-type ATPases and also 
resemble them in function, but they differ in subunit 
composition, sensitivity to ATPase inhibitors and pH optima 
(Inatomi, 1986; Hochstein et al., 1987; Nanba and Mukohata, 
1987; Lubben et al., 1987; Mukohata et al., 1987). The 
particular inhibitor sensitivities found in the archaebacterial 
H+-ATPases are similar to those found in the V-type ATPases 
(Danon and Stoeckenius, 1974; Mukohata and Kaji, 1981; 
Kristjansson et al., 1986; Mukohata and Yoshida, 1987a; Lubben 
and Schafer, 1987; Konishi et al., 1987). The primary 
structure of the H+-ATPase from Sulfolobus acidocaldarius has 
recently been determined and found to bear weak homology to both 
the a and 8 subunits of EF1-ATPase (Danon et al., 1988), although 
a polyclonal antibody raised against the ATP synthase of 
Halobacterium halobium cross-reacts with much higher affinity to 
the anion sensitive ATPase of red beet than to either CF1-ATPase 
or the ca2+_ATPase (Mukohata et al., 1987) . 
Despite the differences between classes, there have been 
attempts to synthesize the observed similarities into a general 
model for active ion pumping (Hammes, 1982; Scarborough, 1984; 
Eisenberg and Hill, 1985; Pedersen and Carafoli, 1987b). This 
kind of model is generally restricted to F- and P-type ATPases 
for which there is extensive mechanistic information. In terms 
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of one such model (Pedersen and Carafoli, 1987b), the enzyme is 
postulated to have a hydrophobic active site which excludes H20 
and makes phosphate transfer an energetically favorable event. 
The main thermodynamic barrier involves the binding of reactants, 
which is facilitated by interaction between residues on the 
protein and on the reactant molecules. A similarity is thus 
seen between the way in which both types overcome a similar 
problem. 
1 . 1 . 1 P-type ATPase structure 
Structurally, the P-type ATPases are all large (a) 
polypeptides of MW 70-140 kDa. The (Na++K+)-ATPase has, in 
addition, a closely associated (a) polypeptide of MW 53 kDa and 
as yet unknown function. The amino acid sequences of a number 
of P-type ATPases have been determined (Hesse et al., 1984; 
Kawakami et al., 1985; MacLennan et al., 1985; Shull et al., 
1985; Addison, 1986; Brandl et al., 1986; Hager et al., 1986; 
Kawakami et al., 1986; Ovchinnikov et al., 1986; Serrano et 
al., 1986; Shull and Lingrel, 1986; Solioz et al., 1987). 
Extensive sequence homology(> 80%) is found in ATPases sharing 
the same ion specificity while pumps of different ion specificity 
show only about 20-30% homology, concentrated in about nine to 
twelve homologous regions scattered throughout the molecule 
(Serrano et al, 1986; Green et al., 1988; Serrano, 1988), 
although a higher degree of homology exists between the (Na+ + 
K+)-ATPases and the (H+ + K+)-ATPases of animal cells (Serrano et 
al., 1986). 
Ten regions of extensive homology have been identified and 
are shown in Fig. 1 .1 (Serrano et al., 1986; Serrano, 1988). 
Of the ten shown, five (b, c, f, h, and i) are the most highly 
conserved. Region f contains the aspartic acid residue 
phosphorylated during catalysis, while regions g and i appear to 
be located in the nucleotide binding site as they contain the 
residues affinity labeled by FITC and 5'-FSBA, respectively. 
Region e is the only conserved region predicted to span the 
membrane. An evolutionary tree relating all known P-type 
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c. 108 OERNAENAIEALKEYEPEMGKVYR ll: 140 IKAKOIVPGOIVEI AVGOKVPAOIRL 165 
Sa-i< 148 OEAKSSKIMESfKNMVPOOALVIR 11: 11 8 INAEEVVVGOLVEVKGGORIPAOLRI 20 3 
H- { 159 OE,K S7S II ASfKN LV POOATVI R 182 189 IN AOOLVVGOLVEMKGGORVPAO:RI 214 
16 l OEfOAGS IVO ELKKTLANTAVVI R l 8 < 191 IP ANE VV PGO ILOL EOGTVI PTOG • I 216 
86 AEGRSKAOANS LKG VKKTAfARK L 109 121 VPAOOLRKGOIVLVE AGOIIPCOGEV 14 6 
C d 
: a 17 5 VOC S,LTGESVSVIK 189 209 fSC7111 AAGKAMGVVVATGVNTE!GK 234 
Sa-!< 211 VON SSLTGESEPOTR 225 242 ff57NCVEGTARGIVVYTGO RTVl1GR 2 67 
r.-~ 222 VONSSLTGESEPOTR 236 2 53 ffS:MCLEGTAOCLVVSTGORTIIG R 27 8 
225 IOOS AITGESLAVOK 239 246 fSSSTVKRGEGfMVVTATGONTfVGR 2 71 
15 3 VO ESAITGESAPV I R 167 171 7~~7,I LSOWLVI ECSVNPGETfLOR 202 
e 
Ca 296 fKIAVALAVAAIP EGLPAVIT 316 326 MA KKN AIVRSLPSVETLGCTSVICSOKTGTLTTN 359 
~a-K 319 VIfLIGIIV ANVPEGLLATVT 339 349 MARKNCLVKNLEAVETLGSTST,CSOKTGTLTON 382 
H- ~ 330 MVffMAIVVAYVPEGLLATVT 350 360 LASKNCVV KNLEAVETLGSTSVICSOKTGTLTON 393 
H 323 LRYTLGITIIGVPVGLPAVVT 343 353 LAKKOAI VOKLSA I ESLAGVEILCSOKTGTLTKN 38 6 
K 252 V7VLVALLVCLIPTTIGGLLS 212 2 82 MLGANVI ATSGRAVEAAGOVOVLLLOKTGTITLG 3 15 
t 
q h 
:a 5 13 VKGAP 517 5 92 fVGCVGMLOPP,:EV ASSVKLC RQAG!RVIMITGONKGTAVAICRRIGI 640 
Sa-!< 505 MKGAP 509 583 fVGLISMIOP PRAAVPOAVGKCRS AG IKVI MVTGOH PI 7AKAI AKGVGI 631 
1-!- i< 5 16 MKGAP 52 0 594 f AGLVS MIOPPi\A:VPOAVLKCRTAGI RVI MVTGOH P ITAKAI AA ~VG ! 642 
47 3 VKGAP 411 52 6 ILGVMP CMO PPR:~TAOTVSEARHLGLRVKMLTGDAVGIAKETCROLGL 57 4 
K 394 RKGSV 398 439 VLGVIALKOIVKGGIKEAFAQLRKMG !KTVM!TGON RLTAAAI AAEAGV 487 
- ·-· ··· ··-·-. : a 675 fAR VEPSHKSKlVEfLOSFOEITAMTGOG\lllOAPA LKKAEIGI AM 719 
SA-K 68 8 f ARTSPOOKL; I VEGCOROCA IVAVTGCG'•~OS PA LK KAO IGVAM 732 
H- ~ 699 f ART SPOOK LV I VESCQR LCA IV A VTGOG'~OSP A LKKAO IGVAM 743 
607 fAEVfPOHKYRVVE!LO NRGYLVAMTGOG\lllOAPS LKKAOTGIAV 651 
K 491 LAEATPEAKLALIROYOAEGRLVAMTGOG7NOAPA LAOA OVAVAM 535 
c. 12 1 SGTAVAKTASEMVLAOONfSTI VAAVEE~,A: 752 
Sd-!< 735 AGSOVSKOAAOMILLOONfASIVTGVEEG,~: 766 
H- ~ 746 AGSOAAKNAAOM!LLDONfl\SIVTGl'EC~,~: 111 
H 65 3 GA70AA RSAAO! VfLAPGLSAIIOALK7S,:: 6 84 
K 537 SGTOAAKEAGNMVDLOSNPTKLIEVVHlGl:~ 5 6 8 
F i gure 1 . 1 Conserved Sequences in P-type ATPases 
The 1 0 areas of homology between 5 P-type ATPases, published 
Se rrano (1988). The enzymes 
ca2+_ATPase (MacLennan et al., 
s heep kidney (Shull et al., 
the compared-are 
1985), the (Na+ + 
twitch slow 
K+)-ATPase 





S . cerevisiae (Serrano et al., 
1985) , 
1986) and the K+-ATPase 
(Hesse et al., 1984). Asterisks represent 
from E.coli 
residues conserved 
a nd dashes conservative replacements. The aspartic acid residue 
phosphorylated during catalysis is marked with an arrow. 
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ATPases to the (Na++ K+)-ATPase is shown in Fig.1 .2 (Jorgensen, 
1988). 
The linear sequence and location of predicted transmembrane 
regions and structural domains in a number of P-type ATPases is 
shown in Fig. 1 .3. Variations in the number and location of 
transmembrane regions, depending on the predictive method used, 
have been reported, but the structure shown here probably 
represents a good average assuming a common structure. The 
organization of the structural domains is very similar between 
groups although the bacterial enzymes are shorter as they lack 
the last two transmembrane regions as well as a portion of the N-
terminus. Both the location of the trypsin sensitive sites and 
the intrans shown in Fig. 1 .3 may delineate structural domains. 
The N-terminus region is the most variable, but nevertheless 
is predicted to have an a-helical structure in all ATPases. It 
is separated by the first two closely spaced transmembrane 
regions from a hydrophilic region made up of about 130-150 amino 
acids and containing the first four regions of homology. This 
region is predicted to be mainly organized into a a-sheet 
structure and is bounded by the next two closely spaced 
transmembrane regions, three and four, with a highly conserved 
region occurring in four. The next region contains a large 
hydrophilic region made up of about 350-450 amino acids and 
containing the other five regions of homology as well as the 
phosphorylation site and the postulated nucleotide binding site. 
This region is predicted to consist mainly of an alternating a/B 
type structure. In both the ca2+_ATPase and the (Na+ + K+)-
ATPase these two hydrophilic domains, which contain most of the 
conserved stretches, are separated by a trypsin sensitive site. 
Following this region, there are another four transmembrane 
regions separated by short hydrophilic stretches and which are 
separated, in the (Na++ K+)-ATPase by the five known introns, 
again suggesting a separation of domains. 
A number of studies have indicated a similarity in the 
secondary and tertiary structures of the P-type ATPases. CD 
spectroscopy has demonstrated that a number of P-type ATPases 
































An evolutionary tree postulated for the known P-type ATPases 
assuming divergence from a common ancestor, and relating all 
species to the a-subunit of the human (Na+ + 
(Jorgensen et al., 1988). 
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K+)-ATPase 
1 2 3 4 5 6 7 8 Ca --- - ~LJ -- --DD DfD fO c::::J L:.L.J 
Tz T, 
Na-K --D'DTI~~ -r-r •• t t c:::J c::LJ f t f 
Tz T3 T, I I I 
H-K -· D'U'D-c:r-" ~ u c::::J c::::r::::J ---- --
H ,-~c:rn Cl_.~"LJ 
c:=r:::J --- - ---t c::::J f 
I I I I 
----D D 'D Cl_.~ -c::::J ---ii c::::J c:::::r:::J ---a b C d e f g h I J 
Figure 1.3 Linear sequence alignment of P-type ATPases 
Comparison of the organization of the linear sequences of the 5 
P-type ATPases compared in Fig.1.1 published by Serrano (1988). 
The enzymes compared are the same as in Fig.1.1, shaded boxes 1-8 
are predicted transmembrane regions and open boxes a-j are the 10 
homologous regions. Trypsin sensitive sites (T) and the 
position of known intrans (I) are also shown. 
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Scarborough, 1988), while Raman spectroscopy has confirmed the 
assignment of secondary structure units in the (Na++ K+)-ATPase 
based on hydrophobicity plots, and has shown unambiguously that 
the transmembrane regions are made up of a-helices (Ovchinnikov 
et al. , 1988) . Similar models for the tertiary structure 
organization of a number of P-type ATPases have been postulated 
(MacLennan et al., 1985; Shull et al., 1985; Addison, 1986; 
Brandl et al., 1986; Hager et al., 1986; Serrano et al., 1986; 
Solioz et al., 1987; Ovchinnikov et al., 1988) . 
Two regions of homology have been identified between P-type 
ATPase~ and other ATPases. The first is an observed homology 
around the phosphorylation site of the P-type ATPases and a 
region of the F1-ATPases (Fig.1 .4) (Modyanov et al., 1985; 
Ernster et al., 1986). In the F1-ATPases the phosphorylated Asp 
residue is replaced by a Thr and adjacent to this is a Lys 
residue which, in the F1-ATPases, is labeled by 8N3ATP (Hollemans 
et al., 1983). Homology has also been detected between the 
region around the site of labeling of the ca2+_ATPase with AP3-PL 
(Yamamoto et al., 1988) and rat embryonic skeletal muscle myosin 
heavy chain (Strehler et al., 1986). 
1 . 1 . 2. Structure of nucleotide binding sites 
First indications of a common nucleotide binding domain 
followed comparisons of the three-dimensional structure of the 
NAO binding site of a number of dehydrogenases as well as the FMN 
binding site of flavodoxin (Chandrasekhar et al., 1973; Buehner 
et al., 1973; Rao and Rossmann, 1973; Rossmann et al., 1974; 
Ohlsson et al., 1974). This recurring super-secondary 
structure, or 'Rossmann fold', consists of three parallel strands 
of pleated sheet connected by helical regions (Rao and Rossmann, 
1973). In the dinucleotide site, two such folds lie adjacent to 
one another with an approximately two-fold symmetry, and 
connected by a helical, or less well defined, region (Rao and 
Rossmann, 1973). The structure of the dehydrogenase NAO binding 
site is shown in Fig. 1.5. The sequence BA, aB, BB, ac, BC 












Bovine mi tochn. TTTKKGS I TSVQ 
Maize ch 1 orop 1. TSTKKGS I TSVQ 
Spinach chloropl. TSTKEGSITSVQ 
R.blastica TSTKAGSITSVQ 





Tobacco chloropl. SSLGEGSMTALP 
Figure 1.4 Homology between the phosphorylation site of P-type 
ATPases and a region in the F-type ATPases 
Comparison of the amino acid sequence in a region around the 
phosphorylation site of a number of P-type ATPases with a 
homologous region in the F-type ATPases, showing the site of 
phosphorylation in the case of the former(*) and the site of 
labeling with 8N3-ATP in the case of the latter(+) (Modyanov et 
al . , 1985; Ernster et al., 1986). 
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Figure 1.5 Structure of the dinucleotide binding site 
Schematic of the coenzyme binding domain in dehydrogenases 
(Ohlsson et al., 1984). a-helices are represented by coils and 
strands of a-sheet by arrows pointing in the direction of the C-
terminus. 
1 1 
binding site occurs in the adjacent BaBaB region (Rossmann et 
al., 1974). 
The basic ADP binding unit of B-sheet and a-helices, is a 
recurring motif which has been found to exist in a number of 
globular proteins (Sternberg and Thornton, 1976; Wierenga et 
al . , 1985). Recognition of this has allowed the refinement of 
the normal secondary structure prediction which is usually< 60% 
efficient (Kabsch and Sander, 1983), to greater than 70% (Taylor 
and Thornton, 1983, 1984). In addition, a 'fingerprint' has 
been described (Wierenga et al., 1986), following identification 
of the essential structural features of several amino acid side 
chains of the BaB fold (Wierenga et al., 1985). The structure 
of a typical BaB fold is shown in Fig. 1.6, with the eleven 
essential elements (Wierenga et al., 1986). The first 
requirement is for a basic or hydrophilic amino acid at the first 
position of the a-strand (open triangle). The hydrophobic core 
between the a-strands and the a-helix is formed by six 
hydrophobic residues (open squ~res). The capability for making 
a sharp turn between the first a-strand and the a-helix is given 
by two Gly residues (closed circles), while the third (middle) 
Gly allows for the close approach of the pyrophosphate group to 
the N-terminus of the a-helix. Lastly, a good H-bond is made 
between the acidic amino acid side chain (divided open circle) 
and the 2'-0H of the ribose moeity. Some variability exists at 
the first position (divided open triangle) as well as at the 
posi tion_s of the hydrophobic residues, so the three Gly residues 
and the acidic residue are defined as an essential 'core' region 
(Wierenga et al., 1986). 
An evolutionary tree has been proposed tracing the 
incorporation and evolution of the mononucleotide binding 
structure in various dehydrogenases (Buehner et al., 1973), 
assuming divergence from a common structure more than 3.2 X 109 
years ago (Rossman et al., 1974; Sternberg and Thornton, 1976). 
Similar structures have been reported to exist in a number of 
kinases (Bryant et al., 1974; Schulz and Schirmer, 1974; Schulz 
et al., 1974; Sachsenheimer and Schulz, 1977; Evans and Hudson, 
1979; Watson et al., 1982; Yuasa et al., 1983). The largest 
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Figure 1.6 Structure of the BaB fold 
0 
0 "'-... I 
p - 0 . / \.._ __ 
0 
'- p - D 
I "O o-fo 
A 
OH 
Schematic of the ADP-binding BaB fold of dogfish lactate 
dehydrogenase showing conserved and core residues. ( ~,basic or 
hydrophilic; D, small and hydrophobic) (Wierenga, 1986). The 
11 ' fingerprint' residues are framed by double lines. 
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body of structural information is available for adenylate kinase 
and the st"ructure of the nucleotide site in this enzyme has been 
used as a model for ATP site structure in a number of other 
enzymes, including the sarcoplasmic reticulum ca2+_ATPase (Green 
et al., 1988), and is therefore considered in some detail. 
1 . 2 . 1 . 1 ADENYLATE KINASE 
Adenylate kinase has been purified from many sources and the 
X-ray structure of the porcine enzyme has been reported in fine 
detail (Schulz and Schirmer, 1974; Sachsenheimer and Schulz, 
1977). The MgATP binding site of this enzyme has been well 
characterized both by X-ray diffraction (Schulz et al., 1974; 
Pai et al., 1977) and NMR (Hamada et al., 1979; Smith and 
Mildvan, 1982; Fry et al., 1985). The structure of the two 
crystal forms of the enzyme as well as the position of bound 
nucleotide is shown in Fig. 1 .7 (Fry et al., 1986). The 
positions of the MgATP binding site from X-ray diffraction and 
NMR analysis differ (Smith and Mildvan, 1982), and at present, 
the more recent postulate appears correct. These authors place 
MgATP in close contact with five strands of parallel a-sheet 
structure and with one of the interconnecting helices (Fry et 
al., 1986) similar to that seen in the dehydrogenases (Rossmann 
et al., 1974). Thus, although there is little sequence homology 
between adenylate kinase and the dehydrogenases, there seems to 
be a distinct similarity in three-dimensional structure in the 
region of the nucleotide binding site (Fry et al., 1986). In 
this model (Fry et al., 1985, 1986), the 2 widely conserved 
consensus sequences described below (Walker et al., 1982) are 
placed in the MgATP site as is Lys-21, the homologous region of 
which, in the F1-ATPases, has been shown to interact with the y-
phosphate of ATP (Parsonage et al., 1988). These findings,in 
addition to the use of salicylate (Fry et al., 1985) to locate 
the ATP site in the earlier study, seem to confirm the 
positioning shown in Fig.1 .7 (Fry et al., 1986). The earlier 
model, however, appears more consistent with recent affinity 
labeling results (Tagaya et al., 1987), although a conformational 
1 4 
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Figure 1.7 Structure of adenylate kinase 
The 2 crystal forms of adenylate kinase are shown (A, solid; B, 
open), with the postulated position of the bound metal-ATP (Fry 
et al., 1986). a-helises are depicted by cylinders and strands 
of a-sheet by arrows pointing from N- to C-terminus. The A 
conformation changes to the B following the binding of ATP. The 
3 homologous segments are shown by stipling in the B 
conformation. 
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change on binding nucleotide could also account for these 
results. 
Two highly conserved regions, A and B, have been identified 
following comparison of the primary structures of adenylate 
kinase with those of phosphofructokinase, myosin, and F1 a and B 
subunits (Walker et al., 1982) . The A sequences have a number 
of conserved features but most notably the conserved sequence: 
G-X-X-X-X-G-K(T)-X-X-X-X-X-X-I/V 
which is usually followed by a basic amino acid. 
sequences have the following conserved sequence: 
The B 
R/K-X-X-X-G-X-X-X-L-Hy-Hy-Hy-Hy-D 
where Hy stands for a hydrophobic residue. In adenylate kinase, 
the A sequence corresponds to the flexible Gly-rich loop 
structure with the basic amino acid (K) following the loop 
forming a favorable interaction with the phosphate group on the 
bound nucleotide, in addition to the extra positive effect of the 
a-helix dipole (Hol et al., 1978). Sequence B forms a 
hydrophobic a-sheet structure at the back of the nucleotide 
binding pocket. A third region has been identified in 
adenylate kinase that is conserved in a number of nucleotide 
binding proteins (Fry et al., 1986) following detailed NMR 
measurements of the interaction of a, y-bidentate cr3+ATP and 
MgATP with rabbit muscle adenylate kinase as well as with a 
synthetic peptide containing the nucleotide binding site (Fry et 
al., 1985). 
The three regions of homology which have been identified in 
a large number of nucleotide binding proteins, although they are 
not always all present in a particular structure, have been 
summarized by Fry et al. (1986). The 3 regions are stippled in 
the structure shown in Fig. 1.7. 
Segment 1, corresponding to sequence A (Walker et al., 




residue, Lys or Arg (Lys-21 in adenylate kinase) and 
interacts with the y-phosphoryl group of MgATP. 
previously thought to be diagnostic of nucleotide 
binding sites, segment 1 may have a more basic role as seen by 
it's presence in the biotin subunit of transcarboxylase, which 
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does not interact with nucleotides, as well as at a site, far 
removed from the AMP binding site, in glycogen phosphorylase 
(McLaughlin et al., 1984). The function of this loop most 
likely involves it's ability to undergo a conformational change. 
Three possible roles for a conformational change at segment 1 
have been suggested (Fry et al., 1986): (i) control of 
accessibility to the substrate binding site, (ii) modification of 
binding site affinities, (iii) relocation of catalytic groups 
toward the reaction center of the bound substrate. In adenylate 
kinase, segment 1 is located in the middle of a cleft and thus it 
may control accessibility to the substrate binding site by 
alternately blocking and opening the cleft. Secondly, a 
conformational change affecting segment 1 could alter the 
affinity of the binding site for MgATP and MgADP by a change in 
orientation of the terminal cationic residue (Lys-21 ). Thirdly, 
a conformational change bringing segment 1 close to the 
triphosphate chain of MgATP could facilitate the phosphoryl 
transfer reaction by proximity to the hydroxyl group of Ser-19 
and the amide NH protons of the protein backbone. 
Segment 2, corresponding to Sequence B from Walker et al. 
(1982), is mainly an a-helix consisting of two lysines separated 
by three residues, two of which are hydrophobic and a third that 
is variable, even among adenylate kinases from different species. 
In ad~nylate kinase the hydrophobic residues form part of the 
pocket in which the adenine-ribose moeity of MgATP is located. 
The fir~t lysine residue, Lys-27, can be positioned such that 
it's NH3+ nitrogen is 5.7 + 2.0 A from the B- and y-phosphorus 
atoms of MgATP and may interact with them. Affinity labeling 
studies of the cyclic nucleotide-dependent and src protein 
kinases with FSBA have shown that in these enzymes the Lys 
residue homologous to Lys-27 is near they-phosphate of bound ATP 
(Kamps et al., 1984). 
Segment 3 is a hydrophobic strand of parallel a-pleated 
sheet terminated by an Asp residue that flanks the triphosphate 
chain of MgATP, including the reaction center. It probably 
serves to exclude H20 and minimize hydrolysis. The end ASP-119 
in adenylate kinase may accept a hydrogen bond from a H20 ligand 
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of Mg2+ on MgATP or alternatively, by directly coordinating Mg2+, 
it may facilitate the migration of Mg2+ from 8, y-coordination in 
MgATP to a, 8-coordination in MgADP. An analogous role has been 
proposed for ASP-372 in phosphoglycerate kinase (Watson et al., 
1982) and possibly also for phosphofructokinase (Evans et al., 
1981), and ras P21 (Gibbs et al., 1984; Shih et al., 1982). 
1 . 1 . 2 . 2 OTHER KINASES 
The structure of a number of other kinases in the region of 
the nucleotide binding site have been determined, two of which 
are shown schematically in Fig.1 .8 (Serrano, 1988). It is 
evident that the folding of the protein and interaction with ATP 
is different both for phosphoglycerate kinase and for 
phosphofructokinase, although both contain the A and B consensus 
sequences (Walker et al., 1982). In phosphoglycerate kinase, 
the two consensus sequences do not appear to be directly involved 
in binding the nucleotide (Bryant et al., 1974; Banks et al., 
1979; Watson et al., 1982). Instead the hydrophobic pocket 
accommodating the adenine ring is formed by two loops while the 
ribose moeity H-bonds to two acidic residues (Banks et al., 1979; 
Watson et al., 1982). The a and 8 phosphates interact with two 
Lys groups and are located at the N-terminus of an a-helix which, 
in this case, however, does not form part of the hydrophobic 
pocket. 
In the case of phosphofructokinase, the nucleotide site 
differs from both adenylate kinase and from phosphoglycerate 
kinase (Evans and Hudson, 1979; Kolb et al., 1980; Evans et 
al., 1981). Here the hydrophobic pocket is made up of an a-
helix and a loop. Again, the adenine and ribose moeities make 
H-bonding interactions with amino acid residues through the 
chelated Mg2+ group (Kolb et al., 1980; Evans et al., 1981). 
In hexokinase, it has also been shown that the ATP binding 
site again is different (Shoham and Steitz, 1980; Steitz et al., 
1981). Here the adenine group is located in a shallow slit 
adjacent to an a-helix with no a-sheet type structure and the 
phosphates are not located at the end of an a-helix (Steitz et 
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Figure 1.8 Nucleotide binding site of phosphoglycerate kinase 
and phosphofructokinase 
The protein folding in the region of the nucleotide binding site 
are shown for phosphofructokinase (A) and for phosphoglycerate 
kinase (B) (Serrano, 1988). a-helises are depicted by cylinders 
and strands of B-sheet by arrows pointing from N- to C-terminus. 
Residues implicated in nucleotide binding or conserved in other 
ATP binding proteins are indicated by dark regions. 
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al . , 1981 ). Similarly, in pyruvate kinase, a novel interaction 
with ATP is seen even though an identifiable mononucleotide 
binding fold exists (Levine et al., 1978). Here the nucleotide 
lies perpendicular to the axis of a a-barrel structure (Levine et 
al. I 1978) . 
1. 1 .2 . 3 ~1 NUCLEOTIDE SITE STRUCTURE 
It is now well accepted that F1 from a variety of sources 
contains six nucleotide binding sites per enzyme unit (Cross and 
Nalin, 1982; Xue et al., 1987a), and that these are located 
sol ely on a and B subunits (Senior and Wise, 1983; Vignais and 
Satre, 1984). It is also generally accepted that the 3 
catalytic sites reside on the B subunit (Senior and Wise, 1983) 
and in terms of the a3B3y6E subunit stoichiometry of F1 that the 
other 3 noncatalytic sites exist either on B or at an interface 
between a and B (Gromet-Elhanan and Khananshvili, 1984; 
Khananshvili and Gromet-Elhanan, 1985; Kironde and Cross, 1987a, 
b) . 
The primary structures of a number of species have been 
determined and extensive homology is seen between a and B 
subunits from different species as well as between a and B 
themselves (Walker et al., 1982, 1985; Gorboczi et al., 1988a). 
Comparison of the primary structures of both a and B subunits 
wi t h a number of other proteins including myosin, adenylate 
kinase and phosphofructokinase have revealed the presence of two 
consensus sequences A and B (Walker et al., 1982). Both these 
sequences occur in the nucleotide binding site of adenylate 
kinase. A corresponds to the Gly-rich flexible loop structure 
and B to a strand of B-sheet forming part of the binding pocket. 
Adjacent to one of the homologous regions is a small stretch 
showing homology with a region around the phosphorylation site in 
the P-type ATPases (Modyanov et al., 1985; Ernster et al., 1986; 
Gorboczi et al., 1988a). 
The predicted secondary structure of the F1-ATPase (Walker 
et al., 1984; Duncan et al., 1986) shows alternating a-helices 
and B-sheets which can be folded into a BaB structure (Gorboczi 
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et al., 1988a) and models of the tertiary structure have been 
predicted in which the nucleotide domain is folded into a 
structure similar to that found in adenylate kinase (Fig.1 .9) 
(Duncan et al., 1986; Gorboczi et al., 1988a). The predicted 
fold contains a number of residues which have been implicated in 
nucleotide binding by chemical labeling studies (Gorboczi et al., 
1988a). The same model is thought to apply to the folding of 
the a subunit (Maggio et al., 1987). It has been postulated 
that the identified site on the a-subunit represents the 
catalytic site (Gorboczi et al., 1988a) while the other 
postulated site (Gromet-Elhanan and Khananshvili, 1984; Kironde 
and Cross, 1987) may be elsewhere and less conserved evolutionary 
(Gorboczi et al., 1987a). 
A number of essential residues, including several within the 
conserved regions, have been specifically mutated (Parsonage et 
al. , 1987a, b, 1988) . In particular, Lys-155 was specifically 
mutated to Gln or Glu (Parsonage et al., 1987a). In the 
postulated three-dimensional structure of F1, Lys-155 corresponds 
to Lys-21 in adenylate kinase, which is located at the end of the 
Gly-rich flexible loop, and has been postulated to interact with 
the phosphate groups of ATP (Fry et al., 1985; Dreusicke and 
Schulz, 1986). Mutation to Glu was found to be less detrimental 
to binding than was mutation to Gln, which apparently contadicts 
the interaction hypothesis (Parsonage et al., 1987a, 1988). 
Both mutations had little effect on catalysis per se and thus 
cannot be directly involved in phosphoryl transfer reactions 
(Parsonage et al., 1988). MgADP binding was not affected and so 
the effect appears specific for they-phosphate group of ATP 
(Parsonage et al., 1988). Another seemingly anomalous finding 
was that two Tyr residues, both highly conserved and modified by 
Nbf-Cl and 5'-FSBA respectively, when changed to Phe, had little 
or no effect on activity (Parsonage et al., 1987a). It has been 
proposed that the mutations may prevent the deformation in the 
twist of the central a-sheet of the nucleotide binding domain 
which results in conformational signal transduction (Parsonage et 
al., 1987b). Another apparent discrepancy is that the sites of 
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Figure 1.9 Postulated tertiary structure of the F1-ATPase B-
subunit 
The postulated tertiary structure of rat liver F1 a-subunit (B) 
(Gorboczi et al., 1988a) based on the structure of adenylate 
kinase (A) as determined by X-ray crystallography and NMR 
spectroscopy (Fry et al., 1985). Shaded areas in (B) represent 
homologous amino acids. 
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sites at which mutation results in inhibition of catalytic 
activity (Gorboczi et al., 1987b). 
A fifty amino acid peptide has been synthesized which 
corresponds to amino acids 141-190, and in the postulated 
structure corresponds to a strand of the B-sheet (sequence B) 
followed by the Gly-rich loop (Sequence A) (Walker et al., 1982) 
and then an a-helix (Gorboczi et al., 1987b). The peptide 
complexes with ATP and precipitates. It also induces a seven-
fold increase in fluorescence of TNP-ATP similar to the intact 
enzyme (Grubmeyer and Penefsky, 1981a). 
Another well characterized enzyme with a nucleotide site 
similar to that in adenylate kinase is the elongation factor (EF-
Tu) from E.coli (Jurnak, 1985; la Couret al., 1985). The 
guanine nucleotide binds to a region composed of a B-sheet with 
flanking a-helices. The phosphates are located at the end of an 
a-helix joined by a Gly-rich flexible loop which is highly 
conserved between species and which have the consensus sequences 
A of Walker et al. (1982) (la Couret al., 1985). 
The A consensus sequence (Walker et al., 1982) has also been 
identified in the ras oncogenes encoding the p21 transforming 
proteins of Harvey and Kirsten murine sarcoma virus (Dhar et al., 
1982; Tsushida et al., 1982; Gay and Walker, 1983). This 
homology has been further extended to a number of other oncogene 
products (Kamps et al., 1984; Gibbs et al., 1984; Sternberg and 
Taylor, 1984), and a model has been postulated for the GDP 
binding domain of p21 based on that of EF-Tu (Fig.1.10) 
(McCormick et al., 1985). 
A large number of other nucleotide binding proteins have 
been identified as containing the A consensus sequence (Moller 
and Amons, 1985; Argos and Leberman, 1985; Husain et al., 1986) 
Doolittle et al., 1986; Higgins et al., 1986; Starzyk et al., 
1987). A note of caution has, however, been sounded as some 
proteins, which are obviously unrelated or do not bind 
nucleotides, have this sequence (Argos and Leberman, 1985; 
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Figure 1.10 Postulated tertiary structures of EF-Tu and p21 
A stylized schematic of the tertiary structure of the GDP-binding 
domain of EF-Tu-GDP determined by X-ray crystallography (top 
left) (Jurnak, 1985) is compared to a model for the tertiary 
structure of p21 (top right) (McCormick et al., 1985) in which 
the broken lines represent regions of sequence 
Schematic representations of the GDP binding sites of 





1 .2 NUCLEOTIDE PROBES OF ACTIVE SITE STRUCTURE 
In general, two different types of reagent have been used to 
obtain specific labeling of proteins, namely group-direc~ed 
reagents and affinity labels. The group-directed reagents are 
directed at particular amino acid side chains although the 
si t uation is often complicated by cross-reactivity with other 
residues (Cohen, 1968). The majority of protein modifications 
depend either on the nucleophilicity of substituents or on their 
ab i lity to undergo oxidation (Cohen, 1968). Affinity labeling 
is differentiated from group-directed labeling by the fact that 
the specificity of labeling is obtained by the properties of the 
reagent which cause it to bind preferentially to the active site. 
This results in an increase in local concentration thereby 
favoring covalent bond formation at the active site as opposed to 
the rest of the protein (Wofsy et al., 1962; Singer, 1967). 
Photoaffinity labeling is a class of affinity labeling where the 
active-site directed probe is inert until activated by light into 
a highly reactive species. Numerous reviews are available on 
the topic of affinity labeling (Wofsy et al., 1962; Singer, 
1967; Jakoby and Wilchek, 1977; Benisek et al., 1982; Plapp, 
1982; Colman, 1983; Vignais and Lunardi, 1985). In addition 
to the above, there are a number of reviews that deal 
specifically with photoaffinity labeling (Knowles, 1972; Bayley 
and Knowles, 1977; Chowdhry and Westheimer, 1979; Czarnecki et 
al . , 1979; Guillory, 1979; Bayley, 1979; Potter and Hayley, 
1983). What follows below is an outline of some of the more 
important affinity and photoaffinity analogs that have been used 
to specifically modify nucleotide binding sites. 
1.2.1 AFFINITY LABELING 
1.2 . 1.1. Fluorescein 5'-isothiocyanate 
Fluorescein 5'-isothiocyanate (FITC) has been extensively 
used to covalently modify P-type ATPases. The reagent reacts 
with unprotonated primary amino groups and appears to behave as 
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an affinity analog of ATP by binding specifically to nucleotide 
sites (Pick, 1981b). 
The interaction of FITC with SR vesicles has been well 
characterized (Pick and Karlish, 1980; Pick, 1981a, b; Pick and 
Bassilian, 1981). The probe binds specifically and with high 
affinity to the ca2+_ATPase where it undergoes covalent 
attachment to a lysine residue not essential for activity. 
Covalent incorporation of the probe, however, inhibits activity, 
with 100 % inactivation extrapolating to about 7 nmol/mg protein 
or 1 mol/mol ATPase (Andersen et al., 1982). The site of 
labeling has been localized to the 45 kDa B fragment postulated 
to contain the ATP binding site (Pick and Karlish, 1980). Lys-
515 has been identified as the amino acid labeled in fast twitch 
fibers (Mitchinson et al., 1982; Brandl et al., 1986). The 
incorporation is specifically inhibited by ATP and ADP and 
results in the inhibition of ATP dependent activity of the pump 
(Pick and Bassilian, 1981). Phosphorylation of the enzyme by 
Pi, however, is unaffected, as is AcP induced ca2+ uptake (Pick 
and Bassilian, 1981). Quenching of the fluorescein fluorescence 
observed upon binding of ca2+ is thought to report a 
conformational change (Pick, 1981a). 
Extensive sequence homology around the site of labeling of a 
number of P-type ATPases with FITC is observed (Fig.1.11) 
especially between different species with the same ion 
specificity. 
1 .2.1 .2. 5'-p-fluorosulfonylbenzoyl adenosine 
Another affinity label which has been extensively used in 
identifying nucleotide site residues is 5'-p-
fluorosulfonylbenzoyl adenosine (5'-FSBA) (Pal et al., 1975). 
The molecule is arranged in an extended conformation with the 
reactive sulfonyl fluoride moeity postulated to be located in an 
analogous position to they-phosphate of ATP or to the 5'-
position of the ribose moeity adjacent to the nicotinamide group 
of NAD (Wyatt and Colman, 1977). The sulfonyl fluoride group is 
a reactive electrophilic reagent that can react covalently with 
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* Ca-ATPase Crabb it) (slow) MFVKGAPEGVIORCTHIRV (a ) 
Ca-ATPase Crabb it) (fast) MFVKGAPEGVIORCNYVRV Cb ) 
Ca-A fPase Crabb it) (skeletal) MFVKGAPEGVIOKKNYVR Cc ) 
Ca-A TPase (dog) Cske 1 eta l) MFVKGAPEGVIORKNYVR Cd) 
Ca-ATPase (lobster) (skeletal) MFVKGAPEGVLOR Ce ) 
Ca-A TPase (dog) (cardiac) MFVKGAPEGVA?GOK (f) 
Ca-ATPase (red cell membr.) MYSKGASEIILR Cg) 
Na / K-ATPase (reno 1) LLVMKGAPERILORCSSILI Ch) 
Na / K-ATPase (Helo ce 11) LLVMKGAPERILORCSSILL Ci ) 
Na / K- ATPase (Torpedo) LLVMKGAPERILORCSTILL CJ) 
Na/ K-ATPase Cray and shrimp) LLVMKGAPER Ck ) 
H/K-ATPase (rat stomach) LLVMKGAPERVLERCSSILI ( l) 
H/K-ATPase (hog gastric) VLVMKGAPEQLSIR Cm) 
H-,\ TPase CN. crassa) ITCVKGAfLFVLKTVEEDHP Cn) 
H-ATPase (yeast) VCVKGAPLSALK Co) 
k-ATPase CE. co 1 i) MIRKGSVOAIRR Cp) 
Figure 1 .11 Homology about the FITC binding domain of P-type 
ATPases 
The linear sequences around the site labeled with FITC of the 
known P-type ATPases are collected into 3 groups. The areas of 
homology are boxed. The references are · as follows: a, 
(Mitchinson et al., 1982; MacLennan et al., 1985); b, (Brandl 
et al., 1986); c, (Kirley et al., 1985); d, (Kirley et al., 
1985); e, (Mitchinson et al., 1982); f, (Kirley etal., 1985); 
g, (Filoteo et al., 1987); h, (Farley et al., 1984; Kirley et 
al., 1984; Shull et al., 1985; Ovchinnikov et al., 1986); i, 
(Kawakami et al., 1986); j, (Kawakami et al., 1985); k, (Ohta 
et al., 1985); 1, (Shull and Lingrel, 1986); m, (Farley and 
Faller, 1985); n, (Addison, 1986; Hager et al., 1986); o, 
(Serrano et al., 1986); p, (Hesse et al., 1984); q, (Solioz et 
al., 1987); r, (Walderhaug et al., 1985). 
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several amino acids including Tyr, Lys, His, Ser and Cys. A 
number of nucleotide binding enzymes have been successfully 
mod i fied with 5'-FSBA including dehydrogenases, kinases and 
ATPases (for review see Colman, 1983) . Related compounds 
include 3'-FSBA and the fluorescent derivatives 5'-p-
fl uorosulfonylbenzoyl-1,N6-ethanoadenosine (5'-FSBEA) and 5'-p-
fl uorosulfonylbenzoyl-2-aza-1,N6-ethanoadenosine. 
Early work on MF1 demonstrated specific labeling by 5'-FSBA 
with most of the incorporation occurring in the a and B subunits 
(Esch and Allison, 1978). The site of labeling was identified 
as a Tyr residue (B - Tyr-368). Labeling of the a-subunit was 
found to be nonspecific (Esch and Allison, 1979). In a later 
study it was found that while modification of Tyr-368 occurs 
rap i dly at alkaline pH, at neutral pH modification of another 
residue, B-His-427, occurs at a slower rate (Bullough and 
All i son, 1986). It was concluded that both these residues are 
loc ated in a single site to which 5'-FSBA binds. 
An enzyme which shows structural homology with F1 and has 
been specifically labeled with 5'-FSBA is the rec A protein from 
E.coli. The attachment · of 5'-FSBA was found to occur at a 
single site, Tyr-364 (Knight and McEntee, 1985b). This site was 
identical to that labeled by 8N3ATP, a surprising result 
considering the relative positions of the reactive groups (Knight 
and McEntee, 1985b). The authors postulated that the enzyme 
must bind 8N3ATP in the strictly unfavorable anti conformation in 
order to position the azido group in a similar place to the 
sulfonyl fluoride group (Knight and McEntee, 1985c). 
5'-FSBA has also been successfully used to label the (Na+ + 
K+) - ATPase following an initial report that this enzyme is slowly 
inactivated by incubation with millimolar concentrations of 5'-
FSBA over an extended period in an ATP protectable way (Cooper 
and Winter, 1980). More recently, two specifically labeled 
peptides have been purified from the 5'-FSBA modified dog 
enzyme (Ohta et al., 1986). Both peptides are 
conserved across species while the homology of one 






homology of a number of ATPases in the region of this latter site 
of l abeling is shown in Fig.1 .12. 
1.2 . 1 . 3. Pyridoxal-phosphate and adenosine polyphosphopyridoxal 
Since the discovery that pyridoxal 5'-phosphate (PLP) is an 
inhi bitor of several enzymes, besides acting as a cofactor for 
others, it has been widely used as a group-directed reagent with 
particular affinity for sugar-phosphate binding sites (McKinley-
McKee and Morris, 1972; Murphy, 1977; Minchiotti et al., 1981; 
Koga and Cross, 1982; Tagaya and Fukui, 1986). The pyridoxal 
group is specific for the £-amino group of lysine with which it 
forms a reversible Schiff base, and is conveniently monitored by 
it ' s absorbance peak at 440 nm. Reduction of the Schiff base by 
borohydride results in the formation of a stable covalent bond. 
Extension -of the usefulness of the pyridoxal moeity resulted from 
the synthesis of the adenosine polyphosphopyridoxals in which the 
pyridoxal group is attached to the terminal phosphate of AMP, 
ADP, ATP or adenosine 5'-tetraphosphate (AP-PL, AP2-PL, AP3-PL, 
and AP4-PL, respectively) (Tamura et al., 1986; Tagaya and 
Fukui, 1986). 
PLP has been shown to inactivate a number of enzymes by 
reaction at an active site (substrate protectable) Lys residue. 
Some specificity is probably conferred on the probe by the 
phosphate group (McKinley-McKee and Morris, 1972) and, in 
addition, active site residues are often either more reactive or 
occur in an environment more favorable for reaction to occur. A 
number of residues in addition to the substrate protectable Lys 
are usually modified under conditions leading to extensive 
inactivation of the enzyme (McKinley-McKee and Morris, 1972; 
Koga and Cross, 1982; Tagaya and Fukui, 1986). The SR ca2+_ 
ATPase, however, is specifically labeled on the A1 tryptic 
fragment with PLP, at low concentrations of PLP, resulting in up 
to 40% inactivation of the enzyme (Murphy, 1977). Further 
modification was found to result in deviation from the line 
extrapolating to modification of 1 residue. The site of 
labeling, however, remains to be identified. A similar sort of 
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Ca-ATPase (rabbit) (slow) 
Ca-ATPase (rabbit) (fast) 
FOEITAMTGOGVOOAPALKKAEIGIAMGSG (1) 
YOEITAMTGOGVNOAPALKKAEIGIAMGSG (2) 
Na/K-ATPase (sheep kidney) QGAIVAVTGOGVNOSPALKKAOIGVAMGIA (3) 
Na/K-ATPase (yeast) 
H/K-ATPase (rat stomach) 




EGRLVAMTGOGTNOAPALA AOVAVAMNSG (6) 
QGKKVIMVGOGINOAPSLARATIGMAIGAG (7) 
Figure 1.12 Homology amongst P-type ATPases around the site of 
labeling of the (Na!:+ K±.)-ATPase with 5'-FSBA 
The linear sequences of a number of ATPases are aligned against 
the region of the (Na++ K+)-ATPase labeled with S'-FSBA (Site 
II) (Ohta et al., 1986). The postulated site of labeling is 
marked (*). The references are as follows: a, (MacLennan et 
al., 1985); b, (Brandl et al., 1986); c, (Shull et al., 1985); 
d, (Serrano et al., 1986); e, (Shull and Lingrel, 1986); f, 
(Hesse et al., 1984); g, (Solioz et al., 1987). 
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specificity was seen for rabbit muscle pyruvate kinase (Johnson 
and Deal, 1970). Specific modification also appears to have 
been obtained in 6-phosphogluconate dehydrogenase where 2 
residues were modified and sequenced out of a number of possible 
sites (Minchiotti et al., 1981). In view of it's low 
specificity, however, it does appear that PLP will be of limited 
use in the identification of amino acids making up the nucleotide 
binding site (Koga and Cross, 1982). 
Possible improvement of the nucleotide site 
properties of PLP may be obtained by coupling the 
adenosine, AMP, ADP or ATP (Tamura et al., 1986; 







for a number of dehydrogenases and kinases. It was, however, 
found that modification of MF1 with AP2-PL gave a similar result 
to PLP i.e. Full inactivation extrapolated to a value of 10 
mol/mol enzyme (Tamura et al., 1986). A similar result was 
obtained for EF1 labeling with AP2-PL (Noumi et al., 1987). 
AP3-PL and AP4-PL, however, were found to specifically modify EF1 
to the extent of about 1 mol/mol enzyme (Noumi et al., 1987), 
resulting in complete inhibition of ATP hydrolysis. The 
modification obtained was completely reversed by ATP and resulted 
in a two thirds modification of the a subunit and the rest on the 
B subunit (Noumi et al., 1987). Contrary to the finding above, 
Rao et al. (1988) obtained specific labeling of isolated EF1 a-
subunit with AP2-PL and identified the site of labeling as Lys-
201 . This residue is located in a region predicted to form part 
of a nucleotide binding fold based on secondary structure 
predictions and sequence homology with nucleotide binding domains 
in proteins of known structure (Maggio et al., 1987), and is 
strongly conserved in twelve species for which the a-subunit 
structure is known (Rao et al., 1988). Lys-201 occurs at the 
COOH terminal end of a-strand number 2 of the nucleotide binding 
domain, which is postulated to be the approximate position of the 
y-phosphate group of ATP. 
Specific labeling of adenylate kinase was obtained with AP2-
PL, with incorporation of 1.0 mol reagent/mol enzyme 
extrapolating to 100% inactivation (Tagaya et al., 1987). 
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Protection from labeling was afforded by ADP, ATP and MgATP, but 
not AMP, identifying the metal-ATP site as the site of 
modification. Lys-21 was identified as the exclusive site of 
labeling (Tagaya et al., 1987). The site of labeling here is 
more consistent with the positioning of the nucleotide site 
postulated by Pai et al. (1977) based on crystallographic 
measurements of the substrate soaked enzyme. A more recent 
postulate based on NMR data of the interaction between B, y-
bidentate CrATP and the enzyme (Fry et al., 1985) position the 
nucleotide away from the side chain of Lys-21 (Tagaya et al., 
1987). As pointed out by Tagaya et al. (1987), however, the 
position of Lys-21 at the end of a flexible glycine rich region, 
may bring it into contact with substrate following a 
conformational change on ATP binding. In addition, it was noted 
that there is, as yet, no direct evidence supporting the 
positioning of the 4-formyl group of adenosine 
polyphosphopyridoxal exactly as for the y-phosphate group of 
ATP, although a number of observations support this conclusion 
(Tagaya et al., 1987). The Lys residue in the ras oncogene 
product, P21, analogous to Lys-21 in adenylate kinase has also 
been labeled with GP3-PL (guanosine triphosphopyridoxal) (Ohmi et 
al., unpublished observations). 
The glycine rich region containing Lys-21 at the end is a 
highly conserved region found in a number of ATP binding proteins 
and is referred to as sequence A (Walker et al., 1982). The 
homologo~s region in F1 a-subunit is Lys-175, although Lys-201 is 
the residue labeled with AP2-PL (see above) (Rao et al., 1988). 
So this probe is positioned in a way that makes the labeling of 
Lys-201 more likely than Lys-175. The residue in the B subunit 
equivalent to Lys-21 is Arg-182. This probably explains the 
lack of labeling of the F1 a-subunit with AP2-PL (Tamura et al., 
1986; Noumi et al., 1987). 
Specific modification of the SR ca2+_ATPase was obtained 
with AP3-PL; with 100% inactivation extrapolating to 1 mol/mol 
of incorporated AP3-PL (6.7 nmol/mg of SR protein), and protected 
by ATP and ADP (Yamamoto et al., 1988). A single labeled 
peptide was purified and the site of labeling identified as Lys-
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684 . This residue is located on the B tryptic fragment and is 
clearly different from the Lys residue labeled by Murphy (1977) 
wi th PLP which most probably represents another Lys in the active 
si t e or a uniquely reactive residue. There is no homologue of 
the conserved sequence A described above in the ca2+_ATPase and 
the amino acid sequence around the AP3-PL binding site is quite 
di f ferent from that described for adenylate kinase (Tagaya et 
al ., 1987). Similar regions were found in other P-type ATPases, 
however, as well as in myosin heavy chain (Fig. 1 .13). In the 
(Na+ + K+)-ATPase the FSBA binding region abutts directly on the 
region homologous to the AP3-PL binding region in the ca2+_ 
ATPase . This region has it's homologue in the ca2+_ATPase as 
we l l. 
In summary, PLP shows the characteristics of a classical 
group-directed reagent although some specificity is conferred on 
the molecule by the phosphate group. Conversion of the compound 
into an affinity label by attachment of adenosine makes the 
compound potentially more specific and hence more useful . The 
use of the affinity label in mapping studies is also evident, and 
the usefulness of t .his approach even as an adjunct to 
crystallographic information is shown in the work on adenylate 
kinase . Similarly, although crystallographic data indicates 
that no Lys residue is present in the active site of hexokinase 
(Shoham and Steitz, 1980), specific labeling was obtained with 
AP2-PL (Tamura et al., 1986) indicating that a conformational 
change must occur on nucleotide binding bringing a Lys residue 
into the active site. 
1.2.2. Photoaffinity Labeling 
Photoaffinity labeling as a subset of the general affinity 
labeling technique is differentiated by the characteristic that 
the label is inert until activated by light at which stage a 
reactive radical is generated which can undergo covalent 
incorporation. In general, photoactivated radicals are highly 
reactive, the advantage being that the more reactive is the 
reagent, generally the less selective it is and the wider the 
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X 
Ca-ATPase Crabb it) 674 - CCFARVEPSHKSKIVE - 689 
Na/K-ATPase (sheep) 681 - IVFARTSPQQKLIIVE - 696 
H/K-ATPase (rat) 697 - MVFARTSPQQKLVIVE - 712 
H-ATPase CN. crassa) 605 - OGFAEVFPQHKYRVVE - 620 
K-ATPasEa CE. co Ii) 489 - DFLAEATPEAKLALIR - 504 
myosin HC (rat) 395 - LLKALKYPRVKVGNEY - 410 
Figure 1.13 Homology of a number of P type ATPases about the site 
of labeling of the Ca.!1:-ATPase with APJ-PL 
The amino acid sequences of a number of P-type ATPases homologous 
to the region in the ca2+_ATPase labeled with APJ-PL are compared 
as demonstrated by Yamamoto et al. (1988) 
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spectrum of amino acid residues with which it can react (Singer, 
1967). 
The photoaffinity labeling technique has some particular 
advantages over classical affinity labeling (Benisek et al., 
1982). Thus temporal decoupling of the covalent reaction step 
from the noncovalent binding step allows the experimenter to wait 
until the system has attained a particular state before allowing 
labeling to occur (Benisek et al., 1982). Another advantage 
over the kcat and classical affinity probes is the relatively 
broad reactivity spectrum of the photogenerated carbenes, 
nitrenes and ketone excited states towards hydrocarbon and 
nucleophilic groups. Nitrenes and ketones are generally 
reactive towards nucleophilic groups (Benisek et al., 1982). 
The other advantage is the relatively short lifetimes in solution 
of some photogenerated reactive species. This helps to minimize 
nonspecific labeling as reagents in solution are usually not in 
close contact with the protein, making covalent bond formation 
less likely. 
The only chemical species potentially capable of insertion 
into C-H bonds are carbenes and nitrenes (Fleet et al., 1969), 
both of which were the active components of the two earliest 
reports on photoaffinity labeling (Singh et al., 1962; Fleet et 
al., 1969). While aliphatic diazo or azide compounds are highly 
reactive chemically and also tend to undergo rearrangement to 
ketenes on photolysis, arylazides are optimally suited to 
photoaffinity labeling (Fleet et al, 1969). 
The first photoaffinity analog of ATP to be synthesized was 
8N3ATP (Haley and Hoffman, 1974) and it was used to label red 
cell membranes, while 8N3ADP was used to label the adenine 
nucleotide translocator (Schafer et al., 1976). 
1 .2.2.1. 8-AZIDO-NUCLEOTIDES 
The first enzyme for which extensive use was made of 8N3ATP 
was the F1-ATPase. 8N3ATP was found to be a substrate for MF1 
and, following illumination, was specifically incorporated into 
the B subunit to the extent of 2 mol/mol ATPase, completely 
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inhibiting activity (Wagenvoord et al., 1977). A similar result 
was reported for EF1 with 8N3ATP except that> 90% inactivation, 
in this case, extrapolated to 1 mol/mol ATPase and the labeling 
was located mainly on the a subunit (Verheijen et al., 1978). 
8N3ADP was found to label about equally the a and B subunits of 
MF1 in the absence of Mg2+, and mainly the a subunit in the 
presence of Mg2+ (Wagenvoord et al., 1979). Again, 
extrapolation to 100% inactivation corresponded to 2 mol/mol 
ATPase, and incorporation was found to have no effect on the 
levels of tightly bound nucleotides (Wagenvoord et al., 1979). 
8N3ADP was found to behave in a similar way with CF1 (Wagenvoord 
et al., 1981). Finally, it was found that if MF1 was irradiated 
with 8N3ATP in the absence of Mg2+, followed by 8N3ADP in the 
presence of Mg2+, 4 mol/mol ATPase were labeled and 2 mol/mol 
tightly bound nucleotides remained (Wagenvoord et al., 1980). 
This was one of the earliest demonstrations of 6 nucleotide sites 
on intact F1. The site of labeling of 8N3ATP on the B subunit 
has been localized to two regions, residues 1-12, a site which is 
not essential for catalysis, and the residues Lys-301, Ile-304, 
and Tyr-311 (Runswick and Walker, 1983; Hollemans et al., 1983). 
8N3ATP has also been used to label the rec A protein from 
E.coli (Knight and McEntee, 1985a, c), with a reported efficiency 
of between 10 and 70% (Kowalczykowski, 1986). In this case, the 
enzyme was specifically labeled with 8N3ATP and the site of 
labeling localized to the peptide spanning residues 257-280, but 
sequencing was prevented at this stage by the presence of a 
cyclized N-terminal Gln residue (Knight and McEntee, 1985a). 
After further digestion, the site was identified as Tyr-264 
(Knight and McEntee, 1985c), the same residue that is labeled 
with 5'-FSBA (Knight and McEntee, 1985b). This resulted in the 
conclusion that 8N3ATP must be bound in the sterically 
unfavorable anti conformation in order that the azido group is 
located in a similar position to that expected for the reactive 
end of 5'-FSBA (Knight and· McEntee, 1985c). Attempts to label 
the ca2+_ATPase specifically at the active site have been largely 
unsuccessful and are discussed below. 
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1 . 2.2.2. Arylazido modified nucleotides 
A family of photoaffinity analogs in which an N-4-azido-2-
nitrophenyl group is attached to the 3'-0H group of the 
nucleotide ribose moeity by aliphatic chains of varying lengths 
have been described (Jeng and Guillory, 1975; Guillory and Jeng, 
1977). Arylazido-8-alanine ATP (NAP3-ATP) was found to be 
hydrolyzed by myosin subfragment 1 (SF1) analogously to ATP and 
along with arylazido-4-aminobutyric ATP (NAP4-ATP) and arylazido-
6-aminocaproic ATP (NAPG-ATP) was specifically photoincorporated 
into SF1 (Guillory and Jeng, 1977). 
NAP3-ATP and NAP4-ATP were also found to be substrates for 
MF1-ATPase and to be specifically incorporated into the a and a 
subunits (Guillory and Jeng, 1977; Lunardi et al., 1977; Cosson 
and Guillory, 1979). In addition, both NAP3-ADP and NAP4-ADP 
were found to be competitive inhibitors of MF1 and to be 
specifically incorporated into both a and 8 subunits (Russell et 
al ., 1976; Lunardi et al., 1977; Weber et al., 1985). A non 
hydrolysable analog, NAP4-AMP-PNP has also been specifically 
incorporated into both a and 8 subunits at high concentrations 
and primarily into the a subunit at low concentrations (Lunardi 
and Vignais, 1982). Schafer et al. (1983) have synthesized a 
cross-linking reagent, NAP3-8N3ADP, and obtained specific cross-
linking of both a and 8 subunits. An analogous compound, 3'-o-
(5-azidonaphthoyl]-ADP has been synthesized and covalently 
incorpor~ted into the a and 8 subunits of MF1 (Lubben et al., 
1984). NAP4-ADP has been found to be a competitive inhibitor of 
ADP phosphorylation by CF1-ATPase although it does not act itself 
as a substrate (Schafer et al., 1978a). NAP4-ATP acts as a 
substrate and NAP4-ADP as an inhibitor of bacterial F1 and both 
are incorporated into a and a subunits at high concentrations of 
probe and into the a mainly, at lower concentrations (Lunardi et 
al ., 1981). A similar result was obtained with two analogs with 
shorter linking chains Lunardi et al., 1981) 
NAP3-ATP has also been found to be a substrate for the (Na+ 
+ K+)-ATPase and a competitive inhibitor of ATP hydrolysis 
(Rempeters and Schaner, 1981; Munson, 1981). In addition the 
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chromium (III) coordination complex of NAP3-ATP has been 
synthesized and found to be a nonhydrolysable competitive 
inhibitor of the (Na++ K+)-ATPase (Munson, 1981). Following 
incorporation of the tritiated isotope of CrNAP3-ATP, three 
labeled peptides were identified (Munson, 1983). NAP3-ATP has 
also been used in the ca2+_ATPase and is dealt with below 
(Carvalho-Alves et al., 1985; Oliveira et al., 1988). 
1 . 2 • 2 . 3 • 3' (2' )-o-(4-Benzoyl)benzoyl ATP 
3' (2' )-o-(4-Benzoyl)benzoyl ATP (Bz2ATP) is a photoaffiniy 
nucleotide analog that has been used in a number of ATP binding 
enzymes (Williams and Coleman, 1982; Bar-Zvi et al., 1983; 
Mahmood and Yount, 1984; Tran and Farley, 1986). The probe 
contains a photoreactive benzophenone group attached either to 
the 3' or 2 1 -0H groups of the nucleotide ribose moeity in an 
approximate ratio of 60:40, respectively (Mahmood et al, 1987). 
This group is an a,B unsaturated ketone capable of being excited 
to a highly reactive di-radical triplet state intermediate by low 
intensity, long wavelength UV irradiation (Williams and Coleman, 
1982). Radical oxygen then abstracts a hydrogen atom from 
nearby methylene residues present in the protein resulting in a 
transient caged radical pair which quickly degenerates to form a 
C-C covalent bond (Williams and Coleman, 1982; Kambouris and 
Hammes, 1985). The advantages of this probe compared to nitrene 
evolving species are that it is unreactive towards H20 and that 
the carbon-carbon bond formed is more stable than covalent bonds 
involving nitrogen (Bayley and Knowles, 1977). Another 
advantage is that the covalent bond formation is a fairly 
nonspecific process allowing labeling of a wide range of sites 
(Williams and Coleman, 1982). The disadvantages with this probe 
are the instability of the benzophenone nucleotide ester bond 
(Adman and Hammes, 1987) and the location of the reactive part of 
the molecule may not be conducive for mapping studies. 
Bz2-ATP was found to be a good substrate for the MF1-ATPase 
and was covalently incorporated into both a and B subunits 
(Williams and Coleman, 1982). Bz2-ADP was found to be a strong 
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competitor of ADP and ATP in CF1 although it did not act itself 
as a substrate for photophosphorylation (Bar-Zvi et al, 1983; 
Kambouris and Hammes, 1985). Photoincorporation of Bz2-ATP into 
the tight ADP site resulted in mainly B subunit labeling while 
labeling the tight ADP site resulted in only B subunit labeling, 
and the labeling of a third site resulted in approximately equal 
labeling of a and B (Bar-Zvi et al., 1983; Kambouris and Hammes, 
1985; Admen and Hammes, 1987). The efficiency of incorporation 
into the tight site following removal of free nucleotide was 
found to be 70% and there was an indication that a subunit 
labeling may be nonspecific (Bar-Zvi and Shavit, 1984; Admen and 
Hammes, 1987). Two labeled peptides were isolated following 
photoincorporation of Bz2-ATP into CF1 corresponding to residues 
360-378 and 393-397 (Admen and Hammes, 1987). In the former, 
specific labeling of two residues, Tyr-362 and Asp-369 was 
obtained; this peptide is highly conserved in a number of F1-
ATPases and probably forms part of the nucleotide binding site. 
The latter peptide contained low levels of radioactivity in all 
residues and may be artifactual. Tyr-362 in beef heart MF1-
ATPase is the residue labeled with 5'-FSBA (Bullough and Allison, 
1986). 
Bz2ATP is also hydrolyzed analogously to ATP by myosin 
subfragment 1 (SF1) and the product, Bz2ADP, has a single site on 
SF1 (Mahmood and Yount, 1984). Incubation of SF1 with Bz2ATP 
results in photoincorporation into the 20, 23, and 50 kDa 
peptides but only that in the 50 kDa is specific (Mahmood and 
Yount, 1984; Mahmood et al., 1987). In order to get specific 
labeling only it is necessary to trap the Bz2ATP at the active 
site with a thiol cross-linker and remove all the free probe 
before irradiation (Mahmood and Yount, 1984). Two fluorescent 
derivatives, 2'-deoxy-3'-o-(4-benzoylbenzoyl)- and 3' (2' )-o-(4-
Benzoylbenzoyl)-1,N6-ethanoadenosine 5'-diphosphate have also 
been synthesized and behave in a similar way to Bz2ADP in SF1 
(Creme and Yount, 1987). 
The interaction of Bz2ATP with a number of P-type ATPases 
has been reported (Tran and Farley, 1986). It was found that 
incorporation was not prevented by ATP, but . was substantially 
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reduced by prior labeling with FITC. Bz2ATP did, however, 
inhibit high affinity ATP binding. A number of labeled peptides 
were obtained, none of which was protected either by ATP or FITC. 
The authors concluded that the labeling is nonspecific. It has 
also been reported that specific incorporation of Bz2ATP occurs 
into the ca2+_ATPase to the extent of 1 .3 nmol/mg of SR protein 
and that most of the labeling occurs on the A tryptic fragment 
with some labeling of the B fragment and proteolipid (Cable and 
Briggs, 1984). This labeling, however, was not completely 
inhibited by ATP and may be explained by labeling outside the 
active site (Tran and Farley, 1986). 
1 .2.2.4. 2-azido-nucleotides 
2-azido-adenosine (Schaeffer and Thomas, 1958), as well as 
it's mono-, di-, and triphosphate derivatives, has been used in a 
number of systems. They have been shown to act as ADP and AMP 
analogs in binding to the outer membrane of human platelets and 
inducing aggregation (Cusack and Born, 1976, 1977; MacFarlane et 
al, 1982), and were also shown to irreversibly photoinactivate 
adenosine deaminase (Cusack and Born, 1976). 2N3AMP was also 
used to spec{fically label the AMP allosteric site on pig kidney 
fructose 1,6-bisphosphatase (Riquelme and Czarnecki, 1983). 2-
azido-adenosine nucleotides have also been reported to be 
substrates for pyruvate kinase, phosphofructokinase, adenylate 
kinase and hexokinase (Czarnecki, 1984). In these cases the 
binding appeared to be related to whether the nucleotide at the 
active site is bound in an anti (Ohta et al, 1980) or syn 
(Danenberg and Cleland, 1975) conformation. 2N3AMP was found to 
not act as a substrate for adenylate kinase (Czarnecki, 1984) 
probably as a result of a strict site specificity rather than a 
nucleotide conformation specificity as 8-Br-AMP is also not a 
substrate (Lascu et al, 1979). The main area of use, however, 
has been in the F1 H+-ATPases (Czarneki et al, 1982; Dalbon et 
al, 1985; Wise et al, 1987). 
An advantage obtained with 2-azido-nucleotides stems from 




N- glycosidic linkage (Czarnecki 
1984) similar to the natural adenine 
et al, 1982; 
nucleotides in 
solution (Ikehara et al, 1972a,b; Davies and Danyluk, 1974). 
Nucleotides with a bulky substituent in the 8 position tend to 
adopt a syn conformation as a result of unfavorable steric and 
electrostatic interactions between the bulky group and the 
ribofuranose - phosphate system (Ikehara, et al 1972a, b) which, 
in turn, affects the sugar - phosphate conformation (Fig. 1 .14) 
(Sarma et al, 1974). Both the unsubstituted and 8 - substituted 
nucleotides adopt the g'g' (gauche' - gauche') conformation (0) 
about the C(5') - 0(5') bond. The conformation about the C(4') 
C(5') bond, however, is affected by glycosyl torsion. Thus 
the preferred conformation in unsubstituted purine nucleotides is 
anti - g/g (Davies and Danyluk, 1974), while in 8 substituted 
derivatives the onset of syn orientation is followed by rotation 
of C(4') ~ C(5') into the g/t conformations (Sarma et al, 1974). 
The ribose moeity of 5'-B-purine nucleotides (whether anti g/g or 
syn g/t) exists as an equilibrium of Sand N conformations with 
the anti g/g showing a slight bias towards the S conformer (Sarma 
et al, 1974). The conformations of the 8 substituted 
nucleotides, moreover, are sensitive to the degree of protonation 
of the phosphate group and the base N(1). Thus as the pH of the 
solution is decreased and the monophosphate dianion is converted 
into a monoanion bearing a protonated N(1) there is an increase 
of about 15 - 20% in the gg population possibly as a result of a 
reduction in repulsive electrostatic interactions (Sarma et al, 
1972). It does appear, however, that 8 substituted 
nucleotides can be constrained into an anti conformation upon 
binding to enzymes (Stolarski et al, 1984). 
One potential disadvantage with the 2-azido derivatives, 
however, is their tendency to isomerize in solution to the light 
insensitive tetrazole forms (MacFarlane et al, 1982). Purines 
substituted with azides in the 2 and 6 positions isomerize to 
form tetrazole tautomers (Temple et al, 1966a, b) and their 
potential as phototaffinity analogs appears to be limited by the 
predominance of the tetrazole tautomer (Wiegand and Kaleja, 
1976). Conditions have, however, been described in which the 
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Figure 1.14 Conformations of 2- and a-substituted nucleotides 
Schematic representations of the conformations of nucleotides and 
their 2- and a-substituted derivitives (Ikehara et al., 1972a,b; 
Sarma et al., 1974; Davies and Danyluk, 1974). The 
con formation about the N-glycosidic bond is shown illustrating 
the syn and anti conformations. 
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nucleotide is present predominantly in the azido form at least 
for the time required to carry out the photoaffinity labeling 
process (Czarnecki, 1984; Melese et al, 1988). Thus when a 
methanolic solution of the 2-azido-nucleotide is added to the 
reaction mixture the predominant species present is the azido 
form which then undergoes a pH and temperature dependent 
tautomerism (Czarnecki, 1984). At neutral pH solution 
approximately 55% of the analog exists in the tetrazole isomer 
while the azido form is favored at acid pH (Czarnecki, 1984). 
It has been found, however, that the tetraz.ole form also binds 
tightly to MF1 and CF1-ATPase and when bound equilibrates to the 
az i do form with a to.5 at 25 °c of about 41 min (Boulay et al, 
1985; Melese et al, 1988). Thus exposure for 50 min resulted 
in almost complete photoincorporation of the available probe 
(Melese et al, 1988) . 
. Both 2N3ATP and 2N3ADP have been used extensively in studies 
into the nature of the nucleotide sites on the F1-ATPases from 
mitochondria (MF1) and chloroplasts (CF1) and recently a report 
has appeared on E.Coli F1 (EF1), 2N3ADP was initially used to 
study the tight binding of nucleotides to thylakoid membranes 
(Czarnecki et al, 1982; van Dongen et al, 1986) on account of 
the strict specificity these sites exhibit towards their 
nucleotide substrates evidenced by the failure of 8-azido-
nucleotides to displace tightly bound nucleotides (Schafer et al, 
1978a; Wagenvoord et al, 1980, 1981). It was found, however, 
that 2N3ADP inhibits tight binding of ADP and, in addition, binds 
itself to membrane bound CF1 with half maximal binding occurring 
at about 1 µM 2N3ADP which is inhibited by the presence of ADP 
(Czarnecki et al, 1982, 1983). In addition, 2N3ADP is 
phosphorylated to 2N3ATP by membrane bound CF1 and this 2N3ATP 
binds tightly to the B subunit (Abbott et al, 1984). 2N3ADP 
could be successfully photoincorporated into CF1 and, under all 
conditions, the site of labeling was identified as the B subunit 
(Czarnecki et al, 1982,1983; Abbott et al, 1984) and the tight 
binding sites for ADP and ATP were located on identical portions 
of the B subunit polypeptide (Abbott et al, 1984). 2N3ADP has 
also been used to study nucleotide binding sites in intact and 
43 
inside out mitochondria (Dalbon et al, 1985). It was found to 
bind with high affinity to the ADP/ATP carrier but not to be 
transported across the membrane (Dalbon et al, 1985). It has 
previously been shown that the ADP/ATP carrier has a stricter 
specificity towards the adenine ring and ribose moeity of ATP and 
less so for ATPases (Vignais and Lunardi, 1985). Photoaffinity 
labeling of inside out submitochondrial particles with 2N3ADP 
resulted in specific photoincorporation into the ATP/ADP carrier 
as well as the B subunit of the F1-ATPase (Dalbon et al, 1985). 
Further evidence was obtained from the finding that 2N3ADP could 
' be phosphorylated by membrane bound CF1-ATPase (Czarnecki et al, 
1983; Abbott et al, 1984). 
2N3ATP is readily hydrolyzed by both CF1 (Melese and Boyer, 
1985) and MF1 (van Dongen et al, 1986) and from the kinetics with 
respect to MF1, it was concluded that 2N3-nucleotides are better 
substrates than their 8-azido counterparts and are similar to the 
native nucleotides (van Dongen et al, 1986). The higher Km and 
Vmax values measured for 2N3ATP compared with ATP may be due to 
the proportion of nucleotide present as the terazole form, as the 
azido isomer has been found to be a better substrate than the 
tetrazole (Czarnecki, 1984; van Dongen et al., 1986). Initial 
reports on photoincorporation of 2N3ADP/ATf into CF1 showed that 
2N3ATP could be photoincorporated into 30% of B subunits probably 
representing 1 labeled subunit/F1 and leave the enzyme quite 
active (Melese and Boyer, 1985). The enzyme, furthermore, was 
able to bind ATP tightly and then release it indicating the 
retention of catalytic cooperativity between at least two sites 
(Melese and Boyer, 1985; Czarnecki et al, 1985). 
In the mitochondrial system it was found that 3 mol/mol of 
2N3ADP could be bound to intact F1, in addition to the 3 mol/mol 
of endogenous nucleotide, confirming the number of binding site 
on MF1 (Boulay et al, 1985). Following photoincorporation of 
the bound nucleotide, a linear relationship was obtained between 
% inactivation and photoincorporation extrapolating to a value of 
2 mol/mol F1 for> 90% inactivation (Boulay et al, 1985). It 
has been suggested that this value may only be 1 if only 
catalytic sites are labeled (Kironde and Cross, 1986) and 
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extrapolation to a value of 0.92 mol label/ mol F1 at full 
inactivation has been reported (Czarnecki et al, 1985; van 
Dongen et al, 1986; Lunardi et al, 1987). In CF1, it has been 
found that with either catalytic or predominantly noncatalytic 
si te modification, activity loss approximately parallels the 
extent of modification of a single 8 subunit (Melese et al, 
1988), although some 5 - 20% of activity may remain after 
labeling under these conditions. When both catalytic and 
noncatalytic sites are labeled about equally, however, to a total 
of 1 mol/mol F1 some 40 - 50% of activity is retained (Melese et 
al , 1988). It has, however, also been reported that following 
extensive incubation, the 2N3ADP could be exchanged into the 
tight nucleotide sites and that the patterns of photolabeling 
obtained after enriching either the 'loose' or the 'tight' sites 
were different (Boulay et al, 1985). Under the former condition 
only the 8 subunit was labeled whilst under the latter both 8 
(90%) and a (10%) were labeled concluding that MF1 has three 
'loose' sites located exclusively on the 8 subunit and three 
'tight' sites located at the junction between the a and 8 
subunits (Boulay et al, 1985; van Dongen and Berden, 1987). A 
model summarizing the photoaffinity labeling data with both 
8N3AXP and 2N3AXP and MF1 and the postulated interrelationships 
between the nucleotide binding sites has been reported by van 
Dongen and Berden (1987) (Fig. 1 .15). 
2N3ADP was also used to provide the first demonstration that 
CF1 is, in fact, similar to MF1 and EF1 in having six nucleotide 
sites per functional unit (Xue et al, 1987a). It was found that 
CF1 can bind more than 3 mole nucleotide per enzyme unit, and 
specific double incorporation of 8 subunits was demonstrated (Xue 
et al, 1987a). 2N3ADP only is bound at catalytic sites while 
both 2N3ADP and 2N3ATP are bound at noncatalytic sites (Xue et 
al, 1987a). Similar to CF1 (Boulay et al, 1985), it was found 
that under conditions of catalytic and noncatalytic site labeling 






Figure 1.15 Models of the interaction of azido-nucleotides with 
the nucleotide site/s of MF1 
Two proposed models are shown for the interaction of nucleotides 
with the a-subunit of beef heart MF1. The diagram on the left 
shows the proposed folding pattern around the site of labeling 
with both 8N3ATP and 2N3ATP assuming that the 2 nucleotides bind 
in the same way and that the different regions labeled (304-311 
and 342-349, respectively) arises on account of the different 
orientation of the azido group (Garin et al., 1986). The 
diagram on the right shows the proposed sites of binding of ATP 
and of ADP (Cross et al., 1987). 
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The site of labeling with 2N3ADP has been determined for 
MF 1 , CF1 and EF1. In MF1 the site of labeling was identified as 
peptide CB9 and the following amino acids appeared to be modified 
Leu-342, Ile-344, Tyr-345 and Pro-346 (Garin et al, 1986). It 
was noted that Tyr-345 was more substantially labeled than the 
others and it was postulated that the Pro-346 labeling may be an 
artifact of carry-over from Tyr-345 labeling during the 
sequencing process (Garin et al, 1986). Cross et al (1987) have 
also identified the sites of photoincorporation both under 
conditions of catalytic and noncatalytic site labeling. In the 
case of noncatalytic site labeling Tyr-345 was also identified 
(Garin et al, 1986) while Tyr-368 was identified as the site of 
catalytic site labeling (Cross et al, 1987). They also 
concluded that either one third of the catalytic or two thirds of 
the noncatalytic sites had to be modified to obtain near complete 
inhibition of catalytic activity (Cross et al, 1987). This 
explains the results of Boulay et al (1985) where 100% 
inactivation was extrapolated to a value of 2 mole 2N3 ADP/rnol F1 
while van Dongen et al (1986) and Lunardi et al (1987) obtained a 
value of 1 mol/mol. After labeling with both 8N3ADP and 2N3ADP 
it was furthermore shown that catalytic sites in isolated F1 can 
be in a tight site (van Dongen and Berden, 1987). In addition 
to the sites identified above, another site of labeling (Gly-72 -
Arg-83) has been identified following labeling under extensive 
conditions resulting in nearly 4 mol/mol F1 (Lunardi et al, 
1987). The labeling of a subunit previously identified by this 
laboratory (Boulay et al, 1985) was still seen (Lunardi et al, 
1987) and has been confirmed in EF1 (Wise et al, 1987). The 
site of noncatalytic site labeling (Leu-342 - Pro-346) (Garin et 
al,1986) is highly conserved in E.coli F1 and maize and spinach 
chloroplast F1 (Walker et al, 1984) as well as in B subunits of 
human F1 (Ohta and Kagawa, 1986). 8N3ATP labels the sequence 
Lys-301 Tyr-311 (Hollemans et al, 1983) and it has been 
postulated that labeling by 8N3ATP occurs only via the small 
proportion of molecules present in the anti conformation as part 
of the equilibrium about the N-glycosidic bond (Garin et al, 
1986). Thus it is seen that 8N3ATP (anti conformation) binds to 
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the same site as 2N3ATP but labels a different section of the 
primary sequence (Garin et al, 1986). Tyr-368 is also labeled 
by FSBA (Esch and Allison, 1978). 
Evidence was also presented for CF1 that under conditions of 
catalytic and noncatalytic site labeling different tryptic 
peptides were labeled (Xue et al, 1987a). These studies were 
extended and the sites of catalytic and noncatalytic site 
labeling identified as Tyr-362 and Tyr-385 respectively (Xue et 
al, 1987b). Tyr-362 is also derivatized by 2' ,3'-o-(4-
benzoyl)benzoyl-ADP (Adman and Hammes, 1987). Analogously to 
MF1 (Lunardi et al, 1987) and EF1 (Wise et al, 1987) the 
possibility was raised that some of the sites could be at a/8 
subunit interfaces (Xue et al, 1987b). 
A similar situation was found for EF1 and 
labeling with 2N3ADP were identified as Tyr-354 
site) and . Tyr-331 (catalytic site) (Wise et al, 
the sites of 
(noncatalytic 
1987), with 
between 5 and 10% of the labeling located on the a subunit (Wise 
et al, 1987). Two models of protein folding in the region of 
the nucleotide binding site based on results obtained with the 
azido nucleotides are shown in Fig. 1 .15. 
In summary, the 2N3nucleotides have provided evidence that 
the catalytic nucleotides of CF1, MF1, and EF1 comprise portions 
of the polypeptide around Tyr-362, Tyr-368, and Tyr-331, 
respectively, and the noncatalytic sites around Tyr-385, Tyr-345, 
and Tyr-354, respectively, both on the B subunit. In addition 
to tyrosyl residues, Leu, Ile, and Pro residues have been 
labeled, indicating that although Tyr may be a preferred target, 
other, non-nucleophilic residues may also be targets for covalent 
reaction. The labeling of several residues in a single binding 
pocket suggests that the nucleotide is not stationary with 
respect to the protein. In addition, the residue with the 
majority of the label may not necessarily be the closest, but 
simply the most reactive of those in the vicinity of the azido 
group. The 8-azido and 2-azido derivatives provide 
complementary information on the structure of the nucleotide 
binding sites allowing a detailed map of the residues around the 
adenine ring to be constructed. 
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1 . 2 . 3 TNP-NUCLEOTIDES 
The TNP-nucleotides are not structural probes in the sense 
that they have no potential for covalent reaction, but they have 
been useful on account of their high affinity and fluorescent 
properties. They have been especially useful in distinguishing 
different types of nucleotide binding sites of the ca2+_ATPase 
(see below) and we chose them, in combination with the azido 
group, to form the basis for the synthesis of a photoaffinity 
probe specifically for the ca2+_ATPase. 
Reaction of trinitrobenzenesulfonic acid (TNBS) with the 
ribose moeity of adenosine results in the formation of the 
Meissenheimer complex 2' ,3'-o-(2,4,6-tri~itrophenyl)adenosine 
(Azegami and Iwai, 1964). The corresponding nucleotides, TNP-
ATP, TNP-ADP and TNP-AMP (Hiratsuka and Uchida, 1973) as well as 




have been utilized in a number of enzyme systems 
the myosin ATPase (Hiratsuka and Uchida, 1973), brain 
kinase (Churchich and Wu, 1981), eel electroplax and 
canine renal medulla (Na++ K+)-ATPase (Moczydlowski and Fortes, 
1981a and b; Munson, 1981), mitochondrial F1-ATPase (Grubmeyer 
and Penefsky, 1981a and b), adenosine deaminase, alkaline 
phosphatase and adenylate kinase (Hiratsuka, 1982), ca2+_ATPase 
(Dupont et al, 1982; Watanabe and Inesi, 1982), aspartokinase 
(Broglie and Takahashi, 1983), chloroplast F1-ATPase (Wagner et 
al, 1986) and DNA polymerase I (Oberfelder and McHenry, 1987). 
TNP-ATP has been found to not act as a substrate for hog cerebral 
cortex (Na+ + K+)-ATPase and firefly luciferase (Hiratsuka, 
1982), but this does not mean that these enzymes do not bind TNP-
ATP. 
The TNP group forms a Meissenheimer complex with the 2' and 
3' hydroxyl groups of the ribose moeity at alkaline pH resulting 
in a characteristic absorbance spectrum in the visible region 
(Hiratsuka and Uchida, 1973). The chromophoric properties, 
however, are dependent on pH and a progressive decrease in the 
visible absorbance spectrum occurs along with protonation of the 
2' hydroxyl group, with measured pK of 5.1 (Hiratsuka and Uchida, 
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1973). The TNP group is also fluorescent and has a single 
emission peak at 561 nm with the excitation spectrum 
corresponding roughly to the absorbance spectrum. These 
properties are largely independent of the phosphorylation status 
of the molecule, but do depend on the polarity of the 
environment. As the polarity is decreased, the absorption 
maxima are blue shifted while the fluorescence emission maxima 
are blue shifted and accompanied by an increase in quantum yield 
(Hiratsuka and Uchida, 1973). NMR and IR spectroscopic data 
have indicated an interaction between the adenine base and TNP 
group (Hiratsuka, 1975), in particular C8 of the adenine ring. 
As a result the molecule is considered to exist in free solution 
in a folded anti conformation with the adenine and TNP rings 
stacking and sharing the pi electron cloud (Hiratsuka, 1975). 
TNP-ATP is hydrolyzed by heavy meromyosin (HMM) with very 
similar Km and Vmax values to ATP (Hiratsuka and Uchida, 1973). 
Binding of the probe to the catalytic site is accompanied by a 
red shift in the absorbance spectrum postulated to be due to an 
increase in the hydrophobicity of the environment surrounding the 
TNP group. The resultant difference spectrum can be used to 
titrate the number of binding sites (Hiratsuka and Uchida, 1973). 
Similarly, the fluorescence emission peak of TNP-ATP is blue 
shifted and increased upon binding to HMM. Fluorescence 
titration of the nucleotide binding sites has revealed two 
binding sites for TNP-ATP on HMM with a Kd of 0.8 µM (Hiratsuka, 
1976). _The TNP-nucleotide bound to the active site has also 
been used as an energy transfer acceptor from N-(iodoacetyl)-N'-
(S-sulfo-1-naphthyl)ethylenediamine (1,5-IAEDANS) bound to the 
alkali I light chain (Moss and Trentham, 1983) or to the 'fast 
reacting' sulfhydryl, SH1 (Tao and Lamkin, 1981). The two TNP-
ATP molecules bound to HMM are not homogeneous as 1 mol/mol can 
be displaced by low concentrations of ATP or ammonium sulfate 
precipitation while the other molecule is stable to this 
treatment (Hiratsuka et al., 1977). The former is thought to be 
located at the initial burst site while the latter is at the 
steady state ATPase site and is thought to form a stable complex 
with an amine group (Hiratsuka et al., 1977). As regards the 
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nature of the difference spectrum, evidence has 
(Hiratsuka, 1975) that the difference spectrum 
disruption of the adenine-TNP interaction by 
been presented 
is the result of 
stacking of the 
adenine ring on an aromatic amino acid at the active site, most 
likely tryptophan. 
Although not a substrate for the (Na++ K+)-ATPase, TNP-ATP 
binds with high affinity to both eel electroplax (Moczydlowski 
and Fortes, 1981a and b) and dog renal medulla (Na++ K+)-ATPase 
(Munson, 1981 ). In the eel electroplax (Na++ K+)-ATPase, the 
increase in fluorescence seen on TNP-ATP binqing was used to 
titrate the TNP-ATP binding sites yielding a value of 1 site per 
aB protomer (Moczydlowski and Fortes, 1981a). 
shown to bind homogeneously to both catalytic 
sites and it was thus concluded that the (Na++ 
TNP-ATP was also 
and regulatory 
K+)-ATPase has 
only one site for TNP-ATP that interconverts between high and low 
affinity states during the catalytic cycle (Moczydlowski and 
Fortes, 1981b). 
Both TNP-ATP and TNP-ADP have been found to be potent 
inhibitors of the mitochondrial F1 ATPase (Grubmeyer 
Penefsky, 1981a and b; Kormer et al, 1982; 
inhibiting both ATP hydrolysis and synthesis. 
analogs was measured both by difference 
fluorescence titration yielding a value of two 












first site with an affinity too high to measure and the second 
with a Kd of 20 - 80 nM. Both these sites are equally competent 
at hydrolyzing TNP-ATP and occupancy of the second site 
accelerates hydrolysis at the first giving rise to a model of 
catalytic site cooperativity (Grubmeyer and Penefsky, 1981b). 
Alternatively, it has been shown that binding of TNP-ATP to the 
catalytic site of F1 results in a difference absorbance spectrum 
but not in an increase in fluorescence (Kormer et al, 1982), 
while binding to the tight nucleotide site results in an increase 
in fluorescence. TNP-ADP has also been found to be a potent 
inhibitor of photophosphorylation by thylakoid membranes (Wagner 
et al, 1986). Equilibrium binding measurement with [14_c]-TNP-
ADP yielded a value of about three binding sites. TNP-ADP is 
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poorly phosphorylated to TNP-ATP, but mimics the behavior of ADP 
+ Pi in stimulating basal electron transport. Both TNP-ATP and 
' 
TNP-ADP have been incorporated into E.coli F1 to the extent of 1 
mol/mol on the B subunit and 1 mol/mol on the a subunit (Rao et 
al, 1988). The fluorescence enhancement upon incorporation into 
the B subunit was about 50 - 33% of that into F1 which has been 
interpreted as due to the assembled B having a tighter and more 
hydrophobic site (Rao et al, 1988). The fluorescence upon 
binding to the a subunit was totally quenched and the binding was 
very tight (Rao et al, 1988). Recently, a fifty amino acid 
peptide has been synthesized which, on the basis of a postulated 
homology with adenylate kinase, should be located in the active 
site of the enzyme (Gorboczi et al., 1988). Further evidence 
for this hypothesis was obtained following the observation that 
the peptide induced a seven-fold increase in the fluorescence of 
added TNP-ATP, similar to intact F1-ATPase. 
TNP-ATP is also an inhibitor of ATP dependent initiation 
complex formation reaction between the E.coli DNA polymerase III 
holoenzyme and primed DNA (Oberfelder and McHenry, 1987). TNP-
ATP does not serve as a substrate for the enzyme but the fact 
that it inhibits all three identified holoenzyme reactions to a 
similar extent was used to demonstrate that all three functions 
share a common ATP binding site. TNP-ATP has also been used to 
probe the threonine promoted conformational changes in the 
aspartokinase region of aspartokinase homoserine dehydrogenase I 
(Broglie and Takahashi, 1983). TNP-ATP functions as a substrate 
for the enzyme with a similar Km to ATP but lower Vmax· Binding 
results in a nine fold increase in fluorescence while binding of 
threonine results in a further 77% increase indicating an 
increase in rigidity or hydrophobicity of the nucleotide binding 
site in the inhibited form of the enzyme (Broglie and Takahashi, 
1983). 
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1 . 2. 3. 1 TNP-NUCLEOTIDE INTERACTIONS WITH SR 
TNP-nucleotides have been used extensively in the SR system 
following initial reports (Dupont, 1982; Watanabe and Inesi, 
1982) that TNP-ATP binds specifically to the ca2+_ATPase with 
high affinity to the extent of 6-8 nmol/mg protein (1 mol/mol 
ATPase). Binding is accompanied by a shift in the visible 
absorbance spectrum as well as a blue shift and seven fold 
increase in quantum yield of the fluorescence emission spectrum. 
The most striking feature, however, is that in the presence of 
micromolar concentrations of ATP and ca2+ bound TNP-ATP undergoes 
a very large increase in fluorescence (Watanabe and Inesi, 1982). 
This led to the postulate that TNP-ATP is bound to a separate 
regulatory site following dissociation of ADP (Watanabe and 
Inesi, 1982). The increase in fluorescence was seen as a result 
of a protein conformational change resulting in an increase in 
hydrophobicity of the binding site (Dupont and Pougeois, 1983) as 
a result of H20 exclusion (Dupont and Pougeois, 1983; Nakamoto 
and Inesi, 1984). 
The large increase in fluorescence of TNP-nucleotides bound 
under turnover conditions has been correlated with 
phosphorylation of the enzyme (Bishop et al, 1984; Nakamoto and 
Inesi, 1984; Davidson and Berman, 1987). Prior labeling with 
FITC or inclusion of ADP prevents TNP-nucleotide binding 
(Nakamoto and Inesi, 1984). Kinetic studies identified two 
binding sites (Bishop et al, 1984). The first coincides with 
the catalytic site (kD = 2 - 4 µM) with a slow Koff· Following 
dissociation from this site, a second site was detected to which 
TNP-ATP binds resulting in the large fluorescence increase. 
Further characterization has shown that TNP-ATP binds 
competitively to two sites of equal concentration (3.5 nmol/mg 
protein) and that the affinity and appearance of these sites are 
modulated by the presence of Mg2+ and H+ (Dupont et al, 1985). 
Thus in the absence of Mg2+ or at acid pH the sites behave like 
one homogeneous population of intermediate affinity (ko = 20 µM). 
At pH> 7 or in the presence of Mg2+, however, they split into 
two populations of high (ko = 2 - 4 µM) and low (ko > 1 mM) 
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affinity (Dupont et al, 1985). Correlation of the high affinity 
site with the regulatory nucleotide site has been obtained 
following the finding that TNP-ATP binding to the phosphorylated 
enzyme accelerates ca2+ activated hydrolysis (Dupont et al, 
1985). 
The effects of the monovalent cations H+ and K+ on the 
turnover dependent fluorescence increase have provided insights 
into the mechanism involved (Bishop et al, 1984, 1986; Davidson 
and Berman, 1985; Wakabayashi et al, 1986). The presence of K+ 
decreases the fluorescence with a ko.5 of 48 and 135 mM in the 
absence and presence respectively of valinomycin (Davidson and 
Berman, 1985), while the absence of H+ has the same effect 
(Wakabayashi et al, 1986). These conditions have been shown to 
have no effect on the steady state E-P levels (Davidson and 
Berman, 1985) and have alternately been described to variations 
in affinity for TNP-ATP (Bishop et al, 1986) and not to 
variations in the E-P levels (Bishop et al, 1986), or rather to 
conversion from E1-P to E2-P (Wakabayashi et al, 1986). Further 
evidence for this latter conclusion has been obtained from 
results where TNP-ATP fluorescence was increased in conditions 
leading to stabilization of the ADP insensitive phosphoenzyme 
(Dupont and Pougeois, 1983; Andersen et al, 1985). It has 
furthermore been shown that uncoupling of the ca2+_ATPase results 
in a decrease in the ATP or Pi induced high fluorescence, without 
a decrease in binding (Berman, 1986). This has been postulated 
to be due to partial denaturation of the enzyme in the uncoupled 
state preventing the "synchronized conformational changes 
resulting in ordered access or restriction of H20" (Berman, 
1986). 
Direct evidence of TNP-nucleotide binding to the regulatory 
site has been obtained in a number of ways (Bishop et al, 1987). 
TNP-AMP has been shown to block secondary activation of ATPase 
activity without itself stimulating activity, and this site of 
binding has been shown to be the high fluorescence site. A 
difference in binding affinity for the dephosphorylated (ko = 20 
nM) and phosphorylated (kD = 0.4 µM) enzyme has been shown 
indicating two sites of binding (Bishop et al, 1987). Lastly, 
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it has been shown that TNP-AMP blocks the ADP dependent rapid 
burst of E-P decomposition, identifying the TNP-AMP binding site 
with the ADP site (Bishop et al, 1987). The above phenomena 
have been shown to occur in the monomeric preparation as well 
(Bishop et al, 1987). It has also been shown that TNP-ATP 
undergoes a large increase in fluorescence under turnover 
conditions in the monomeric preparation demonstrating that the 
monomer undergoes the ADP sensitive E1-P to ADP insensitive E2-P 
transition (Andersen et al, 1985). Finally, it has been found 
that low concentrations of TNP-ATP accelerate ATP turnover 
(Dupont et al., 1985) as well as E-P hydrolysis (Champeil et al., 
1988). 
Fluorescence energy transfer experiments between TNP-AMP and 
Pr3+ as energy acceptors and IAEDANS as donor have led to a model 
in which the B tryptic fragment is seen as spanning most of the 
major access of the cytoplasmic region of the enzyme while the A 
fragment is abutted to the B fragment together forming the 
nucleotide binding site (Squier et al, 1987) 
In summary, TNP-ATP has proved to be a useful probe. It 
has been used in a large number of systems where it usually binds 
with high affinity to the nucleotide binding site. The 
absorbance and fluorescence properties allow easy monitoring of 
binding and also act as reporters of nucleotide site 
characteristics. TNP-nucleotides have also been shown in a 
number of systems to differentiate between kinetically defined 
catalytic and regulatory sites. 
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1 . 3. STRUCTURE AND FUNCTION OF SR VESICLES 
Calcium is widely used in regulation in biological systems 
and it's concentration in various cellular compartments is 
strictly controlled. The intracellular calcium concentration is 
normally maintained several orders of magnitude below that in the 
extracellular fluid. This is achieved by the presence of energy 
dependent ca2+ transport proteins located in the cell membrane. 
Intracellular compartments can be used as calcium sinks and in 
specialized tissues where rapid delivery and removal of calcium 
is required these pumps are present in high concentration in the 
membrane. Such an example is skeletal muscle where the SR is 
used as a storage site for calcium which is rapidly released into 
the sarcoplasm causing myofibril contraction. To initiate 
relaxation, the calcium is then removed from the sarcoplasm by 
the ca2+_ATPase which in the process, develops a gradient of 
calcium across the SR membrane of several orders of magnitude. 
The SR is a vesicular structure surrounding the myofibrils 
and abutts directly on the T-tubules which are plasma membrane 
invaginations which transmit the wave of depolarization from the 
muscle end plate to the interior of the muscle cell (Peachey, 
1965). 
1. 3. 1. Ultrastructure of SR vesicles 
SR yesicle preparations are usually obtained by differential 
centrifugation of white skeletal muscle homogenates from the back 
and hind leg muscles of young rabbits (Eletr and Inesi, 1972). 
Further purification may be obtained by detergent extraction 
(MacLennan, 1970; Meissner et al., 1973) or by separation into 
light and heavy fractions by isopycnic density gradient 
centrifugation (Meissner, 1975; Lau et al., 1977; Volpe et al., 
1987). Light and heavy SR vesicles are derived from 
longitudinal and terminal cisternal regions of the SR 
respectively, and the differences in bouyant density reflect 
their different protein contents and protein:lipid ratios. The 
primary function of the longitudinal region is ca2+ uptake and 
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consequently the predominant protein species is the ca2+_ATPase 
(Me i ssner, 1975). The terminal cisternae are more involved with 
ca2+ storage and release and so calsequestrin and lower MW 
proteins make 
con tent (Smith 
probably located 
and Wong, 1971; 
et al., 1984). 
up a greater percentage of 
et al., 1985; Somlyo, 1985). 
the total protein 
Calsequestrin is 
exclusively in the terminal cisternae (MacLennan 
Meissner, 1975; Jorgensen et al., 1983; Saito 
' 
That part of the terminal cisterna abutting 
directly on the transverse tubule is known as the junctional SR 
and it is connected by bridging structures called ' feet' to the 
T- t ubule forming a structure called the triad (Franzini-
Armstrong, 1970). The junctional membrane is devoid of ca2+_ 
ATPase (Jorgensen et al., 1979, 1982). Detergent extraction of 
the SR vesicle preparation removes proteins loosely associated 
with the membranes (MacLennan, 1970; Meissner et al., 1973) 
Protein makes up 60 - 70% of SR vesicles with the balance 
being lipid (Bailin and Blumenkrantz, 1987). The lipid 
component is made up of about 80% phospholipid and the rest 
neutral lipid, mainly cholesterol. The phospholipids consist of 
phosphatidylcholine (65 - 73%), phosphatidylethanolamine (12 
19%), phosphatidylinositol (about 9%), phosphatidylserine (about 
2% ), sphingomyelin (about 4%) and cardiolipin (0.1 - 0.3%) (Tada 
et al . , 1978. 
The Mr 110 kDa ca2+_ATPase accounts for approximately 70 
90% of the protein component of SR vesicle preparations (Tada et 
al . , 1978). The Mr 45 - 55 kDa acidic calcium binding protein 
calsequestrin accounts for about 10 20% of the protein 
(MacLennan and Wong, 1971). The high affinity calcium binding 
protein (Mr 55 - 65 kDa) is a minor component of skeletal SR and 
together with 4 other minor proteins (Mr 20 - 38 kDa) and a 12 
kDa proteolipid makes up about 10 - 20% of the total protein 
(Bailin and Blumenkrantz, 1987). Two glycoproteins of 53 kDa 
(Chiesi and Carafoli, 1982; Leonards and Kutchai, 1985) and 160 
kDa (Campbell and MacLennan, 1983) have been identified. Their 
exact roles are unclear although they may be involved in ca2+_ 
ATPase regulation (Racker and Eyton, 1975). Additional proteins 
sometimes found in SR vesicle preparations include myosin, 
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myokinase, phosphorylase and a high MW protein of Mr about 170 
kDa (Ross, 1987). The latter 2 can be removed by further 
centrifugation at low ionic strength in the presence of glycogen 
(Ross, 1987). 
A number of studies have demonstrated an asymmetric 
orientation of the ca2+_ATPase in the SR membrane (MacLennan et 
al., 1971; Dupont et al., 1973; Thorley-Lawson and Green 
1973; Inesi and Scales, 1974; Stewart and MacLennan, 1974; 
Jilka et al., 1975; Saito et al., 1978; Taylor et al., 1986). 
When visualized under the electron microscope, the vesicles are 
seen to be made up of membranes of 60 A thickness covered with 
particles of about 35 A (MacLennan et al., 1971; Jilka et al., 
1975). The 30 A knobs can be removed by treatment of the 
membranes with trypsin (Thorley-Lawson and Green, 1973; Inesi 
and Scales, 1974; Saito et al., 1978). Upon freeze-fracture of 
the membranes, 90 A particles are seen projecting from the 
cytoplasmic half of the bilayer (MacLennan et al., 1971; Inesi 
and Scales, 1974). This has resulted in the conclusion that the 
ATPase consists of a hydrophobic portion embedded in the membrane 
and a hydrophilic portion projecting onto the cytoplasmic side 
(Stewart and MacLennan, 1974). The ca2+_ATPase appears to have 
an overall elongated shape with a length of 110 A and a width of 
75 A (le Maire et al., 1981). The 3-dimensional structure of 
the ca2+_ATPase has been determined to 25 A resolution by image 
reconstruction of crystals incubated in NaV04 (Taylor et al., 
1986). The ATPase monomers are crystallized in the form of 
dimers and appear as pear-shaped molecules with a lobe projecting 
out along one side parallel to the plane of the membrane (Taylor 
et al., 1986). 
Two-dimensional crystalline arrays of ca2+_ATPase molecules 
have been observed by negative staining SR vesicles with uranyl 
acetate (Dux and Martonosi, 1983a,b,c,d; Dux et al., 1985). 
Two different crystalline units are seen depending on whether the 
enzyme is crystallized in the E1 or E2 form. Crystallization in 
the E2 form is obtained by incubating the vesicles with NaV04 and 
is inhibited by treatment with ca2+ and ATP but not with ADP, 
AMP-PNP or AMP-PCP (Dux and Martonosi, 1983a,c). The crystals 
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formed in this conformation are arranged in pairs consistent with 
ATPase dimers (Taylor et al., 1984). Crystallization in the E 1 
form is obtained following incubation with ca2+ or lanthanide 
ions and results in a different pattern to that obtained in the 
E2 form (Dux et al., 1985). The rate of vanadate-induced 
cry~tallization is increased by an inside positive membrane 
potential (Dux and Martonosi, 1983d), while ca2+ induced 
crystallization is increased by an inside negative potential (Dux 
et al., 1985). These findings have resulted in the postulate 
that the E1 to E2 transition may involve a change in 
oligomericity of the pump (Dux et al., 1985). More recently, 
crystallization in a form similar to that obtained in the 
presence of ca2+ has been obtained in detergent raising the 
possibility that a preparation suitable for X-ray diffraction 
studies may be obtained (Dux et al., 1987). 
1.3.2. Structure of the cal.±.-ATPase 
Initial work on the primary structure of the protein was 
restricted to the water soluble extra-membranous segments and a 
number of sequences were obtained (Allen and Green, 1978; Allen, 
1980a, b; Allen et al., 1980a, b) leading to the elucidation of 
about 80% of the primary structure of the protein. The entire 
sequence was later obtained following sequencing of a cDNA for 
the ca2+_ATPase (MacLennan et al., 1985; Brandl et al., 1986). 
Limited tryptic digestion has also been used as a tool in 
structural studies. Initial cleavage occurs at a site labeled 
T1 resulting in two polypeptides, A and B, of approximately equal 
molecular weight (Thorley-Lawson and Green, 1973; Inesi and 
Scales, 1974; Stewart and MacLennan, 1974; Rizzolo et al., 
1976). A second cleavage takes place at a site labeled T2, 
cleaving the A fragment into two fragments, A1 and A2, of MW 33 
and 22 kDa, respectively (Thorley-Lawson and Green, 1973). The 
fragments are located in the linear sequence with the A2 fragment 
at the N-terminus, the B fragment at the C-terminus and the A1 
fragment in between (Allen et al., 1980a). Each fragment has a 
hydrophobic portion situated in the membrane and so the molecule 
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remains intact following cleavage at T1 and T2 (Thorley-Lawson 
and Green, 1973; Stewart and MacLennan, 1974; Inesi and Scales, 
1974). Initial cleavage results in a small activation of 
activity but more extensive digestion results in a decline in 
activity along with the release of peptides from the vesicles 
(Stewart and MacLennan, 1974; Saito et al., 1978). The trypsin 
sensitive sites may delineate structural domains (MacLennan et 
al. , 1 985) . 
The most important development in ca2+_ATPase structure has 
been the elucidation of the amino acid sequences of rabbit 
skeletal muscle ca2+_ATPase from both fast (type II) (Brandl et 
al., 1986) and slow (type I) (MacLennan et al., 1985) fibers. 
The two enzymes are very similar with the fast twitch form having 
four additional residues, three at the C terminus and one near 
the T1 cleavage site (Brandl et al., 1986). There are 164 
changes in. amino acid, 66 of which are conservative (S/T, D/E, 
K/R, F/Y/W, I/L/V/M). The differences have little effect on the 
predicted secondary structure (Brandl et al., 1986) (Fig.1 .16). 
Most of the variations are found in a helices and bends while the 
B strands are highly conserved. The most variability occurs in 
helices at the amino terminus and in the phosphorylation and 
nucleotide binding domains. The residues making up the helices 
in the predicted . transmembrane regions, the stalk region and a 
hypothetical hinge region show less variability. The a-
subdomain or hinge region and the stalk segment connecting the 
fourth transmembrane segment to the phosphorylation domain are 
the most highly conserved regions. Although there are 
differences between cardiac and slow skeletal muscle ca2+_ATPase 
they have been postulated as resulting from the same gene, 
perhaps with alternate splicing (Brandl et al., 1986). 
It is known from freeze-fracture and other studies that the 
ca2+_ATPase is a transmembrane protein and the regions in the 
sequence located in the membrane were predicted by means of a 
polarity plot (MacLennan et al., 1985). MacLennan et al. (1985) 
predicted 10 such stretches which are connected, on the lumenal 
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Figure 1.16 Postulated domain folding of the ca1±.-ATPase 
A schematic representation of the proposed folding pattern of the 
ca2+_ATPase is shown, as well as the proposed division into 
domains MacLennan et al., 1985; Brandl et al., 1986). The 
model assumes 10 intramembranous sections. 
sensitive sites, T1 and T2, are shown. 
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The two trypsin 
the cytoplasmic side of the membrane where it has been postulated 
to be arranged into three domains delineated by hydrophobic 
regions and trypsin sensitive sites (Fig. 1 .16). In this model, 
the hydrophilic domains are connected to the first five 
transmembrane stretches by five connecting segments arranged into 
an a-helical net and called the stalk region. The first three 
stalk segments contain a number of aligned Glu residues which 
make this region a candidate for the high affinity ca2+ binding 
site. The first globular domain (residues 132-238) is located 
between the first and second pairs of transmembrane segments. 
This region termed the transduction domain consists of seven B 
strands which likely form an anti-parallel a sandwich and 
contains the T2 cleavage site. The large hydrophilic region 
between the second and third pairs of transmembrane regions is 
predicted to be made up of alternating a-helix and a-strand which 
would probably fold to form parallel a-sheets. It is predicted 
to be arranged into two domains divided by the T1 tryptic site. 
The N-terminal domain (residues 330-505) contains the 
phosphorylation site and the C-terminal one (residues 505-680) 
the site of labeling with FITC and thus the nucleotide binding 
site. The nucleotide binding domain is connected to the fifth 
transmembrane segment by a short a-helical segment called the 
hinge region by analogy to the organization in kinases and 
dehydrogenases (Bennett and Huber, 1984). 
1.3.2.1 SR AFFINITY LABELING WITH THIOL DIRECTED REAGENTS 
The ca2+_ATPase contains twenty-four sulfhydryl residues 
(Brandl et al., 1986), of which six probably form disulfide 
linkages tentatively located on the B fragment, while fourteen 
are probably located on the surface of the protein (Thorley-
Lawson and Green, 1977). The highest density of exposed SH 
groups is found on the A1 fragment, three of which are in the 
thirty-one residue tryptic peptide containing the phosphorylated 
aspartic acid residue (Thorley-Lawson and Green, 1977). 
Four of these SH residues may be distinguished by their 
reactivity to NEM (Thorley-Lawson and Green, 1977; Yamada and 
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Ikemoto, 1978; 
the first SH 
Kawakita et al., 1980). 
group to be modified 
On incubation with NEM 
is termed SHN in the 
terminology of Kawakita et al (1980), after which, SHn, SHN•,and 
SHF are modified. SHN modification has no effect on enzyme 
activity (Yamada and Ikemoto, 1978). Modification of SHo is 
accompanied by decreased ca2+ transport as a result of inhibition 
of E-P decomposition and this effect is markedly accelerated when 
the labeling is carried out in the presence of ca2+ (Kawakita et 
al ., 1980). Specific modification of SHo occurs when carried 
out under mild conditions in the presence of AMP-PNP (Kawakita et 
al. , 1980). The SHo modified enzyme cannot be phosphorylated 
from Pi which indicates that the E2-P conformation is 
unattainable under these conditions (Davidson and Berman, 1987). 
Addition of detergent to the SHo modified enzyme, however, causes 
a rapid loss of E-P probably by another route (Yamamoto et al., 
1984). Further incubation leads to labeling of a 3rd SH 
residue, SHN', modification of which has no effect on ca2+ 
transport (Kawakita et al., 1980). The labeling of SHF causes 
inhibition of E-P formation and thus ca2+ transport (Yamada and 
Ikemoto, 1978). SHF is not labeled in the presence of AMP-PNP 
(Kawakita et al., 1980). 
SHo has been located on the A1 tryptic fragment (Saito et 
al., 1984), while modification of SHN has led to the modification 
of 2 residues Cys 344 and Cys 364 to the extent of 0.5 mol/mol 
ATPase each, with modification of one perhaps inhibiting 
modification of the other (Saito-Nakatsuka et al., 1987). 
Labeling of both SHN and SHo, resulting in inhibition of ATPase 
activity, resulted in the same 2 residues being modified. Thus 
when either is labeled activity is unaffected but when both are 
modified ca2+ transport is prevented (Kawakita and Yamashita, 
1987). 
Spin labeled and fluorescent maleimide and iodoacetamide 
derivatives have been used to obtain information concerning the 
conformational transitions of the enzyme especially during ligand 
binding (Yu et al., 1977; Yasuoka-Yabe et al., 1983). 
Maleimide spin labels have been shown to have a similar 
selectivity of reactivity towards the ca2+_ATPase as NEM (Yu et 
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al., 1977; Yasuoka-Yabe and Kawakita, 1983). One such probe 
incorporated specifically into the SH groups essential for ATPase 
a c tivity was found to be located in a highly ordered, less fluid 
environment than molecules incorporated elsewhere on the enzyme 
(Yu et al., 1977). It was further shown that this is a result 
of the tertiary structure of the protein rather than as a result 
of being buried in a lipid environment (Yu et al., 1977). 
Another spin labeled probe detected a difference in conformation 
between ADP binding to E1-P. The maleimide fluorescent probe 
ANM has also been shown to have the same selectivity as NEM and 
the probe has been shown to have a characteristic fluorescence 
whose intensity is relative to the binding of ca2+ and was 
ascribed to a conformational change on ca2+ binding to the 
transport sites (Miki et al., 1981; Yasuoka-Yabe and Kawakita, 
1983). Further fluorescent effects were observed on 
phosphorylating from ATP (Miki et al., 1981) and on binding of 
AMP-PNP in the presence of ca2+, irrespective of whether the 
probe was attached to SHo or SHN (Yasuoka-Yabe et al., 1983). 
The fluorescent probe pyrene maleimide is specifically 
incorporated into one SH residue under appropriate conditions 
(Kutenbach and Verjovski-Almeida, 1985). Both the extent and 
rate of incorporation are increased in the presence of Pi and 
protected by ATP(Kurtenbach and Verjovski-Almeida, 1985). 
Evidence was obtained that occupancy of the high affinity ca2+ 
sites increases the accessibility of medium solvent into 
hydrophobic domains of the enzyme (Kurtenbach and Verjovski-
Almeida, 1985). 
Under controlled conditions iodoacetamide spin labels can be 
incorporated into about 2 SH groups per enzyme without affecting 
activity (Coan and Inesi, 1977; Laggner et al., 1981). The 
reaction rate is sensitive to pH and temperature and, in addition 
when the reaction is carried out in the presence of ATP and ca2+ 
the rate of labeling is increased and the 'strongly immobilized' 
signal is enhanced (Champeil et al., 1978). The EPR spectrum 
has been used to monitor conformational changes induced by ligand 
binding (Coan and Inesi, 1977; Laggner et al.,1981). Thus, a 
small but specific broadening of the spectrum occurs on binding 
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of substrates and Pi (Coan and Inesi, 1977; Laggner et al., 
1981). ca2+ greatly increases this effect but reverses the 
effect of Pi (Coan and Inesi, 1977, 1979). In the absence of 
substrate, the spin label is incorporated into a homogeneous 
population of sites while in the presence of ca2+ and substrate 
the sites labeied appear split into 2 equal populations one of 
which has a reactivity with the spin label which is increased 10 
fold (Coan and Keating, 1982). It has thus been postulated that 
there are 2 conformations of the substrate binding site present 
during turnover (Coan and Keating, 1982). It was later found 
that Pi in the presence of Me2SO also induces this split in the 
sites (Coan, 1983). The site of labeling of iodoacetamide and 
IAEDANS has been shown to be Cys-674 (Suzuki et al., 1987; 
Yamashita and Kawakita, 1987). The same residue (Cys-674) as 
well as Cys-670 have been labeled with IAF (iodoacetamido 
fluorescein) and a model postulated in which the two residues are 
located at adjacent positions in an a-helical structure 
both to be labeled with approximately equal probability 
et al., 1988). 
allowing 
(Bishop 
1 .3.2.2 INTRAMOLECULAR CROSSLINKING OF THE ca..£t.-ATPase 
It has recently been found that the SR ca2+_ATPase can be 
specifically modified with bifunctional aldehyde reagents 
resulting in intramolecular cross-linking of the ATPase molecule 
(Ross and McIntosh, 1987a,b). These reagents which react 
preferentially with lysine groups were found to modify the ca2+_ 





polyacrylamide gels, properties 
exhibiting 
of 125 kDa 
when 
an increased apparent MW for the cross-linked species 
(Ross and McIntosh, 1987a). More extensive treatment 
results in intermolecular cross-linking to higher MW oligomeric 
species. Reaction with the reagent glutaraldehyde, under 
optimal conditions, results in close to 100% modification, which 
can be completely prevented by the binding of nucleotides or 
decavanadate, or partially inhibited by prior labeling of the 
enzyme with FITC or PLP (Ross and McIntosh, 1987a). It has 
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further been shown that cross-link formation is inhibited upon 
formation of E2-P, but not E1-P, and been postulated that the 
active site is closed in E2-P (Ross and McIntosh, 1987b). 
Inhibition of cross-linking in E1-P, however is observed in the 
presence of millimolar concentrations of ATP, demonstrating 
binding of ATP to a low affinity site on E1-P (Ross and McIntosh, 
1987b). From the pattern of tryptic digestion, it was 
established that the cross-link is located between the A1 and B 
tryptic fragments (Ross and McIntosh, 1987a). 
1.3.2.3 PHOTOAFFINITY LABELING OF SR VESICLES 
At present eight reports have been published reporting the 
photoaffinity labeling of SR vesicles including 8N3ATP (Briggs et 
al., 1980; Cable and Briggs, 1984; Campbell and MacLennan, 
1983), 3'-o-[3-(2-nitro-4-azidophenyl)-propionyl]-ATP (NAP3-ATP) 
(Schaner et al., 1982), 3'-o-(4-benzoyl)benzoic ATP (BzATP) 
(Cable and Briggs, 1984), 3'~arylazido-ATP (Cable and Briggs, 
1984; Carvalho-Alves et al., 1985; Oliveira et al.,1988) and 
UTP (Ferreira, S.T., and Verjovski-Almeida, S., 1988). The 
photoaffinity labeling of integral membrane protein components of 
the SR has also been reported with two arylazido 
phosphatidylcholine analogs (Volpe et al., 1987) 
Contrary to an initial report (Briggs et al., 1980), 
irradiation of SR vesicles in the presence of 8N3ATP under 
conditions favoring turnover of the pump, results in little 
specific photoincorporation (Campbell and MacLennan, 1983; Cable 
and Briggs, 1984). This could be due to conversion of 8N3ATP to 
8N3ADP under these conditions as suggested (Campbell and 
MacLennan, 1983). Another possibility is that the ca2+_ATPase 
has a low affinity for 8- substituted nucleotides reported to 
adopt a syn conformation (Ikehara et al., 1972; Sarma et al., 
1974). This latter possibility is unlikely, however, in view of 
the finding that 8-BrATP supports ca2+ transport as well as ATP 
(Champeil et al., 1988) and does 8N3ATP (McIntosh and Seebregts, 
unpublished observations). Under conditions in which the 
hydrolysis of 8N3ATP is low, the probe labeled two intrinsic 
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membrane glycoproteins of MW 53 kDa and 160 kDa (Campbell and 
MacLennan, 1983). 
Photoincorporation of BzATP was obtained to the extent of 
1 . 3 nmol/mg protein under select conditions (Cable and Briggs, 
1984). There was a good correlation between BzATP incorporation 
and inhibition of ATPase activity, and both parameters were 
antagonized by ATP (Cable and Briggs, 1984). The label was 
located predominantly on the ATPase A fragment (72 %) but a 
portion was also found on the B fragment (28 %), and a smaller 
component on the phospholipid or proteolipid (Cable and Briggs, 
1984). In the same study, it was reported that arylazido-ATP is 
ineffective as a photoaffinity probe, although more recent 
studies have found arylazido-ATP to be a useful photoaffinity 
label (Carvalho-Alves et al., 1985; Oliveira et al., 1988). 
Arylazido-ATP (aATP) competitively inhibits ATP hydrolysis 
with a Ki of 10 µMand is itself hydrolyzed by SR vesicles at a 
slow rate (Carvalho-Alves et al., 1985). The hydrolysis is ca2+ 
independent and exhibits a biphasic dependence on ATP 
concentration, with ko.s values of about 10 µMand 300 µM at 
postulated high and low affinity sites respectively and results 
in a low level of phosphorylation of about 0.6 nmol/mg protein 
(Carvalho-Alves et al., 1985; Oliveira et al., 1988). It is 
postulated that the hydrophobicity of the molecule allows it to 
mimic Pi+ Me2SO in phosphorylating the enzyme (Oliveira et al., 
1988). A similar biphasic dependence on aATP concentration was 
observed for photoincorporation, which occurred to the extent of 
about 1 mol/mol ATPase (6 - 9 nmol/mg protein and 1.0 1.5 
mol/mol ATPase (up to 22 nmol/mg protein) to the high and low 
affinity sites respectively (Carvalho-Alves et al., 1985). 
Photoincorporation was inhibited by ATP, Pi, TNP-ATP or ca2+ 
although the 'kinetic protection' afforded by these compounds did 
not decrease the photoincorporation by more than 50 % (Carvalho-
Alves et al., 1985). Photoaffinity labeling of the high 
affinity site inhibits the hydrolysis of added free aATP but not 
ATP while photolabeling the low affinity site irreversibly 
inhibits ATPase activity (Carvalho-Alves et al., 1985). This is 
probably due to aATP labeling residues outside the active site; 
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extensive labeling on non-ca2+_ATPase components was seen 
(Carvalho-Alves et al., 1985). More recently, specific 
photolabeling of the A2 fragment has been obtained by direct 
illumination of UTP in the nucleotide site (Ferreira and 
Verjovski-Almeida, 1988). Although low levels of labeling were 
obtained (0.12 nmol/mg protein), this result has been interpreted 
as indicating that the postulated transduction domain makes up 
part of the nucleotide binding site (Ferreira and Verjovski-
Almeida, 1988). A surprising result is that the incorporation 
of UTP is not inhibited by the prior modification of the enzyme 
with F!TC, although phosphorylation by UTP is inhibited. This 
has been interpreted as meaning that both probes can fit in the 
nucleotide site (Ferreira and Verjovski-Almeida, 1988). 
1 . 3. 3. ca2+ translocation and the Catalytic Cycle 
ca2+ ions are transported across the SR membrane coupled to 
ATP hydrolysis by the ca2+_ATPase, and the mechanism of action of 
this enzyme has been the subject of a number of reviews (for 
example Tada et al., 1978; de Meis and Vianna, 1979; Berman, 
1982; Inesi, 1985). The overall reaction catalyzed by the 
ca2+_ATPase is given below: 
2 ca2+. + MgATP· in i 
A reaction cycle based on the E1, E2 model postulated for P-type 
ATPases is often used (Fig. 1.17) (de Meis and Vianna, 
Inesi, 1985). The cycle involves some of the intermediates 




characterized partial reactions. The cycle begins with 
substrate binding followed by phosphorylation of the enzyme. 
Thereafter, the two ca2+ ions are rapidly internalized and the 
enzyme undergoes a slow conformational change leading to ca2+ 
release inside the vesicles followed by dephosphorylation and 
completion of the cycle. The cycle is readily reversible and 
the enzyme can be phosphorylated by Pi and reverse the direction 
of ca2+ transport. 
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Figure 1.17 Reaction cycle of the cal.±.-ATPase 
The commonly used reaction cycle of the ca2+_ATPase containing 
most of the principle postulated intermediate species is shown 
(de Meis and Vianna, 1979). 
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Jencks and coworkers have postulated that ca2+ transport is 
governed by a set of rules defining the chemical and vectorial 
specificity of the enzyme as well as utilization of binding 
energy to make the reaction proceed at a reasonable rate (Jencks, 
1980, 1983; Pickart and Jencks, 1984; Khananshvili and Jencks, 
1988). It has, moreover, been found that certain of these rules 
are incompatible with an E1E2 model and been suggested that as 
some of the postulated intermediates have never been seen, a 
notation based solely on the chemical composition of the species 
be adopted (Fig. 1 .18) (Stahl and Jencks, 1987). In this 
model, chemical specificity is obtained by virtue of the fact 
that the E-P species alone can react with H20 and Pi while E.ca 
can react with ADP and ATP ie. ca2+ acts as a chemical switch, 
defining the chemical reactivity of the enzyme. Vectorial 
specificity is obtained by allowing E or E.ATP only to interact 
with the ca2+ on the outside and E-P or E-P.ca2+ to interact with 
ca2+ on the inside ie. phosphorylation acts as a vectorial 
switch. Only by obeying these rules, then, is it possible to 
get tightly coupled ca2+ translocation. 
ca2+ BINDING 
ca2+ binds with high affinity (Km= 0.1-0.4 µM) to the 
outwardly oriented calcium binding sites of the ca2+_ATPase 
(Weber et al., 1966; Yamamoto and Tonomura, 1967; Yamamoto et 
al., 1979; Vianna, 1975; Arav et al., 1983) in a cooperative 
manner (nH = 1 .8) (Dupont and Leigh, 1978; Inesi et al., 1980; 
Moller et al., 1980; Arav et al., 1983), with a stoichiometry of 
2 ca2+ ions per phosphorylation site (Weber et al., 1966; Inesi 
et al., 1980). At higher concentrations of ca2+, binding occurs 
to the inwardly oriented low affinity calcium binding sites (Km 
0.6 1 mM) (Ikemoto, 1974, 1975). ca2+ binding is pH 
dependent, with an increased affinity occurring at alkaline pH 
(Meissner, 1973; Verjovski-Almeida and de Meis, 1977; Chiesi 
and Inesi, 1980) and a model has been proposed in· which ca2+ and 
H+ compete for the same site (Hill and Inesi, 1982; Inesi and 














Figure 1.18 Predominant conformational states of the ca.£:t.-ATPase 
A minimal reaction cycle is shown consisting of the 4 main 
conformations of the ca2+_ATPase which have been postulated to be 
required for pumping to occur (Khaanshvili and Jencks, 1988). 
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fluorescence (Dupont and Leigh, 1978; Dupont, 
al . , 1983; Fernandez-Belda et al., 1984), EPR 
and Inesi, 1977; Inesi et al., 1980) and SH 
(Ikemoto et al., 1978), demonstrated that 
1982; Champeil et 
spectroscopy (Coan 
group reactivity 
ca2+ binding is 
accompanied by a slow conformational change. The rate of ca2+ 
binding is accelerated by ATP (Sumida et al., 1978; Takisawa and 
Tonomura, 1978; Scofano et al., 1979; Inesi et al., 1980; 
Guillain et al., 1981; Pickart and Jencks, 1984; Fernandez-
Belda et al., 1984), probably by acting on a conformational 
change associated with binding (Stahl and Jencks, 1984, 1987). 
A sequential binding mechanism has been postulated in which 
binding of ca2+ to the first site induces a second site with 
higher affinity (Dupont, 1982; Champeil et al., 1983) according 
to the following scheme (Inesi et al., 1980; Fernandez-Belda et 
al. , 1 984) 
E + ca2+ E.ca2+ E' .ca2+ + ca2+ 
More recent isotope exchange experiments have confirmed these 
results and shown that both ca2+ binding and release occur 
sequentially and also that the ion bound first is always released 
first (Inesi, 1987; Khananshvili and Jencks, 1988). It has 
been postulated that the ca2+ binding sites are located in 
glutamic acid rich stalk region of the ca2+_ATPase and 
the 
that 
rotation of the residues results in ca2+ translocation (MacLennan 
et al., 1985). In an extension of the model, it has been 
suggested that binding of the first ca2+ draws the subdomains 
together by electrostatic interactions creating a second site for 
ca2+ (Tanford (et al., 1987). Binding of the second ca2+ causes 
a conformational change resulting both in occlusion of the 2 ca2+ 
ions as well as moving of the phosphorylation and nucleotide 
binding domains together (Tanford et al., 1987). 
ATP BINDING 
ca2+ translocation is obligatorily coupled to the hydrolysis 
of ATP and pump activity shows a complex non Michaelis-Menten 
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dependence on substrate concentration (Yamamoto and Tonomura, 
1967; Inesi et al., 1967). Direct titration of the nucleotide 
si t es present on SR vesicles has been carried out with ATP in the 
abs ence of ca2+ (Dupont, 1977; Moller et al., 1980; Arav et 
al ., 1983) as well as with nonhydrolysable and slowly 
hydrolysable analogs (Dupont, 1977; Pang and Briggs, 1977). In 
al l cases, one high affinity site was titrated with Ka between 2 
and 10 µM. In addition, another site was indicated with Ka for 
ATP > 0.5 mM (Dupont, 1977). Attempts to titrate postulated low 
affinity sites has been hindered by difficulties encountered in 
measuring binding at ATP concentrations above about 0.2 mM (Yates 
and Duance, 1976). Similar results were obtained with the 
nonhydrolysable analogs AMP-PNP and AMP-PCP (Dupont, 1977; 
and Briggs, 1977) and the slowly hydrolysable analog 
Pang 
AMPCPP 
(Dupont, 1977). The high affinity TNP-nucleotides have also 
been used to titrate the nucleotide binding sites of the ca2+_ 
ATPase and been found to bind to a total of 1 mol/mol enzyme 
(Dupont, 1982; Watanabe and Inesi, 1982; Davidson, 1986; 
Bishop et al., 1987). Saturation of the high affinity sites · in 
the presence of ca2+ results in the formation of an 
aspartophosphoryl-protein intermediate and catalytic activity 
(Yamamoto and Tonomura, 1967; Makinose, 1969; Inesi et al., 
1970; Bastide et al., 1973; Degani and Boyer, 1973). Evidence 
has been presented for a conformational change following ATP 
binding (Coan and Inesi, 1977; Coan et al., 1979; Arav et al., 
1983) and further evidence has been presented that a rate 
limiting conformational change occurs of the E.ca2+.ATP 
intermediate prior to phosphoryl transfer (Petithory and Jencks, 
1986; Stahl and Jencks, 1987). Higher concentrations of ATP 
result in a stimulation of activity (Yamamoto and Tonomura, 1967; 
Inesi et al., 1967; Kanazawa et al., 1971; The and Hasselbach, 
1972; de Meis and Fialho de Mello, 1973; Verjovski-Almeida and 
Inesi, 1979; Taylor and Hattan, 1979; Ariki and Boyer, 1980; 
Moller et al., 1980; McIntosh and Boyer, 1983) and various 
models have been postulated to explain this phenomenon (see 
below). 
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1 . 3 . 3 . 2 PHOSPHOENZYME FORMATION 
Reaction of the enzyme with catalytic concentrations of ATP 
and ca2+ results in the formation of an ADP-sensitive 
phosphoenzyme, E1-P followed by an ADP-insensitive phosphoenzyme, 
E2 - P (Makinose, 1969; Kanazawa et al., 1971; Shigekawa et al., 
1978; Shigekawa and Dougherty, 1978a, b). Evidence has been 
presented for a rate limiting conformational change of the 
E.ca2+.ATP intermediate prior to phosphoryl transfer (Petithory 
and Jencks, 1986; Stahl and Jencks, 1987). There is a rapid 
burst of E-P formation followed by a decrease to steady-state 
levels; similarly, Pi production, after an initial lag phase 
corresponding to enzyme phosphorylation, rapidly increases then 
settles down to a steady-state rate (Kanazawa et al., 1971; 
Froehlich and Taylor, 1975, 1976). Occlusion of bound ca2+ ions 
occurs in parallel with formation of E1-P (Nakamura and Tonomura, 
1982; Takisawa and Makinose, 1983; Wakabayashi and Shigekawa, 
1984). Evidence has been presented that an ADP-insensitive E2-P 
is formed after E1-P (Bastide et al., 1973; Shigekawa and 
Dougherty, 1978b), and that this transformation is very rapid 
(Froehlich and Heller, 1985; Wang, 1987). Although ca2+ 
release has been correlated with E-P transformation (Takisawa and 
Makinose, 1983; Andersen et al., 1985) it has also been 
suggested that ca2+ remains occluded following phosphoenzyme 
isomerization, which is a rapid process, and is released 
following a slow conformational change (Froehlich and Heller, 
1985). Alternatively, it has also been suggested that the ca2+ 
ions are released before formation of the ADP-insensitive E2-P 
(Pickart and Jencks, 1982). The discrepancy has arisen largely 
as a result of the interpretation of the biphasic kinetics 
observed following ADP induced decomposition of the 
phosphorylated enzyme. This has been interpreted as due to 
rapid dephosphorylation of the ADP-sensitive component followed 
by a slower conversion of the ADP-insensitive to ADP-sensitive E-
P (Froehlich and Heller, 1985). The alternative view is that 
the biphasic kinetics is due to the rapid binding of ADP and 
phosphoryl transfer, and the slow rate-limiting dissociation of 
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ATP (Pickart and Jencks, 1982; Fernandez-Belda and Inesi, 1986; 
Stahl and Jencks, 1987). 
Maximal phosphorylation levels with MgATP and ca2+ as 
substrates, are approximately 4 nmol/mg of SR protein (Froehlich 
and Taylor, 1975; Verjovski-Almeida et al., 1978), which 
corresponds to about 0.5 mol/mol ATPase. Higher levels are 
obtained when Pi and Me2SO are used, in a ca2+-depleted medium 
(de Meis et al., 1982). The fact that less than stoichiometric 
amounts of E-P are obtained has been ascribed to the presence 
both of other protein contaminants as well as inactive ATPases 
(Barrabin et al., 1984). Following HPLC purification values 
close to 7 nmol of E-P/mg of SR protein have been obtained in the 
presence of ATP and ca2+ (Barrabin et al., 1984). This data has 
received another interpretation in which it is postulated that 
the HPLC purification separates out phosphorylated from 
nonphosphorylated enzymes, both active, rather than active from 
inactive (Ferreira and Verjovski-Almeida, 1988). These authors 
favor a postulate of "half-of-the-sites" reactivity with ATP as 
substrate and "full sites" phosphorylation with UTP as substrate 
(Ferreira and Verjovski-Almeida, 1988). 
1.3.3.3 CALCIUM PUMP REVERSAL 
The catalytic cycle of the ca2+_ATPase is readily reversible 
and vesicles preloaded with ca2+ will drive ATP synthesis coupled 
to ca2+ efflux when incubated in a medium containing ADP, Pi, and 
EGTA (Hasselbach, 1978; de Meis and Vianna, 1979). The ca2+_ 
ATPase may be phosphorylated by high concentrations of Pi at acid 
pH in the presenc.e of Mg2+ and absence of ca2+ (Masuda and de 
Meis, 1973; Kanazawa and Boyer, 1973), and that the E-P so 
formed can 'drive' ATP synthesis from ADP when a ca2+ jump is 
performed in the absence of a ca2+ gradient (Knowles and Racker, 
1975; Beil et al., 1977; Punzengruber et al., 1978; Kolassa et 
al ., 1979). It was subsequently shown by de Meis et al. (1980) 
that in the presence of organic solvent phosphorylation of the 
enzyme by Pi occurred readily independent of pH and temperature. 
This resulted in the important conclusion that the main 
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thermodynamic barrier is partitioning of Pi from the aqueous 
medium into the hydrophobic active site and that once there the 
reaction occurs spontaneously (de Meis et al., 1980). This 
result has been confirmed in a study in which it was shown that 
the binding of Mg2+.Pi occurs slowly followed by a more rapid 
enzyme phosphorylation (Champeil et al., 1985). The true 
substrate for the phosphorylation reaction is Mg2+.Pi (Champeil 
et al., 1985), although higher concentrations result in 
inhibition probably as a result of the formation of an unreactive 
E.Mg2+ complex (Guillain et al., 1982, 1984). 
1. 3. 3. 4 NUCLEOTIDE MODULATION OF ACTIVITY 
The activity of the ca2+_ATPase is modulated by it's 
substrate ATP in a complex way (Ikemoto, 1982). The situation 
is complicated by several unanswered questions regarding for 
example the oligomericity of the pump and the stoichiometry of 
active sites. 
In initial experiments, it was found that at concentrations 
of ATP higher than that required for saturation of the high 
affinity catalytic site, acceleration of activity occurred (Weber 
et al., 1966; Inesi et al., 1967), often seen as downward 
curvature of ' Lineweaver-Burke plots (Yamamoto and Tonomura, 1967; 
Kanazawa et al., 1971; Moller et ,al., 1980). A number of 
steady state and pre-steady state kinetic experiments have 
suggested that this is the result of an effect on phosphoenzyme 
turnover (Verjovski-Almeida et al., 1978), variously ascribed to 
acceleration of E-P formation (Kanazawa et al., 1971), E-P 
hydrolysis (de Meis and de Mello, 1973; Froehlich and Taylor, 
1975; McIntosh and Boyer, 1983; Cable et al., 1985; Champeil 
and Guillain, 1986; Ross and McIntosh, 1987b; Champeil et al., 
1988) and Pi release (de Meis and Boyer, 1978). Alternatively, 
it has also been attributed to acceleration of the E2 to E1 
transition (Froehlich and Taylor, 1975; Sumida et al., 1978; 
Takisawa and Tonomura, 1978; Scofano et al., 1979; Guillain et 
al., 1981; Stahl and Jencks, 1984), or to an effect brought 
about as a result of binding at a second nucleotide site 
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(Froehlich and Taylor, 1975) in a dimeric model (Froehlich and 
Taylor, 1976; Verjovski-Almeida and Inesi, 1979; Hymel et al., 
1984), or on the same enzyme monomer (Taylor and Hattan, 1979), 
or as a result of cooperativity in a monomeric model in which 
nucleotide binding induces a slow transition between two active 
forms of the enzyme (Neet and Green, 1977). As the modulatory 
effects are reproduced by the nonphosphorylating analogs AMP-PCP 
(Yates and Duance, 1976; Taylor and Hattan, 1979; Cable et al., 
1985) and TNP-ATP (Dupont et al., 1985), they cannot be the 
result of phosphorylation of the enzyme. 
ATP modulation shows 2-3 distinct phases depending on the 
substrate concentration (Moller et al., 1980; McIntosh and 
Boyer, 1983; Dupont et al., 1985). At lower concentrations the 
acceleration has been interpreted in terms of 
cooperativity in a dimeric model (Moller et al., 1980; 
negative 
McIntosh 
and Boyer; 1983), as it was found to be absent in detergent 
solubilized preparations (Dean and Tanford, 1978; Moller et al., 
1980), and it may be related to an inhibition of E-P hydrolysis 
observed in this range (McIntosh and Boyer, 1983). At higher 
concentrations acceleration is again observed and was postulated 
to be due to ATP binding to the catalytic site after ADP 
departure (McIntosh and Boyer, 1983). This latter model is 
seemingly contradicted by the lack of competition by ATP of 
product induced inhibition of turnover by ADP (Taylor and Hattan, 
1979; Coll and Murphy, 1985). 
Support for a different family of nucleotide sites was 
obtained with the ATP analog TNP-ATP (Dupont et al., 1982; 
Watanabe and Inesi, 1982; Bishop et al., 1984). TNP-ATP was 
found to bind to one site per ATPase monomer, and half of the 
bound probe was displaced to a site of higher fluorescence in the 
presence of catalytic concentrations of ATP and ca2+. 
Occupation of the high fluorescence site by TNP-ATP was 
furthermore correlated with acceleration of turnover (Dupont et 
al., 1985), while occupation by TNP-AMP inhibited acceleration by 
millimolar concentrations of ATP (Bishop et al., 1987). The 
binding of TNP-nucleotides was also found to be inhibited either 
by prior labeling of the enzyme with FITC or by addition of ADP 
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to the phosphorylated enzyme-TNP-nucleotide complex (Nakamoto and 
Inesi, 1984). This has been interpreted as support for the 
model in which accelerating ATP occupies the phosphorylated 
catalytic site following ADP departure (Nakamoto and Inesi, 
1984). It was further shown that 2 classes of sites can be 
distinguished based on their affinity for TNP-ATP in the presence 
of Mg2+ or absence of H+ and interpreted as evidence for a 
dimeric model (Dupont et al., 1985). 
More recently, it has been shown that millimolar 
concentrations of ATP accelerate phosphoenzyme isomerization 
following binding to Ca2E1-P (Champeil et al., 1986; Champeil 
and Guillain, 1986; Ross and McIntosh, 1987b). It was 
furthermore found that this effect is only produced by metal-free 
ATP than by Mg.ATP (Champeil et al., 1986; Champeil and 
Guillain, 1986). ATP acceleration of dephosphorylation has also 
recently been demonstrated in the 10-100 µM range, by rapid 
filtration, and again it was found that the metal-free form is 
responsible for the modulatory effect (Champeil et al., 1988). 
In summary, it seems that nucleotides are able to bind to 
the phosphorylated catalytic site following ADP departure 
(McIntosh and Boyer, 1983), and accelerate the rates of various 
partial reactions leading to dephosphorylation of the enzyme. 
The site of acceleration of turnover depends on the step which is 
rate limiting under the conditions of the reaction. Under 
turnover conditions, most of the enzyme is found in a 
phosphorylated form and consequently, acceleration of E1-P to E2-
P or dephosphorylation (depending on conditions), are probably 
responsible for the overall acceleration observed (Champeil et 
al., 1986). 
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2 EXPERIMENTAL PROCEDURES 
2.1 MATERIALS 
ATP (disodium salt) was from Sigma. HPLC grade acetonitrile, 
methanol and isopropanol were from Burdick and Jackson. TEA 
(Fluka) was distilled from ninhydrin and stored at 4 °c under 
nitrogen. DMF (BDH) was dried over molecular sieve 4A (Merck). 
TFA was Sequanal grade from Pierce. Constant boiling (6 N) HCl, 
PITC and amino acid standards (H) were from Pierce. The 
following synthetic peptides, kindly donated by Dr.R. de L . 
Milton, were used: #AE8 (PSTDCPMEVIK), #AD6 
(KSRLPGPSDTPILPQ(OH)) and #AC9 (SQRGKQGGKARA). All other 
chemicals used were of analytical grade. 
[2-3H]-ATP (ammonium salt), [a-14c]-ATP (ammonium salt), 
[32p]pi and [6,6'(n)-3H] sucrose were from Amersham. 
2.2 HPLC METHODS 
Analytical and semi-preparative HPLC of nucleotides, proteins 
and peptides was carried out on a WATERS reversed phase Radial-
Pak C18 (microbondapak or novapak, of particle size 10 µrn and 4 
µrn, respectively) column contained within a Z module radial 
compression unit. Solvent was delivered by a Spectra-Physics 
8700 XR pump and gradient controller with low pressure mixing and 
ternary gradient capability. Effluent was monitored on a 
Spectra-Physics 8300 fixed wavelength (254 nm) detector and/or an 
LKB 2151 variable wavelength detector. 
Amino acid analysis and sequencing were carried 
complete WATERS picotag system in pyrolyzed tubes. 
out 
The 
derivatives were analysed on a Picotag (Waters C18) column 
at 45 °c in a temperature controller and PTH derivatives 






maintained at 45 °c. Solvent was delivered by a model 510 pump 
and a model M-45 pump with model 680 gradient controller and 
model 712 WISP autosampler. Effluent was monitored using a 
model 441 fixed wavelength detector (254 nm) and data collected 
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on a model 740 data collection module and/or a Tectronix 4054 A 
desktop computer. 
2 . 3 SYNTHESIS AND PURIFICATION OF TNP-8N3-NUCLEOTIDES 
TNP-8N3-nucleotides were synthesized in three steps. 
Firstly ATP was brominated in the 8 position on the adenine ring. 
In the second step, the Br was replaced with an azido group and 
finally, the trinitrophenyl group was added to the ribose moeity. 
2. 3. 1 Synthesis and purification of 8-BrATP 
Bromination of ATP was carried out according to the method of 
Ikehara and Uesugi (1969), modified slightly to accomodate a 
five-fold increase in starting material. ATP (3 g) was 
dissolved in 200 ml sodium acetate buffer (1 M, pH 4.0). 
Freshly prepared saturated bromine water, 50 ml, was added to 
this and the reaction mixture incubated overnight (17 h) at room 
temperature in the dark. The solution was neutralized by 
addition of 1.5 ml NaHS03 solution (37%, Merck) and left to stand 
for 1 hat room temperature. Solvent was removed in vacuo at 35 
0 c with small additions of methanol. The residue was dissolved 
in 500 ml H20 and applied to a column (3 X 25 cm) of H20 washed 
Dowex 1 x 8 (c1- form, 100 - 200 mesh) by gravity. The loaded 
column was then washed with 1.8 1 H20 at a flow rate of 300 ml/h 
and then a linear gradient applied from 0.13 M LiCl + 0.001 N HCl 
to 0.25 M LiCl + 0.001 N HCl (4 1 + 4 1) at the same flow rate. 
The absorbance of the effluent was monitored at 254 nm with an 
LKB Uvicord detector. At the end of the gradient the column was 
washed with a further 2 1 of the more concentrated eluent to 
elute the remaining 8-BrATP. Fractions corresponding to the 8-
BrATP peak were identified spectrophotometrically ( max = 263 
nm), pooled and lyophilized to dryness. The lyophilizate was 
redissolved in methanol:H20 (1:1, v/v) and the nucleotide 
precipitated by addition of excess acetone (13.3 ml fo+ every ml 
methanol:H20 added). The precipitate was collected on filters, 
dried and stored in solid form at -20 oc. Purity was checked by 
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HPLC on a Radial Pak SAX column eluting with a gradient of 0 
10% acetonitrile in 0.15 M KH2P04, pH 7.0. Brominated 
nucleotides elute after their unmodified counterparts under these 
conditions. 
2.3.2 Synthesis and purification of 8-N3-nucleotides 
Displacement of the Br group with an azido group was carried 
out at high temperature in organic solvent by reaction with 
triethylammonium azide according to the method of Schafer et al. 
(1978b)~ In order to make the nucleotide soluble in the organic 
solvent it was first converted to the triethylammonium salt. 8-
BrATP (0.9 g, Li salt) was loaded onto a column (1 .5 x 7 cm) of 
DEAE-Sephadex A-25 (HC03- form), eluted with 0.5 M TEA.HC03- and 
then dried in vacuo by coevaporating with small additions of 
methanol. The nucleotides were dried in vacuo over P205 for 12 
h, and finally dissolved in 30 ml dry DMF. 
The synthesis of triethylammonium azide was carried out 
according to Vogel (1962) in the following way: NaN3, 3 g, was 
added to a boiling tube on ice and 12 ml H20 added slowly with 
stirring. 10 ml benzene was layered on top and 0.96 ml 
concentrated H2S04 added dropwise while stirring. The mixture 
was stirred for 15 min. A portion of the organic layer (6 ml) 
was removed and added with 1.1 ml redistilled TEA to the DMF 
containing 8-BrATP in a stoppered 40 ml boiling tube. 
The reaction mixture was heated to 75 oc in a water bath in 
the dark overnight (15 h), and then the solvent was removed in 
vacuo at 50 °c. The residue was redissolved in 20 ml H20 and 
applied to a column (3 X 60 cm) of H20 washed DEAE-Sephadex A-25 
(HC03- form) in the dark at 5 oc. The nucleotides were applied 
by gravity and the column was washed with 100 ml H20. The 
nucleotides were eluted with a gradient of 0.06 - 0.6 M TEA.HC03-
(3 1 + 3 1) at a flow rate of 150 ml/h. Fractions (25 ml each) 
corresponding to 8N3AMP, 8N3ADP and 8N3ATP were identified 
spectrophotometrically, pooled and evaporated to dryness. Last 
traces of TEA.HC03- were removed by coevaporation with small 
additions of methanol. Purified 8N3-nucleotides were stored in 
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methanol at -60 oc. Purity was checked by HPLC on a reversed 
phase C18 column eluting with acetonitrile in KH2P04 pH 7.0. 
2 . 3.3 Synthesis and purification of TNP-8N3-nucleotides 
Introduction of the trinitrophenyl group was carried out 
using a modification of the method developed for ATP by Hiratsuka 
(1982). A solution of 218 mg of Na2C03 and 151 mg of NaHC03 in 
2.4 ml H20 was added to a suspension of 96 mg of TNBS and 200 mg 
of DTNB in H20. Immediately thereafter, the reaction mixture 
was added to 100 umoles of lyophilized 8N3- nucleotide, and 
incubated overnight in the dark at room temperature with 
• 
continuous stirring. 
Purification was carried out by HPLC in the following way. 
1 .2 ml amounts were fractionated on a Radial Pak C18 column using 
a gradient from O - 30% acetonitrile in either 20 or 75 mM 
KH2P04, pH 5.0 at a flow rate of 5 ml/min. The shape of the 
gradient and phosphate concentration were altered to optimally 
position the TNP-8N3-nucleotide peak. TNP-8N3-nucleotide peaks 
were identified spectrophotometrically by the presence of 
absorbance maxima at 281, 408 and 468 nm, pooled and lyophilized 
to dryness in the dark. When necessary a second purification 
was carried out under the same conditions. Samples were 
desalted on the same column with acetonitrile:H20 (1:1, v/v) as 
solvent. The nucleotides were judged pure by the following 
criteria: a single peak on HPLC, a single spot on TLC and a 
spectrophotometric peak with UV absorption maxima between 280 and 
283 nm and visible absorption maxima at 408 and 468 nm. TLC was 
carried out on polyethyleneimine cellulose TLC plates developed 
in 2 M formic acid+ 0.5 M LiCl. 
TNP-ATP was synthesized as described by Hiratsuka (1982). 
2.4 SYNTHESIS AND PURIFICATION OF RADIOACTIVE NUCLEOTIDES 
2.4.1 Synthesis and purification of [y-32p]-nucleotides 
[y-32p]-ATP was synthesized by the exchange reaction of Glynn 
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and Chappel (1964). TNP-[y-32p]-ATP and TNP-8N3-[y-32p]-ATP 
were synthesized by the same method as modified by Watanabe and 
Inesi (1982). In the case of the azido derivatives, 
dithiothreitol was not included in the reaction mixture as it 
reduces the azido group (Briggs et al., 1980). The [y-32p]-
nucleotides were purified by anion exchange chromatography and 
assayed for purity on PEI-cellulose TLC plates developed in 2 M 
formic acid + 0.5 M LiCl. Pure compounds gave a single UV 
absorbing spot coinciding with a peak of radioactivity seen by 
proportional gas flow scanning. 
2.4.2 Synthesis and purification of [8-l!c]- and [2-lH]-
nucleotides 
TNP-8N3-[a-14c]-nucleotides and TNP-8N3-[2-3H]-nucleotides 
were synthesized from [a-14c]-ATP and [2-3H]-ATP (both ammonium 
salt, Amersham) using the methods described above for the cold 
synthesis but adapted for the micro amounts involved. [a-14c]-
ATP (ammonium salt, 255 nmoles) in aqueous solution was converted 
to the sodium salt by passage through a column (0.7 x 9 cm) of 
Dowex SOW X 2 (100-200 mesh, Na+ form). This step was necessary 
as we found that the ammonium ion in the radioactive solution 
discharged the colour of the reaction mixture on mixing with 
bromine water. The eluate was lyophilized to dryness, added to 
5 umoles of unlabeled ATP (disodium salt), and dissolved in 0.3 
ml acetate buffer (1 M, pH 4.0) in a 0.4 ml sealed plastic tube. 
Freshly prepared, saturated bromine water (0.1 ml) was added and 
the reaction mixture incubated overnight at room temperature in 
the dark. The mixture was injected directly on to a Radial Pak 
C18 HPLC column and fractionated on a gradient of O 5% 
acetonitrile containing 0.1 M TEA.HC03- (pH 7.0) over 25 min at a 
flow rate of 4 ml/min. The 8-Br-[a-14c]-ATP peak was collected 
and lyophilized to dryness. Last traces of TEA.HC03- were 
removed by coevaporating four times with 0.5 ml methanol and the 
nucleotides were finally dried over P205 at 100 mtorr. The 
azido substitution reaction was carried out by dissolving the 8-
Br-[a-14c]-ATP in 0.3 ml dry DMF and adding to this 12 µl 
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redistilled TEA and 60 µl benzene saturated with hydrazoic acid 
prepared as described in section 2.3.2. The reaction mixture 
was incubated in the dark at 75 °c for 12 hand then evaporated 
to dryness at 40 oc under reduced pressure. 
The reaction with TNBS was carried out with 0.24 ml of the 
buffered TNBS and OTNB reaction mixture described in section 
2.3.2, and were purified by the same HPLC protocol. Mono-, di-, 
and triphosphate derivatives were fairly well separated from all 
other species with one HPLC elution, but each was routinely 
rechromatographed to obtain the pure compound. Purity was 
assesed by the same criteria as for the nonradiolabelled 
nucleotides, but in addition TLC plates were checked by 
proportional gas flow scanning to ensure that peaks of 
radioactivity coincided with the positions of the TNP-8N3-
nucleotides. Nucleotides were stored as an aqueous solution at 
-20 °c. 
TNP-8N3-[2-3H]-nucleotides were synthesized by the same 
method. The yield of radioactive nucleotide in this case, 
however, was less (approx. 1%) as the bromination reaction 
mixture was found to promote exchange of the tritium label. 
2.5 SOS PAGE ON SLAB GELS • 
sos PAGE of solubilized SR vesicles was carried out 
according to the method of Laemmli (1970). The running gel 
contained 7% acrylamide and was topped by a layer of stacking gel 
containing 3% acrylamide. The concentration of BIS acrylamide 
cross-linker used was 4% of the total amount of acrylamide and 
the SOS concentration was 0.1% throughout. Protein samples, 8-
10 µg, were dissolved in an appropriate volume of solubilization 
buffer (2% sos, 5 M urea, 0.5% 2-mercaptoethanol and a few grains 
of bromophenol blue), then loaded onto the gel. Gels were 
electrophoresed at 5 oc at a constant current of 20-30 mA for a 
few hours until the tracking dye was located a few cm from the 
bottom. The gels were then removed, fixed in 30% methanol+ 10% 
acetic acid for 30 min, and then stained in 0.1% (w/v) · Coomassie 
Blue in 30% methanol+ 10% trichloroacetic acid for at least 3 h. 
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Destaining was carried out by means of a single 
ethanol + 10% acetic acid followed by clarification 
of washes of 7% acetic acid. The gels were then 
and dried. 
2.6 SR VESICLE PREPARATION 
wash in 30% 
in a couple 
photographed 
SR vesicles were prepared by differential centrifugation of 
back and hind leg muscle homogenates from fasted rabbits 
according to the method of Eletr and Inesi (1972). The vesicles 
were finally resuspended in a medium of 5 mM imidazole, pH 7.4 + 
0.3 M sucrose at a concentration of about 10 mg/ml. Aliquots 
were rapidly frozen in liquid nitrogen and stored at -60 oc. 
Protein concentration was determined from the absorbance at 280 
nm of an aliquot dissolved in 20 mM MOPS.TRIS, pH 7.2 and 1% SDS 
using a conversion factor of 0.90 standardized by the method of 
Lowry et al. (1951) using bovine serum albumin as standard. 
Protein composition was routinely checked by SDS PAGE (Laemmli, 
1970) and the vesicles usually consisted of 80 - 90% ca2+_ATPase 
with small amounts of calsequestrin and sometimes phosphorylase 
and myosin as additional proteins. 
2.7 ATPase ASSAY 
Hydrolysis of the y-phosphate group from nucleoside 
triphosphates catalyzed by SR vesicles was assayed by three 
different methods: by measurement of radioactive [32p]pi 
following extraction of the nucleotide into charcoal (Grubmeyer 
and Penefsky, 1981a), by coupling ADP production to oxidation of 
NADH measured spectrophotometrically (Horgan et al., 1972) and 
lastly by measuring protons released in a pH-stat method (Dupont, 
1985). 
2.7.1 Charcoal method 
The conditions we used were those described by Dupont et al. 
(1982). This involved incubation of SR vesicles (0.1 mg of SR 
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protein/ml) in a medium of 20 mM MOPS, pH 7.2 (25 oc), 100 mM 
KCl, 5 mM MgCl2, 5 mM oxalate, 1 mM EGTA or 0.1 mM CaCl2, and 
varying concentrations of TNP-8N3-nucleotides. Hydrolysis was 
initiated by the addition of [y-32p]-ATP to a final concentration 
of 40, 100 or 200 µMand then 0.2 ml aliquots were removed after 
10, 20 and 30 sand quenched with 6% (v/v) ice cold perchloric 
acid. 0.2 ml charcoal suspension in 0.1 N HCl (250 mg/ml) was 
then added and vortexed. After spinning down the charcoal in a 
microfuge at room temperature, 0.2 ml of the supernatant 
containing hydrolysed [32p]pi was removed and counted in 5 ml 
Insta-gel. 
Hydrolysis of TNP-8N3-[y-32p]-ATP was measured in a medium 
of 50 mM MOPS, pH 7.0 (25 °c), 100 mM KCl, 0.1 mg of SR 
protein/ml, 4% (w/w) A23187 and either (i) 1 .5 mM EDTA, (ii) 5 mM 
MgCl2 and 0.2 mM EGTA or (iii) 5 mM MgCl2 and 0.1 mM CaCl2. The 
reaction was initiated by addition of TNP-8N3-[y-32p]-ATP (final 
concentration = 0.2 mM) and the amount of released Pi was 
determined by the charcoal procedure described above (Dupont et 
al., 1982). 
2.7.2 Coupled enzyme method 
Final concentrations in the Stock Buffer were: 20 mM MOPS, 
pH 6.8, (25 Oc), 100 mM KCL, 5 mM MgCl2, 0.5 mM EGTA, 2.5 mM 
phosphoenolpyruvate, 0.1 mM NADH, 8 units of pyruvate kinase and 
8 units of lactate dehydrogenase. To 2.5 ml of Stock Buffer was 
added 25 µl SR vesicles (0.2 mg/ml) and 4% (w/w) A 23187. 
Reaction was initiated by addition of ATP to 1 mM and 
dependent activity determined spectrophotometrically 
change in absorbance at 340 nm. Following this ca2+ 
to 0.5 mM and the total activity recorded. The ca2+ 






activity from the total activity and converting to umoles/min 
using the extinction coefficient of NADH (6.22 Abs.units.mM-1. 
cm-1 ) . 
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2.7.3 pH-stat method 
The pH-stat assay was carried out in the same medium used by 
Dupont et al. (1985). Final concentrations in the reaction 
mixture were: 1 mM MOPS, pH 7.4, 100 mM KCl, 5 mM MgCl2, 40 µM 
X-537A, 100 µM CaCl2, 22 µg of SR protein/ml, 75 µM ATP and 2 - 5 
µM TNP-8N3-nucleotide. The Mg2+-dependent activity was recorded 
by addition of ATP to the ca2+-depleted medium and measurement of 
the time dependent addition of aliquots of NaOH solution via an 
autoburette to maintain the pH at 7.4. Total activity was 
recorded after addition of ca2+, and ca2+ dependent activity 
calculated by subtraction. H+ release was converted to nmoles 
Pi hydrolysed using a conversion factor of 0.7 H+/pi released. 
2.8 BINDING ASSAYS 
Binding of TNP-8N3-nucleotides to SR vesicles was measured 
by a filtration method (Champeil and Guillain, 1986), inhibition 
of active site cross-linking by glutaraldehyde (Ross and 
McIntosh, 1987a, b) and fluorescence titration (Dupont et al., 
1982; Nakamoto and Inesi, 1984). All manipulations were 
carried out in the dark, or in dim light. 
2.8.1 Filtration assay 
Nucleotide binding by the filtration assay was carried out 
by equilibrating SR vesicles (0.3 mg of protein) with varying 
concentrations of TNP-8N3-[8-14c]-nucleotides in 50 mM MOPS.TRIS, 
pH 7.0 at room temperature, 0.1 mM [3H] sucrose and 5 mM MgCl2. 
At low concentrations of nucleotide, the reaction volume was 
increased up to 20 ml to ensure an excess of free over bound 
nucleotide. After mixing, and equilibrating at room temperature 
for 15 min, the suspension was filtered through two glassfiber 
filters (Whatman GF/F) under mild vacuum. The filters were 
removed, shaken overnight separately in 10 ml Insta-gel (Packard 
Instruments) + 10 µl perchloric acid and counted by liquid 
scintillation counting. The [3H] count was used to calculate 
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the wet volume of the filter and the second filter served as a 
check on this value. 
2.8 . 2 Cross-linking assay 
Intramolecular cross-linking by glutaraldehyde was carried 
out by a modified procedure of that described previously (Ross 
and McIntosh, 1987b). SR vesicles, 0.1 mg, were added to 20 ml 
of 50 mM MOPS/TEA, pH 8.0 with either 1 mM EDTA or 1 mM EGTA + 5 
mM MgCl2 and equilibrated at room temperature with the required 
concentration of TNP-8N3-nucleotide. The large volume ensured 
that the free/bound nucleotide ratio was high. Cross-linking 
was initiated by the addition of 0.5 mM glutaraldehyde and 
quenched after 2.5 min by addition of 25 µl hydrazine. Vesicles 
were collected on GF/F filters by filtration under reduced 
pressure and washed once with 50 mM phosphate pH 7.0. Filters 
were shaken vigorously overnight in 1 ml electrophoresis sample 
buffer (0.1% (w/v sodium dodecyl sulfate, 0.01% (v/v) Bromophenol 
Blue, 0.1% (v/v) 2-mercaptoethanol and 0.1 mM sodium phosphate, 
pH 7.0). Aliquots of 60 µl were then electrophoresed on 7% 
acrylamide gels (Ross and McIntosh, 1987a, b). The dried gels 
were scanned and the appropriate peaks integrated. 
2.8.3 Fluorescence titration 
Fluorescence titration of TNP-8N3-nucleotide binding to SR 
vesicles was carried out under nonturnover and turnover 
conditions. In the case of the former, final concentrations in 
the cuvettes were 0.2 mg of protein/ml, 50 mM MOPS/TRIS, pH 7.0, 
either 1 mM EDTA or 20 mM MgCl2 and variable concentrations of 
TNP-nucleotides. Measurements were made on an Aminco 
spectrofluorimeter (model SPF-500) with the excitation and 
emission wavelengths set at 418 and 530 nm respectively. In the 
experiments involving enzyme turnover, the final concentrations 
were 0.2 mg of protein/ ml, 20 mM MOPS/TRIS, pH 8.0, 20% (w/v) 
glycerol, 5 mM MgCl2, 50 µM CaCl2 and variable concentrations of 
TNP-nucleotides. Turnover was initiated by the addition of 100 
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µM ATP and 50 µM CaCl2 and then stopped by addition of 1 mM EGTA. 
The decrease in fluorescence upon addition of EGTA was taken as 
indicating the extent of binding to the superfluorescent site. 
2.9 PHOTOAFFINITY LABELING OF SR VESICLES 
TNP-8N3-nucleotides were irradiated at room temperature in 
quartz cuvettes positioned 8 cm from a Xenon light source of 150 
W and with a front facing reflector positioned behind the 
cuvette. The light beam was filtered in front and behind by 
toluene contained in standard (1 cm path length) quartz cuvettes. 
Irradiation time was usually 3 min. Under these conditions and 
in the absence of azido nucleotide, inactivation of ATPase 
activity was less than 3%. 
The standard irradiation medium was 20 mM Buffer, 20% (w/v) 
glycerol, 5 mM MgCl2, 0.2 mg of SR protein/ml and concentrations 
of TNP-8N3-[2-3H]-AMP, EGTA, CaCl2 and ATP indicated in the 
legends to the figures. The Buffers were as follows: pH 6.0-6.5, 
MES/TMAH; pH 7.0-7.5, MOPS/TMAH; pH 8.0-8.5, HEPPS/TMAH; pH 9.0-
9.5, CHES/TMAH. Controls were prepared by irradiating the 
vesicles in the absence of azido-nucleotide and then adding the 
latter to the particular concentration of the test samples. 
Covalent labeling of SR vesicles was measured using the 
radiolabeled nucleotide derivatives. The vesicles (0.2 mg of 
protein/ml) were collected on glass fiber filters (Whatman GF/F) 
under mild vacuum and the filters were washed extensively with 50 
mM phosphate buffer, pH 7.0. Filters were counted in 10 ml 
Insta-gel. Protein loss was less than 5%. 
2.10 ACTIVE SITE CROSS-LINKING OF PHOTOLABELED VESICLES 
Active site cross-linking of photolabeled vesicles 
glutaraldehyde (Ross and McIntosh, 1987a, b) was carried out 
diluting the irradiated samples 100 fold into 50 ml of 50 
MOPS/TEA, pH 8.0, and 50 µM CaCl2, to lower the concentration 
free nucleotide to below the Ka and then reacting 








reaction was quenched with 5 µl hydrazine and the vesicles 
collected on GF/F filters and washed with 50 mM phosphate buffer, 
pH 7.0. The filters were shaken overnight in 1 ml 
electrophoresis sample buffer (see section 2.8.2) and then 80 µl 
aliquots were electrophoresed on 7% acrylamide gels. The 
concentration of stock glutaraldehyde was determined by isolation 
of the 2,4-dinitrophenyl hydrazone derivative. 
2.11 FLUORESCENCE MEASUREMENTS OF PHOTOLABELED VESICLES 
Photolabeled vesicles were prepared as above in a medium at 
pH 8.5. Controls were prepared by adding TNP-8N3AMP after 
irradiation. Following irradiation, 0.1 mM ATP was added to the 
samples, if ATP was not already present, and then passed through 
a column (0.3 x 1 cm) of Dowex 1 X4 resin, equilibrated with the 
irradiation medium to remove noncovalently attached nucleotide. 
Loss of protein was approximately 10 % and the fluorescence of 
the samples was compared to controls that had also been passed 
through the columns. The addition of ATP was found to aid 
removal of noncovalently bound TNP-8N3AMP. The fluorescence was 
measured, as above, on the undiluted samples with the additions 
indicated in the legend to the figure. · 
2.12 TUBE GEL ELECTROPHORESIS 
Location and quantitation of the covalently attached 
nucleotide on the ATPase and tryptic fragments and subfragments 
was carried out using a tube gel electrophoresis method with 10% 
acrylamide (Weber and Osborne, 1969). The gels were either 
stained with Commassie Blue or cut into 1 mm slices and 
dissolved by incubation at 70 oc with 1 ml of 30% hydrogen 
peroxide in scintillation vials. The samples were counted in 10 
ml Insta-gel. 
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2 .1 3 PEPTIDE MAPPING 
2. 13.1 Isolation of labeled peptides 
Covalently labeled tryptic peptides were isolated essentially 
as described by Kirley et al. (1984). Photolabeling was carried 
out in a medium of 25 mM Hepps/TMAH, pH 8.5, 20% glycerol, 5 mM 
MgCl2, 0.5 mM CaCl2, 2 µM TNP-8N3-[2-3H]-AMP, 0.2 mg/ml SR and 
either with or without 250 µM ATP. 40 samples of 2.5 ml, both 
with and without ATP, were irradiated for 3 min and pooled 
separately. The two batches were then diluted 1:2 with H20 and 
centrifuged for 60 min at 50000 rpm. The labeled pellet was 
resuspended in 10 mM MOPS.TEA, pH 7.2, 1 mM EDTA and 15 mM NaCl, 
using a Dounce homogeniser. Trypsin was added to a final 
concentration of 1:20 (w/w, trypsin:SR). The trypsinization 
reaction was carried out at 37 oc for 7.5 h then terminated by 
addition of 5 mM phenylmethylsulfonyl fluoride and the membranes 
pelleted by centrifugation at 40000 rpm for 40 min . The 
supernatant was lyophilized to dryness, redissolved in H20, and 
fractionated by HPLC on a Radial Pak C18 column. Three 
different binary mobile phases were used each of which involved 
injecting the sample on in buffer A and eluting with a gradient 
of buffer B. In the first system, buffer A was 0.1% TFA in H20 
and buffer B was 0.1% TFA in 60% acetonitrile. In the second 
system, buffer A was 5 mM PIC reagent 
phosphateJ WATERS) in H20 and buffer B was 
60% acetonitrile. In the third system 
A (tetrabutylammonium 
5 mM PIC reagent A in 
buffer A was 0.01 M 
ammonium acetate, pH 4.0 and buffer B was 80% isopropanol and 20% 
buffer A. A flow rate of 3 ml/min was used with the first two 
systems and 2 ml/min with the third system. The particular 
mobile phase used is indicated in the legend to the figures. 
The absorbance of the effluent was monitored at 215-240 nm and at 
254 nm and peaks or fractions were collected manually and assayed 
for radioactivity. The radioactive peaks were lyophilized and 
then rechromatographed using a different mobile phase. The 
purified peptides were lyophilized to dryness and stored at -20 
0 c prior to amino acid analysis and sequencing. 
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SR vesicles were also labeled with FITC by incubation at 1 
mg / ml in 100 mM TRIS.HCl, pH 8.6, 2mM EDTA and 5 µM FITC for 30 
min in the dark at room temperature . The reaction was quenched 
by the addition of 15 µM 2-mercaptoethanol and then the vesicles 
col lected by centrifugation at 40000 rpm for 60 min. The 
vesicles were then resuspended in 10 mM MOPS/triethanolamine, pH 
7 .2 , homogenized, pelleted again and - then trypsinized as 
described above for the TNP-8N3AMP labeled peptides. 
2 .1 3.2 Amino acid analysis of labeled peptides 
Purified peptides were dissolved in H20 and an aliquot 
thereof removed into pyrolyzed test-tubes. Amino acid analysis 
was carried out according to the complete Picotag method 
(Waters). Samples were dried in vacuo using the Waters 
workstation and evacuation vessels. Vapour Phase hydrolysis was 
carried out overnight (17 h) with constant boiling HCl at 75 oc 
fo l lowed by removal of the gas, neutralization with TEA and 
derivatization with PITC. After removal of the unreacted PITC 
i n vacuo, the derivatized amino acids were dissolved in 100 µl 
sample diluent (Waters) and placed in the WISP autosampler and 
analyzed by HPLC. The two buffers used for HPLC were, Picotag 
Eluent A (0.14 M sodium acetate, pH 6.4 + 6% acetonitrile), and 
Picotag Eluent B (60% acetonitrile in H20). Samples were 
in j ected onto the column in 100% A and eluted with a gradient of 
B. Standard amino acids (Pierce amino acid standard H) were 
incorporated in the general protocol before and after the 
hydrolysis step in order to measure the lability of the different 
ami no acids to acid hydrolysis. 
2 .1 3.3 Amino acid sequencing 
Sequence determination of purified peptides and peptide 
standards was carried out according to the method of Brandt and 
Frank (1988). Filter holders were made by drawing out Kimble 12 
x 75 mm disposable test-tubes over a flame and were fitted with 
10 mm diameter discs of Whatman GF/C filter paper. These were 
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treated with polybrene and then subjected to a blank run of 
fixing, derivatization and hydrolysis described below. 
Thereafter a few microlitres of peptide containing solution was 
applied to the filter and evacuated in a vacuum vessel. 
Sequential Edman degradation of the peptide was then performed as 
described (Brandt and Frank, 1988) and the PTC-amino acids washed 
into pyrolyzed boiling tubes. The PTC-amino acids were then 
converted to the PTH-amino acids by treating with acid and then 
analyzed by HPLC as described above. The gradient used was 10 -
50% acetonitrile in 17 mM ammonium acetate pH 4.5. Experimental 
peaks were identified by comparing both to amino acid standards 
and to similarly treated synthetic peptide standards. 
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3 RESULTS 
3. 1 SYNTHESIS OF TNP 8N3 NUCLEOTIDES 
3 . 1 . 1 Synthesis and purification of 8-Br-ATP 
The elution profil~ of the reaction products following 
bromination of ATP and chromatography on a column of Dowex 1 X8 
anion exchange resin is shown in Fig. 3.1. The absorbance 
spectrum of the purified compound is compared with that of ATP in 
the inset. The peak absorbance at 263 nm is characteristic of 
8-BrATP. It was necessary to obtain a good separation at this 
stage to prevent carryover of ATP which, if allowed, could have 
resulted in contamination of the final prparation with TNP-ATP. 
Contamination with even a small amount of TNP-ATP would 
complicate the interpretation of results because of the high 
affinity of the analog for the ca2+_ATPase. Contaminating ATP 
of the nucleotide prepared in this way was judged to be less than 
5% by HPLC. The yield of 8-Br-ATP was 50 % from starting ATP 
and the final preparation contained a certain amount of LiCl, 
which was removed in the next step. 
3. 1 . 2 Synthesis and Purification of 8-N3-nucleotide 
The elution profile of the reaction products following the 
azido reaction and chromatography on a column of DEAE-Sephadex A-
25 is shown in Fig. 3.2. The absorbance spectrum of 8N3ATP is 
compared with that of 8-BrATP in the inset. A good separation 
was obtained between 8N3AMP, 8N3ADP, and 8N3ATP. Smaller 
amounts of 8-BrAMP, 8-BrADP, and 8-BrATP eluted just ahead and 
were well separated from their respective azido derivatives. 
They are not seen in the profile as they do not absorb strongly 
at 280 nm. The purified compounds had absorbance maxima shifted 
to 281 nm (Fig. 3.2, inset) consistent with the extension of the 
conjugated adenine ring structure by the azido group (Schafer et 
al., 1978). The peak at 281 nm was susceptible to light and 
disappeared after irradiation (see later). 
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Figure 3.1 Anion Exchange Separation and Spectral Properties of 
Brominated Nucleotides. 




1 X8 and eluted with a linear gradient from 0.13 M LiCl + 
N HCl to 0.25 M LiCl + 0.001 N HCl (4 1 + 4 1) followed by 
1 of 0.25 M LiCl + 0.001 N HCl at a flow rate of 300 ml/h. 
Fractions were collected and the absorbance measured at 254 nm. 
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Figure 3.2 Anion Exchange Separation and Spectral Properties of 
Azido Nucleotides. 
Nucleotides (1.0 mmol) were appliied to a column (3 x 60 cm) of 
DEAE-Sephadex A-25 and eluted with a linear gradient from 0.06 
0.6 M TEA.HC03- (3 1 + 3 1) at a flow rate of 150 ml/h. 
Fractions were collected and the absorbance measured at 280 nm. 
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3. 1 . 3 Synthesis and purification of TNP-8N3-nucleotides 
Initially, we performed the synthesis exactly as described by 
Hiratsuka (1982) but substituting 8N3ADP for ADP. The reaction 
products were purified on Sephadex LH20 as described by Hiratsuka 
(1982) (Fig. 3.3). The priciple reaction product had a reduced 
UV absorbance maximum at 273 nm in addition to the visible 
spectrum characteristic of the TNP moeity (Fig. 3.4). However, 
the substituted adenine ring absorbance was unaffected by 
irradiation with UV light and the compound was postulated to be 
TNP-8NH2-ATP. A compound with UV absorbance maximum at 273 nm 
following reduction of 8-azido-adenine has previously been 
postulated to be 8NH2-ATP (Schafer et al., 1978; Fitzpatrick et 
al . , 1985). The reduction of the azido group to the amino group 
is probably caused by the sulfite anion released by TNBS 
attachment of the trinitrophenyl group to the ribose 
(Fitzpatrick et al., 1985) (Fig. 3.5). None of the other 




Using a more rapid HPLC system with better resolving power 
to separate the reaction products, a small amount of TNP-8N3-
nucleotide could be obtained if the reaction mixture was 
fractionated shortly after mixing. A typical profile following 
separation of the mixture by HPLC and using 8N3ATP as starting 
material is shown in Fig. 3.6. The peak identified as TNP-
8N3ATP had absorbance maxima at 281 run, 408 nm, and 468 nm. The 
yield of. TNP-8N3ATP was only 3%, however, and the principle 
reaction products were considered to be 8NH2-ATP and TNP-8NH2-
ATP. 
To increase the yield of TNP-8N3-nucleotides, we 
experimented with the introduction of an oxidising agent into the 
reaction mixture to react with the released S032- and so prevent 
it's reaction with the azido group. Out of a number of agents 
tested, DTNB was found to be the best. Inclusion of DTNB in the 
reaction mixture not only prevented the unwanted reduction .from 
occurring but also improved the yield of the TNP reaction from 
the published value of 50% (Hiratsuka, 1982) to about 80% (Fig. 
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Figure 3.3 Separation of Trinitrophenylation Reaction Mixture on 
Sephadex LH 20. 
Nuc leotides 
Sephadex LH 
(25 µmol) were applied to a column (2 x 16 
20 and eluted with H20 at a flow rate of 
cm) of 
15 ml/h. 
Fractions (4 ml) were collected and the absorbance measured at 















Figure 3.4 Absorbance Spectrum of the Principle Reaction Product 
of the Trinitrophenylation Reaction. 
Fractions 16 - 22 from the separation shown in Fig. 3.3 were 
pooled and lyophilized. The lyophilizate was redissolved in 10 
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HPLC Separation of Trinitrophenylation Reaction 
Mixture. 
The trinitrophenylation reaction mixture, using 8N3ATP as the 
starting material was carried out in the absence of DTNB as 
described in EXPERIMENTAL PROCEDURES. The products of the 
reaction mixture were separated on a Radial Pak C18 column with 
solvent A as 75 mM KH204, pH 5.0 and solvent Bas as for solvent 
A with 60% acetonitrile. The peak identified as TNP-8N3ATP was 
lyophilized, desalted and then scanned in 10 mM MOPS/TRIS, pH 8.0 
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Figure 3.7 HPLC Separation of trintrophenylation reaction mixture 
in the presence of DTNB. 
Conditions were exactly as described in Fig. 3.6 except that DTNB 
was included in the reaction mixture. Aliquots, 1.2 ml, of the 
reaction mixture were then fractionated by HPLC as described 
above and the appropriate peak collected. A and B represent two 
successive purifications of the TNP-8N3-AMP reaction mixture, and 
C is an analytical run. 
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effect on the reaction following the removal of product, S032-. 
TNP-8N3ADP and TNP-8N3AMP were prepared in a similar way 
with similar yields. We optimized the nucleotide separation by 
changing the salt concentration within the 20-100 mM range. 
The absorbance spectrum and proposed structure of TNP-8N3ATP 
are shown in Fig. 3.8. The spectra of TNP-8N3ADP and TNP-8N3AMP 
are similar (data not shown) although we found small differences 
in extinction coefficient (see below). The measured absorbance 
maxima are 281 nm for the 8-azido-adenine group and 408 and 468 
nm for the TNP group. The absorbance at 281 nm is light 
dependent (Fig.3.8) and diminishes after irradiation with UV 
light. As reported for TNP-ATP (Hiratsuka and Uchida, 1973), 
the absorbance of the TNP group is pH dependent and disappears at 
acid pH. Irradiation with the same light source (Xe, 150 W) 
that produces complete disappearance of the 281 nm peak but after 
passing through a 406 nm cuton filter giving about 45% 
transmittance has only a slight effect after 60 min demonstrating 
that light of the wavelength of absorbance of the 8-azido-adenine 
group is required to activate the azido group. 
TNP-8N3-nucleotides were stored as a 15 - 20 mM solution in 
H20 at -20 °c, and were stable for at least two years, on the 
basis of their spectral characteristics. 
3.2. SYNTHESIS AND PURIFICATION OF RADIOLABELED DERIVITIVES 
The method for synthesis of the [8-14c] and 
derivatives of the TNP-8N3-nucleotides was developed because of 
the small amounts of nucleotide involved as well as to minimize 
the number of manipulations. The main differences between this 
method and that used for the large scale preparation of unlabeled 
nucleotides were, firstly, the brominated derivatives were eluted 
from the HPLC column with a gradient of acetonitrile in TEA.HC03-
and evaporated to dryness. This obviated the necessity for a 
separate desalting step and also left the 8-Br-ATP as the TEA 
salt. Secondly, the separation after the azido reaction was 
omitted and the nucleotides trinitrophenylated directly. A new 
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Figure 3.8 Absorption spectra of unphotolysed and photolysed 
TNP-8N3ATP. 
TNP-8N3ATP was scanned in 10 mM MOPS/TRIS, pH 7.0 
line), then the cuvette was removed and irradiated 
(dashed line). The proposed structure of TNP-8N3ATP 
alongside the spectra. 
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(continuous 
for 3 min 
is shown 
triphosphate derivatives. Although a good separation was 
obtained, a second HPLC purification was always carried out even 
if it served only to demonstrate purity. In this way we were 
able to obtain good yields from a three step organic synthesis. 
Yields from starting [8-14c]-ATP were: 11% (TNP-8N3-[8-14c]-
AMP), 4% (TNP-8N3-[8-14c]-ADP) and 10% (TNP-8N3-[8-14c]-ATP) and 
the specific radioactivity of each was 6300 cpm/nmol. Purity 
was checked by the following criteria: a spectrophotometric peak 
with UV absorbance maximum between 281 and 283 nm, a single peak 
on HPLC and single radioactive and UV absorbing spots on TLC 
(Fig. 3;9). 
3.3. CHEMICAL PROPERTIES OF TNP-8N3-NUCLEOTIDES 
Elemental analysis of TNP-8N3ATP was carried out: 
calculating for C16H12N11K5019P3.7.8H20 (1091.29) (for TNP-ATP 
see Hiratsuka and Uchida, 1973): C, 17.61; H,1 .11; N,14.12. 
Found: C, 18.75; H, 2.3; N, 14.1. The extinction 
coefficients for the three compounds were calculated by comparing 
the specific activity of the synthesized TNP-8N3-[8-14c]-AXP with 
that of the starting [8-14c]-ATP using an extinction coefficient 


















The Rf values on PEI-cellulose TLC plates developed in 2 M 
formic acid and 0.5 M LiCl were: TNP-8N3ATP (0.02), TNP-8N3ADP 
(0.33), TNP-8N3AMP (0.59). 
An attempt to analyze the samples by mass spectroscopy was 











Figure 3.9 Separation of TNP-8N3-[8-l!CJ-nucleotides by TLC. 
TNP-8N3-[a-14c]-ATP, -ADP, and -AMP were spotted on a PEI-
cellulose TLC plate (Merck) and developed in 2 M formic acid + 
0.5 M LiCl. The plate was then dried and exposed to NH40H 
fumes. Spots could be seen in visible light (orange) and UV 
light (blue). The plate was then scanned on a proportional gas 
flow scanner to identify areas of radioactivity. 
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3.4. SR PROTEIN COMPOSITION 
The protein content of an SR vesicle preparation stained with 
Coomassie Blue is shown in Fig. 3.10. The predominant protein 
species present is the Mr 110 kDa ca2+_ATPase and Mr 50 kDa 
calsequestrin. 
3.5 EFFECT OF TNP-8N3-NUCLEOTIDES ON ATPase ACTIVITY 
The effect of TNP-8N3ATP on the hydrolysis of (y-32p]-ATP by 
the ca2+_ATPase, under conditions of vesicle loading in the 
presence of oxalate, as assayed by the charcoal method, is shown 
in Fig. 3.11. At all three concentrations of ATP used, TNP-
8N3ATP in the 25-100 µM range, had little effect on the 
hydrolysis of ATP but at higher concentrations, the activity was 
inhibited. This pattern suggests that the interaction of TNP-
8N3ATP with the ca2+_ATPase is complex and cannot simply be 
described by competitive inhibition. 
The effect of TNP-8N3-nucleotides on ATP hydrolysis under 
conditions of maximal enzyme turnover in the presence of ca2+ 
ionophore, was examined using a pH-stat procedure by which Dupont 
et al. (1985) showed that TNP-ATP and TNP-AMPPNP accelerated 
ATPase activity approximately two-fold. 
8N3AMP, TNP-8N3ADP, and TNP-8N3ATP (5 µM 
hydrolysis of ATP (75 µM) 1.0-, 1.4-, and 
Using this method, TNP-
each) accelerated the 
1.5-fold respectively. 
Higher concentrations of nucleotides did not result in greater 
had no acceleration. Dupont et al .. (1985) found that TNP-ADP 
accelerating effect on ATP hydrolysis, and it appears that the 
azido derivative may differ in this respect. However, it has 
been found that TNP-ADP accelerates E2-P hydrolysis approximately 
2-fold (Champeil et al., 1988). 
TNP-8N3ATP itself is hydrolysed at a low rate by SR vesicles 
(< 10 nmol/min/mg of protein at 25 oc) in a medium including 50 
mM MOPS.TRIS, pH 7.0, 0.1 M KCl, 5 mM MgCl2, 200 µM TNP-8N3-[y-
32p]-ATP, 4% (w/w) A23187, 0.1 mg of SR protein/ml and either 
wi~h or without 100 mM CaCl2. 
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Figure 3.10 Electrophoretic Analysis of SR Vesicle Preparation. 
SR vesicles 
polyacrylamide 
The gel was 
dried. 
(10 µg of SR protein) were loaded onto a 
gel (Laemmli, 1970) and electrophoresed at 5 
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Fig~re 3.11. Effect of TNP-8N3-ATP concentration on ATPase 
activity. 
ca2+-stimulated ATPase activity was measured using [y-32p]ATP and 
the charcoal extraction procedure in a medium of 20 mM MOPS pH 
7.2, 100 mM KCl, 5 mM MgCl2, 5 mM oxalate, 0.1 mM CaCl2 and 0.1 
mg of SR protein/ml and the indicated concentrations of TNP-8N3-
nucleotides. 
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3 . 6 . BINDING TO SR VESICLES 
3. 6. 1 Binding under nonturnover conditions 
Binding of TNP-8N3-nucleotides to SR vesicles in the absence 
of ATP using a filtration method is shown in Fig. 3.12. In the 
low concentration range, namely 10-8-10-6 M (see inset for linear 
scale), the nucleotides bound in a saturable manner to the extent 
of 4 - 6 nmoles/ mg protein, an amount equivalent to the active 
ATPases as judged by the levels of phosphoenzyme obtained from Pi 
in the presence of 30% (v/v) Me2SO (McIntosh and Ross, 1988). 
The monophosphate species exhibited the highest affinity (ko.s = 
0.1 µM) and the di- and triphosphate having approximately equal 
affinity (ko.s = 0.2 µM). At concentrations in excess of 10-5 M 
additional binding was observed, which is greatest in the case of 
the triphosphate species and appears to be nonsaturable. 
We were unable to measure binding in the presence of EDTA 
using this technique as the absence of divalent cation appeared 
to destabilize the vesicles under the conditions used resulting 
in low levels of binding being measured. 
On account of this, the effect of MgCl2 on nucleotide 
b inding was examined by means of a fluorescence assay (Fig. 
3.13). In the presence of EDTA (Fig. 3.13A), binding of all 
three nucleotides to a saturable site could be discerned in the 0 
- 2 µM range. In these experiments the concentration of ATPases 
was approximately 1 µMand the binding curves are consistent with 
the titration of the high affinity catalytic site in this 
concentration range. The binding of TNP-ATP was 
indistinguishable from that of the azido nucleotides (results not 
shown). In the presence of 20 mM MgCl2, additional binding, 
especially in the case of the triphosphate species, is evident 
(Fig. 3.13B). The effect of the cation was less marked with 
TNP-ATP. The binding curves in the presence of 1 mM MgCl2 were 
similar to those with EDTA (results not shown). The results 
indicate that high concentrations of MgCl2 enhance the binding of 
the azido nucleotides to SR vesicles. 
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Figure 3.12. Binding of TNP-8N3-nucleotides measured by 
filtration procedure. 
a 
The binding of TNP-8N3-[a-14c]ATP (circles), TNP-8N3-[14c]ADP 
(triangles) and TNP-8N3-[a-14c]AMP (squares) was measured in 50 
.mM MOPS/TRIS, pH 7.0, 5 mM MgCl2, trace of [3H] sucrose, the 
concentrations of TNP-8N3AXP indicated and 0.3 mg of SR protein. 
The binding curve for TNP-ATP was similar to that for TNP-8N3AMP 
and is not shown. A linear plot of the data points up to 1 µM 




1mM EDTA 20mM MgC1 2 
60 
• TNP-8N3AMP 
• TNP-8N 3ADP u. 
• TNP-8N3ATP <l 
~ 40 > -IV 
~ .. 
20 
0 2 4 6 8 10 
TNP-nucleotide (J.1M) 
Figure 3.13. Binding of TNP-8N3_-_n_u_c_l_e_o_t_i_d_e_s _____ m_e_a_s_u_r_e_d ____ b_y_ 
fluorescence. 
Binding was measured in 50 mM MOPS/TRIS, pH 7.0, 0.2 mg of SR 
protein/ml and either 1 mM EDTA (A) or 20 mM MgCl2 (B) and the 
indicated concentration of TNP-8N3-nucleotides. The difference 
in fluorescence intensity before and after addition of nucleotide 
is plotted against nucleotide concentration. 
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Specific binding of nucleotides to the active site 
ca2+_ATPase can be measured by inhibition of active site 




cross-link alters the hydrodynamic properties of the enzyme in 
sodium dodecyl sulfate such that it migrates on electrophoresis 
in polyacrylamide with an apparent molecular weight of 125 kDa 
instead of the usual 110 kDa (Ross and McIntosh, 1987b). The 
binding of TNP-8N3AMP and inhibition of cross-linking is shown in 
Fig. 3.14. The glutaraldehyde concentration and the time of 
cross-linking were adjusted to give approximately 40% E(125) 
formation in the absence of nucleotide (lanes 2 and 10), so that 
initial rates of cross-link formation were measured. The 
concentration of protein was kept low in these experiments (20 µg 
of SR protein/ml) in order to ensure that the bound/unbound 
nucleotide ratio was low. TNP-8N3AMP caused increasing 
inhibition of E(125) formation in the presence of EDTA (lanes 3-
9) and in the presence of 5 mM MgCl2 (lanes 11-17). The results 
obtained in this way, for the mono-, di-, and triphosphate 
species in the presence of 5 mM MgCl2, and expressed as a 
percentage of control rate of E(125) formation are shown in Fig. 
3.15. The data fit well to a mechanism in which there is a 
single noninteractive nucleotide binding site. The Ka values 
obtained for the best fit of the data are in reasonable agreement 
with those obtained by the filtration method (Fig. 3.12). In the 
presence of 1 mM EDTA Ka values of 0.8, 1.0, 0.3 and 0.12 µM were 
obtained for the mono-, di-, and triphosphate azido nucleotides 
and TNP-ATP respectively. MgCl2, therefore, only affected the 
binding of TNP-8N3AMP significantly. 
3.6.2 BINDING UNDER TURNOVER CONDITIONS 
The fluorescence increase observed with TNP-ATP was compared 
with that of the azido derivatives measured under turnover 
conditions as a function of TNP nucleotide concentration (Fig. 
3.16). All of the azido derivatives displayed approximately 
equal superfluorescence, but the amplitude of the fluorescence 
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Figure 3.14. Binding of TNP-8N3AMP measured by inhibition of 
active site cross-linking: gel. 
SR vesicles (5 µg of protein/ml) were equilibrated for 5 min at 
25 °c in 50 mM MOPS/TEA, pH 8.0, either 1 mM EDTA or 1 mM EGTA + 
5 mM MgCl2 and the concentrations of TNP-8N3AMP indicated. 
Samples were then reacted with 0.5 mM glutaraldehyde and quenched 
after 2.5 min with 25 µl hydrazine. Aliquots were 
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3.15. Binding of TNP-8-N3-nucleotides measured by 
inhibition of active site cross-linking 
inhibition curves .. 
Conditions are as described in Fig. 3.14 in the presence of 5 mM 
MgCl2 and 1 mM EGTA. Inhibition curves were fitted to the 
percentage decrease in E(125) species according to the equation 
ko.5 = (E-EL)(L-EL)/EL where E = total site concentration (5.5 
nmol/mg of protein), L = total nucleotide concentration and EL = 
concentration of enzyme.nucleotide complex and using the 
following ko.5 values: TNP-8N3ATP, 0.3 µM; TNP-8N3ADP, 0.4 µM; 
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• TNP-8N3 AOP 
• TNP-8N3 ATP 
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Figure 3.16. Turnover-dependent fluorescence increase of TNP-8N3-
nucleotides. 
Final concentrations were: 20 mM TRIS/MOPS, pH 8.0, 20 % (v/v) 
glycerol, 5 mM MgCl2, 0.2 mg of SR protein/ml, 50 µM CaCl2, 100 
µM ATP and 2-20 µM TNP-8N3ATP (circles), TNP-8N3ADP (closed 
triangles), TNP-8N3AMP (squares) or TNP-ATP (open triangles). 
Enzyme turnover was stopped by addition of 1 mM EGTA and the 
decrease in fluorescence as a result of this addition is plotted 
as a function of nucleotide concentration. 
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appear to have a lower affinity for the superfluorescent site 
compared with TNP-ATP and the competition with ATP may account 
for the lower fluorescence yield. Alternative explanations are 
that the compound has a lower level of intrinsic fluorescence, or 
a slightly different orientation in the nucleotide site. 
3.7. LABELING CONDITIONS 
Irradiation of SR vesicles in quartz cuvettes with an 
unfiltered Xenon light source resulted in inactivation of enzyme 
activity to the extent of about 50% within 3 min. It was thus 
apparent that it would be necessary to filter out the shorter 
wavelength light in the region of protein absorbance. By 
carrying out the illumination in glass cuvettes, inactivation was 
completely prevented but activation of the azido group within the 
times used was also very low. Out of a number of organic 
solvents tested, toluene, which has a cutoff in the UV at 
approximately 285 nm, gave the best result. The filter did not 
appear to substantially affect activation of the azido group and 
a curve of photolabeling of SR vesicles with time showed 
photoincorporation to the extent of 90% within 3 min (Fig. 3.17). 
Inactivation of SR vesicles in the absence of azido nucleotide 
under these conditions was less than 3%. 
Glycerol was included in the irradiation medium to stabilize 
the ATPase, and obviates the need to add glycerol in the 
fluorescence experiments described later in Section 3.10. The 
effect of glycerol on incorporation was found to be slight (Fig. 
3.18) although there appeared to be a slight decrease in 
nonspecific labeling. 
3.8. PHOTOAFFINITY LABELING OF SR VESICLES 
The results of irradiation of SR vesicles in the presence of 
TNP-8N3AMP under four sets of conditions, namely, (A) in the 
presence of ca2+, (B) in the presence of ca2+, Mg2+, and ATP 
(only binding to the regulatory and superfluorescent sites), (C) 
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Figure 3.17. Time dependence of TNP-8N3-AMP labeling with toluene 
filters. 
SR vesicles were irradiated with a Xenon light source through 
toluene filters in a medium containing 20 mM MOPS, pH 8.0, 20% 
glycerol and 2 µM TNP-8N3-[2-3H]-AMP. The vesicles were 
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Figure 3.18. Photoaffinity labeling of SR vesicles in the 
presence and absence of glycerol. 
SR vesicles were irradiated in a medium containing 
8.5, 2 µM TNP-8N3AMP and either with or without 
The vesicles were collected by filtration and then 
radioactivity. 
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20 mM MOPS, pH 
20% glycerol. 
assayed for 
100 µM ATP, is shown in Fig. 3.19. In the series of panels on 
the left, irradiation was done at pH 6.0 (open circles) and 9.0 
(closed circles) as a function of TNP-8N3-nucleotide 
concentration. Under each of the conditions, (A), (B), (C), and 
(D), the labeling at pH 6.0 was simi l ar and nonsaturable in the 
0-10 µM concentration range. At pH 9.0, under nonturnover 
conditions, namely (A) and (C), there was a sharp rise in the 
amount of labeling at low concentrations of nucleotide (0-2 µM) 
to reach a plateau level of 2-2.5 nmol/mg of protein. The 
concentration of active ATPase polypeptides in these experiments 
was approximately 1 µM (0.2 mg of protein/ml and approximately 5 
nmol of ATPases/mg of protein). Hence occupancy of the 
catalytic site, which can be expected to be saturated at 
approximately 2 µM, results in the covalent incorporation of 
nucleotide to the extent of about half the sites. This labeling 





conditions (B), a plateau level of labeling 
at 5 µM TNP-8N3AMP, which correlates with 
is 
the 
the concentration of TNP-nucleotide required to 
superfluorescent (Fig. 3.16) and regulatory (see 
saturate 
above) sites. 
The level of labeling reached was 4.0 nmol/mg of protein, or 
approximately 80% of active ATPases. 
The pH dependence of photolabeling in the presence of 2 µM 
TNP-8N3AMP and the effect on ATPase activity is shown in the 
series of panels on the right-hand side of Fig. 3.19. As 
already seen, there is increased labeling as the pH is increased 
at this concentration of nucleotide irrespective of whether the 
enzyme is turning over (B) or not (A and C). The pH dependence 
under the different conditions was similar. The sites labeled in 
the presence of ATP and EGTA (D) do not show this pH dependence. 
At pH 6.0, there was approximately 10% inactivation of ATPase 
activity despite the fact that there was labeling to the extent 
of about 1.3 nmol/ mg of protein (25% of active ATPases). 
Clearly, most of the labeling was at a site (s) which does not 
affect activity. As the pH was increased, inactivation of 
ATPase activity increased. At pH values above 8.0, there was a 
close correlation between the percentage ATPase labeling (taking 
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Figure 3.19. Covalent incorporation of TNP-8N3AMP into SR 
vesicles. 
In the left hand series of panels, SR vesicles (0.2 mg of 
protein/ml) were irradiated in 20 mM Buffer pH 6.0 (open circles) 
or pH 9.0 (closed circles), 5 mM MgCl2, 20 % (v/v) glycerol, the 
indicated concentrations of [3H]TNP-8N3AMP and either (A) 50 µM 
CaCl2, (B) 50 µM CaCl2 + 100 µM ATP, (C) 0.5 mM EGTA, or (D) 0.5 
mM EGTA + 100 µM ATP. Aliquots containing 0.2 mg of protein were 
then filtered, washed, and counted. On the right hand side, the 
vesicles were irradiated in a similar manner except that the pH 
was varied as indicated and the concentration of TNP-8N3AMP was 2 
µM. Aliquots were then filtered as above or assayed for ATPase 
activity using the coupled enzyme method. The various buffers 
used are described in Experimental Procedures. 
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5 nmol/ mg of protein as the amount of active ATPases) and 
percentage inactivation of ATPase activity, again, irrespective 
of whether the enzyme was turning over (B) or not (A and C). 
Note that the pH dependence of inactivation of ATPase activity 
and of labeling were not identical, the former being shifted to a 
slightly lower range. This is due to the fact that in the 6-7 pH 
range the total amount of labeling does not increase appreciably 
but the locus of labeling is shifted increasingly to the 
catalytic site. This means that in the lower pH range the 
catalytic site was not the only site labeled and the curve cannot 
be used to obtain the pK of the ionizing group. This value is 
obtained from the inactivation of ATPase activity which is due 
only to labeling of the catalytic site and is approximately 7.4 
The above experiments were carried out with 2 µM TNP-8N3AMP. 
According to Fig. 3.19B (left side), a higher level of labeling 
could be obtained under turnover conditions at higher 
concentrations of nucleotide (up to 4.0 nmol/ mg of protein or 
80% of active ATPases). In keeping with this, we found that 
ATPase activity was inhibited to the extent of 80% using 10 µM 
TNP-8N3AMP (Fig. 3.20). A second irradiation, following removal 
of the photolysed nucleotide with Dowex anion exchange resin and 
addition of fresh azido nucleotide, resulted in further 
inactivation of the enzyme (results not shown). This indicated 
that the reason why all ATPases are not labeled in a single 
irradiation period is because the efficiency of labeling is less 
than 100% and not because a population of ATPases were resistant 
to labeling. A similar finding has been reported for the 
photoaffinity labeling of tightly bound 2N3-nucleotides to the 
chloroplast F1 ATPase (Xue et al., 1987). The close correlation 
between extent of labeling at alkaline pH and inactivation of 
ATPase activity suggests that under these conditions there was 
almost exclusive labeling of the catalytic site, whereas at acid 
pH another site(s) is apparently preferentially labeled. 
The photolabeling experiments described above were carried 
out using TNP-8N3AMP. In a less extensive series of experiments, 
we found that the di- and triphosphate species gave similar 
results. 
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Figure 3.20. SR photoaffinity labeling with 10 µM TNP-8N3AMP 
SR vesicles were irradiated in the same medium described in 
3.19(B) (turnover conditions) except that the concentration 




assayed for covalent incorporation and ATPase activity as 
described above (Fig. 3.19). 
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The effect of photolabeling on active site cross-linking was 
also investigated (Fig. 3.21). Under the conditions used, which 
were designed to maximize cross-linkage, 80-90% of ATPases were 
cross-linked to the E(125) species in the absence of irradiation 
(lanes 2-5). The remaining ATPases were mainly cross-linked 
intermolecularly. In the control samples (lanes 2 - 5), there 
was a very small amount of E(110) in the pH range 6 - 9, under 
all conditions used. Note that the medium was diluted 100 fold 
prior to initiating the glutaraldehyde reaction so that the 
concentration of noncovalent nucleotide was well below the Ka for 
binding to the catalytic site, ensuring that only covalent 
nucleotide located at the catalytic site could inhibit cross-
linkage. Irradiation, under nonturnover conditions in the 
absence of ATP (gels labeled "ca2+" and "EGTA") -and under 
turnover conditions (gel labeled "ca2++ATP") resulted in 
inhibition of cross-linkage, the level of which increased as the 
pH increased from 6 to 9. The presence of EGTA and 100 µM ATP 
(gel labeled "EGTA+ATP") prevented inhibition. At pH 9.0, the 
percentage inhibition of cross-linkage (40-60%, depending on 
labeling conditions, last lane) correlates well with the 
percentage of ATPases modified and percentage inhibition of 
ATPase activity (Fig. 3.19). 
3.9. FLUORESCENT PROPERTIES OF COVALENTLY ATTACHED NUCLEOTIDES 
The ability of a TNP-8N3-nucleotide, covalently attached at 
the catalytic site, to exhibit superfluorescence, was 
investigated using ATP (Fig. 3.22, panel A), acetyl phosphate 
(panel B), and Pi (panel C) as substrates. It was anticipated 
that, since the nucleotide was attached at the catalytic site, 
ATP may not be accommodated, but possibly a smaller substrate 
such as acetyl phosphate, or Pi, may gain entry, analogous to the 
situation following FITC modification of the ATPase (Pick, 1981; 
Champeil et al., in press). The vesicles were irradiated in a 
medium containing 5 µM TNP-8N3AMP at pH 8.6 under nonturnover 
conditions, with EGTA (traces A iii, B iii, and C iii), and under 
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Figure 3.21. Inhibition of active site 
photoincorporated TNP-8N3AMP. 
cross-linking by 
SR vesicles (0.2 mg of protein/ml) were irradiated in the same 
media as in Fig. 8, right hand series of panels, A (labeled 
"ca2+"), B (labeled "ca2+ + ATP"), c (labeled "EGTA"), and c 
(labeled "EGTA + ATP") at the pH values indicated. The samples 
were then diluted 100-fold, reacted with glutaraldehyde, 
collected on glass fiber filters, washed, dissolved in 
solubilizing solution and finally electrophoresed in 7% gels, as 
described in Experimental Procedures. In the control samples, 
TNP-nucleotide was added immediately after the irradiation period 
(as indicated). The lane labeled "SR" represents a sample which 
went through a similar procedure but to which hydrazine was added 
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Figure 3.22. Fluorescence properties 
nucleotide. 
of photoincorporated 
SR vesicles (0.2 mg of protein/ml) were irradiated in 20 mM 
CHES/TMAH, pH 8.6, 5 mM MgCl2, 20 % (v/v) glycerol, without 
(traces i and ii) or with (traces iii and iv) 15 µM . TNP-8N3AMP 
under nonturnover (0.5 mM EGTA, trace iii) or turnover (50 µM 
CaCl2 and 100 µM ATP, trace iv) conditions. In the control 
samples (traces i and ii) TNP-8N3AMP (5 µM) was added immediately 
following the irradiation period. Nucleotide not covalently 
attached was removed and the fluorescence measured on undiluted 
samples. In (A) ATP (100 µM), (B) acetyl phosphate (AcP, 5 mM) 
and (C) Pi (5 mM) were used as substrates. In the latter case, 
the pH was adjusted to 6.5 with maleic acid just prior to the 
fluorescence measurements. Where TNP-8N3AMP, EGTA and ca2+ are 
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turnover conditions, with ca2+, Mg2+, and 100 µM ATP (traces A 
iv, B iv, and C iv). The amount of labeling expected was 2 
nmol/mg of protein (or 30% of active ATPase polypeptides) and 2.5 
nmol/mg of protein (or 50% of active ATPase polypeptides) 
respectively (values derived from Fig. 3.19). Following 
irradiation, noncovalently attached nucleotides were removed by 
passage through an anion exchange resin. The effectiveness of 
the latter procedure is shown by the lack of superfluorescence of 
control preparations which had not been irradiated but to which 
TNP-8N3AMP had been added prior to the column (traces A ii, B ii, 
and C ii). The removal of noncovalently bound TNP-nucleotides is 
difficult on account of their high affinity and slow rate of 
dissociation from the ATPase. Effective removal required the 
addition of ATP and very slow passage of the mixture through the 
column. Nevertheless, even with this procedure, in the case of 
the nonturning over enzyme a small amount of free nucleotide 
eluted with the vesicles (see below). In panel A, it is shown 
that the covalently attached nucleotide does not exhibit 
superfluorescence with ATP as substrate irrespective of whether 
the labeling was carried out under nonturnover (iii) or turnover 
(iv) conditions. In the case of (iii), the small amount of 
fluorescence increase seen upon addition of ATP and ca2+, but 
before addition of extra TNP-8N3AMP, is attributed to the 
presence of a small amount of free TNP-nucleotide. Addition of 
TNP-8N3AMP to preparations irradiated in EGTA (iii) and ca2+ + 
ATP (iv), resulted in superfluorescence to the extent of 70% and 
50% of the control (i) respectively, which is equivalent to the 
amount of ATPases expected not to contain attached nucleotide. 
Activation of enzyme turnover with acetyl phosphate, 
resulted in superfluorescence of the covalently attached 
nucleotide if the irradiation was done in EGTA and in ca2+ and 
ATP (panel B, traces iii and iv respectively). The amplitude of 
superfluorescence was 25% and 40% of the control respectively, 
which is slightly less than the percentage of ATPases labeled. 
A similar result was obtained if the phosphoenzyme was 
formed from Pi in excess EGTA at pH 6.5 (Fig. 3.22, panel C). 
Superfluorescence, in amounts proportional to labeling levels, 
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was observed when the irradiation is performed under nonturnover 
(iii) and turnover (iv) conditions of irradiation. The 
amplitude, expressed as a percentage of the control value, namely 
25 % and 40% respectively, was slightly less than the percentage 
of active sites modified (Fig. 3.19). ATP, 2 mM, completely 
inhibited the superfluorescence of control preparations but had 
no effect on that of preparations with the covalently attached 
nucleotide (results not shown), showing that ATP is unable to 
bind to the catalytic site under these conditions. 
The results obtained with a preparation irradiated in the 
presence of ca2+ were essentially the same as those for the 
preparation irradiated in the presence of excess EGTA and are not 
shown. This is in accord with the similar extents of labeling 
under these conditions (Fig. 3.19). 
3.10 LOCATION OF LABELED SITES 
The extent of covalent labeling by TNP-8N3ADP of the protein 
components of SR vesicles and of the primary tryptic fragments 
following SOS-PAGE are shown in Fig. 3.23. A relatively high 
concentration (10 µM) of azido nucleotide was used so that the 
vesicles were labeled to approximately the same extents at pH 6.0 
and at pH 9.0 (see Fig. 3.20). At pH 6.0, the ATPase was not 
labeled to a significant extent (Panel A) and most of the 
labeling was presumably on phospholipid. This conclusion is in 
agreement with the small inhibition of ATPase activity (Fig. 
3.19) and of active site cross-linking (Fig. 3.21) under these 
conditions. In contrast, at pH 9.0 (Panel B), the ATPase was 
labeled to a much higher degree. Tryptic cleavage of the ATPase 
at the T1 site to produce fragments A and B (Fig. 3.23, second 
gel and Panel C) shows that the label is entirely associated with 
the A fragment. At a higher ratio of trypsin to SR protein 
(1:100), which cleaved the A fragment into the A1 and A2 
subfragments, only A1 is labeled (Panel D). The lack of labeling 
of the Band A2 fragments confirms that the nonspecific labeling 
was negligable. Similar results were obtained when the labeling 
was carried out under nonturnover conditions in the 
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Figure 3.23. SDS-PAGE of photolabeled SR proteins and tryptic 
fragments. 
SR vesicles (0.2 mg of protein/ml) were irradiated in 20 mM 
CHES/TMAH, pH 6.0 (A) or pH 9.0 (B, C and D), 5 mM MgCl2, 20 % 
(v/v) glycerol, 50 µM CaCl2, 100 µM ATP and 10 µM TNP-8N3-[2-3H]-
ADP for 3 min. The suspension was then incubated without(~ and 
B) or with (C, 1 :1000 and D, 1:200 mg/ mg of SR protein, 
respectively) trypsin for 15 min at 25 oc. Aliquots (50 mg of 
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presence of 1 mM EGTA and without added ca2+ and ATP (results not 
shown). 
3. 11 . PEPTIDE MAPPING 
In this section we describe a preliminary attempt to locate 
the locus of attachment of the TNP-8N3-nucleotide to the ATPase. 
The analysis was not completed but is included to indicate the 
direction that the research is going and points to some of the 
difficulties which need to be overcome. 
3.11.1 Purification of labeled peptides 
SR vesicles were labeled under conditions resulting in 
specific incorporation of TNP-8N3-[2-3H]-AMP into the turning 
over and nonturning over enzyme (see Fig. 3. 19) . The extent of 
covalent incorporation of the probe was found to be 1 . 5 nmol/mg 
of SR protein, whether labeling was carried out under turnover or 
nonturnover conditions. This value is slightly lower than 
expected from previous results (see Fig. 3.19). Following 
trypsinization of the resuspended vesicles, only 2-5% of the 
counts were pelleted with the membrane fraction, consistent with 
most of the label being associated with the hydrophilic extra 
membranous portion of the ATPase. An initial fractionation by 
reversed phase HPLC of the tryptic peptides released from the 
turnover-labeled preparation, is shown in Fig. 3.24. The 
profile obtained for the nonturnover-labeled preparation was 
similar. The radioactivity profiles for the turnover and 
nonturnover labeled preparations are also shown in Fig. 3.24a and 
b. Two major peaks of radioactivity were found with both 
labeling conditions, the first corresponded to the column void 
volume and the second to species eluting at about 15% 
acetonitrile. A number of smaller peaks of radioactivity were 
seen, but these were not investigated further, at this stage of 
the investigation. The large peak of radioactivity eluting in 
the void volume was also not investigated further. It is 
possible that the TNP-8N3AMP or tritium label is unstable under 
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Figure 3.24. HPLC Purification of TNP-8N3AMP labeled tryptic 
peptide. 
TNP-8N3AMP labeled tryptic peptides were injected onto a 
µBondapak C18 column in 5 mM PICA (Buffer A) and eluted with a 
gradient of acetonitrile + 5 mM PICA at a flow rate of 3 ml/min. 
Absorbance of the effluent was monitored at 240 nm. Fractions 
of 2 ml were collected and 50 µl aliquots were assayed for 
radioactivity in 10 ml Insta-gel. The absorbance trace shown 
here is for the turnover labeled preparation with the 
radioactivity profile drawn below. The radioactivity profile 
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these conditions. Approximately 35-40% of the radioactivity 
applied to the column eluted in the peak at 15% acetonitrile. 
This peak, in both cases, was collected, lyophilized to 
dryness, then reinjected onto the same column using a different 
mobile phase. The absorbance trace at 220 nm for the second 
purification of the turnover labeled preparation is shown in Fig. 
3 . 25. The elution profile for the nonturnover labeled 
preparation was similar. In both cases, the peak of 
radioactivity eluted after several larger peptide peaks at about 
13% isopropanol. This peak was collected and lyophilized to 
dryness~ The similarities between the two preparations as 
regards the HPLC elution of the labeled peptides suggests a 
single site of labeling under both turnover and nonturnover 
conditions. 
SR vesicles were labeled with FITC and treated in the same 
way as the TNP-8N3AMP labeled preparation to act as a control and 
to check on the methodology. The FITC labeled tryptic peptide 
was isolated in a single HPLC elution (Fig. 3.26). A single 
peak with strong absorbance at 254 nm was collected, eluting at 
about 31% isopropanol. The characteristic absorbance spectrum 
of FITC was seen on scanning the fraction at alkaline pH. A 
second HPLC run of the lyophilized peak showed a single peak. 
3.11 .2. Amino acid analysis and sequencing of labeled peptides 
HPLC separation of seventeen standard PITC-amino acids is 
shown in Fig. 3.27. Asn and Gln are hydrolysed to their 
respective acids during the acid hydrolysis. Trp is labile and 
does not appear in the elution profile. A clear separation 
between Asp and Glu as well as betwen Arg and Thr was not 
obtained, but approximate quantitation was achieved using a peak 
separation method in the integrator. The pattern obtained was 
reproducible ~nd retention times of standards did not vary by 
more than a few seconds between successive injections. A 
preparation of amino acids which had been subjected to the acid 
treatment was routinely analyzed to obtain the percentage 
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3.25. Second Purification of TNP-8N3AMP labeled tryptic peptide 
by HPLC. 
The major peak of radioactivity from the initial fractionation 
was reinjected onto the same column in 0.01 M ammonium acetate, 
pH 4.0 and eluted with a gradient of isopropanol in buffer A. 
The absorbance of the effluent was monitored at 220 nm. The 
peak of radioactivity is shown with a cross. The results shown 
here represent the preparation labeled under turnover conditions, 
that labeled under nonturnover conditions was similar. 
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3.26. HPLC purification of FITC-labeled tryptic peptide 
FITC-labeled tryptic peptides were injected onto a uBondapak C18 
column in 0.01 M ammonium acetate, pH 4.0 (Buffer A) and eluted 
with a gradient of isopropanol in Buffer A at aflow rate of 2 
ml/min. Absorbance of the effluent was monitored at 254 nm. 
The main peak of absorbance was collected, scanned at alkaline pH 





~ p 0.5 ~ LO 
N 
RTA 41 
u GH C: 
(II 
.c s ... ,,. 
0 DE ,,. rJ) 
.c ~ ; <( 
,,. 
..... ,,. ,,. ,,. 
L ,,. ,,. 0 ~-- \,, 
I I I 





















~~ --= 0 
I I 
10 12 








10 nmoles of PITC derivitized amino acids (Pierce amino acid 
standard H) were injected onto a Picotag column in Picotag Eluent 
A and eluted with a gradient of Picotag Eluent B. Detection was 
at 254 nm. 
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decomposition of individual amino acids during the acid 
hydrolysis. The main species giving lower yields were Tyr (80% 
yield) and Cys (55% yield). 
The manual method we used for the sequencing of standard 
peptided has the important advantage that a vapour phase Edmann 
degradation is carried out resulting in lower levels of 
background contamination. This results in simplification of the 
identification process. Fig. 3.28 shows four traces 
superimposed on one another representing the first four cycles of 
degradation of the standard peptide AC9. Material from the 
cleavage reaction was washed into pyrrolysed tubes, treated with 
acid and then the PTH-amino acids analysed by HPLC. Data was 
collected on a benchtop computer and then superimposed in a 
single trace staggered with respect to the preceding cycle. 
Unfortunately, analysis of the radioactive material obtained from 
the labeling experiment in Fig. 3.25, using the same procedure, 
did not result in any detectable PTC-amino acids. There are 
several possible reasons for this, but the principle one is 
possibly the lack of sufficient material. A larger amount of 
material was used to sequence the standard peptides than was used 
in the amino acid analysis. As noted above, the covalent adduct 
may be unstable, and more rapid and less severe conditions may 
have to be developed to obtain greater yields of radioactive 
peptides. We plan to invesigate these possibilities in the 
future. Another possibility is that the peptide may contain a 
cyclized N-terminal residue which would prevent it's being 
sequenced by this method. This phenomenon has been noticed 
before, in addition to other problems with the sequencing of 
azido labeled peptides (Knight and McEntee, 1985a, c). 
3.11.3 Amino acid analysis of labeled peptides 
The amino acid analysis of the FITC-labeled peptide is shown 
in Fig. 3.29. The relative levels obtained are consistent with 
those in the published sequence (Brandl et al., 1986). 
The profile obtained for the TNP-8N3AMP labeled peptide 
(nonturnover conditions) is shown in Fig. 3.29. The traces 
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3.28. 4-cycle sequence determination of a model peptide. 
The synthetic peptide AC9 was subjected to manual sequencing by 
Edmann degradation for 4 cycles then the amino acids derivitized 
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3.29. Amino acid analysis of FITC labeled tryptic peptide. 
The isolated FITC labeled tryptic peptide was hydrolysed to 
completion, derivitized and PITC-amino acids analysed by HPLC as 
described. 
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3.30. Amino acid analysis of TNP-8N3AMP labeled tryptic peptide. 
The isolated TNP-8N3-AMP labeled tryptic peptide was hydrolysed 
to completion, derivatized and analyzed by HPLC as described. 
Also shown are the derivatized commercial amino acid standards 
and a blank which consisted of the same amount of sample diluent 
without amino acids. 
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shown represnt sample diluent (A), standards (C), and the 
radiolabeled peak (D), from the purification shown in Fig. 3.25. 
The major amino acids identified are Glu/Gln, Ser, Gly, Thr, and 
Val, but no region on the .A1 fragment, or in any other part of 




In this study we have developed a new class of photoaffinity 
analogs of ATP, ADP and AMP. The compounds combine a light 
sensitive azido group covalently attached to the 8-position of 
the adenine ring with a fluorescent trinitrophenyl group 
attached to the 2' and 3' positions of the ribose moeity. We 
have used these compounds to probe the nucleotide binding sites 
of the sarcoplasmic reticulum ca2+_ATPase. 
Both 2- and 8-azido-ATP derivatives are in common use as 
photoaffinity probes, but our choice of the 8-position for the 
azido group was dictated by reports that the 2-azido derivative 
spontaneously forms an unreactive tetrazole isomer in solution. 
Furthermore, alkaline pH has been shown to alter the 2-
azido/tetrazole equilibrium in favor of the latter isomer, while 
the absorption of visible light by the TNP group is decreased as 
the pH of the medium is lowered (pK = 5.1) (Hiratsuka and Uchida, 
1973). The disadvantage of the 8-azido derivative is that the 
8-azido adenine group adopts a syn conformation about the N-
glycosidic bond instead of the anti conformation favored by ATP. 
However, in preliminary experiments with 8-BrATP and 8N3ATP, it 
was found that these derivatives are as good substrates as ATP 
for the ca2+_ATPase (see Champeil et al., 1988). It is possible 
that binding induces the sterically unfavorable anti conformation 
in these nucleotides bringing the position of the adenine in line 
with that of ATP in the binding cleft. Alternatively, it is 
also possible that the binding site can accommodate this 
orientation or that derivatization with the TNP group results in 
further conformational changes. This should be borne in mind 
when the site of covalent attachment is assessed in relationship 
to amino acid side chains comprising the binding site of ATP. 
This is a general problem when using probes for investigating 
biological function. 
The trinitrophenyl group was introduced for several reasons. 
It has been found that the TNP derivatives of ATP, ADP, and AMP 
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all bind with high affinity to the catalytic site of the ca2+_ 
ATPase with kD values of about 0.1 - 0.3 µM (Watanabe and Inesi, 
1982; Dupont et al., 1982, 1985; Nakamoto and Inesi, 1984; 
Davidson, 1986). Thus the affinity is significantly higher than 
that for ATP (ko about 2 µM). This has two advantages for 
photoaffinity labeling. Firstly, lower levels of nonspecific 
labeling are obtained as the photolabeling reaction can be 
carried 
tighter 
out at a lower concentration of probe, and 
binding increases the probability of obtaining 
attachment to the protein. 
secondly, 
covalent 
The affinity of TNP-nucleotides for the regulatory site is 
also much greater than that of ATP. The kD values for the 
phosphorylated ca2+_ATPase have been reported as 0.95 µM 
(Davidson, 1986) for TNP-ATP and 3.3 µM for TNP-AMP (Bishop et 
al., 1986), while the regulatory site responsible for 
acceleration of activity has an affinity for ATP of about 1 mM 
(de Meis and Vianna, 1979). Thus TNP-nucleotides have an 
affinity for this site which is about three orders of magnitude 
greater than that of ATP. 
Furthermore, the fluorescence of TNP-ATP is increased 
approximately seven-fold on binding to the phosphorylated ca2+_ 
ATPase. The nature of this site is still unknown. It may 
represent a modified catalytic site, the regulatory site, or 
another site. One of the major aims of this study is to attempt 
to differentiate between these possibilities. 
The absorbance and fluorescence properties of the TNP group 
are advantagous in that they provide a very useful means for 
characterizing the interaction of the probe with the enzyme. 
Thus, difference absorbance spectra have been used to monitor the 
binding of TNP-ATP to the ca2+_ATPase while the TNP group 
fluorescence has been used to monitor changes in the nucleotide 
site(s) during catalysis. Other advantages include the fact 
that it is possible to get sel~ctive binding of TNP-nucleotides 
to the catalytic, regulatory and superfluorescent sites under 
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well established conditions and also the fact that the 
interaction of TNP-nucleotides with SR vesicles has been well 
studied. 
enzymes 
Finally, TNP-nucleotides have been used in many 
which means that their photoaffinity analogs may 
more general use. 
other 
be of 
In this study, we have found that the TNP-8N3-nucleotides 
exhibit many of _the characteristics of the parent non-azido TNP-
nucleotides. When incubated with SR vesicles they bind with 
high affinity to the catalytic site of the ca2+_ATPase. Under 
conditions leading to phosphorylation of the enzyme they undergo 
a large increase in fluorescence and under the same conditions, 
the di-, and triphosphate species accelerate ATP hydrolysis. 
Efficient, specific labeling of the enzyme under both turnover 
and nonturnover conditions was obtained at alkaline pH to the A1 
tryptic fragment, resulting in modification of the catalytic site 
in both cases. The covalently incorporated TNP-8N3-nucleotide, 
whether turnover or nonturnover labeled, increases it's 
fluorescence in the presence of Pi and Me2SO or AcP and ca2+ but 
not in the presence of ATP and ca2+. We conclude that the 
catalytic and regulatory nucleotide sites share the same locus, 
and the results are consistent with a model in which the A1 
tryptic fragment forms part of the nucleotide binding domain. 
4.1 Synthesis of TNP-8N3-nucleotides 
The TNP-8N3-nucleotides were synthesized from ATP in 
essentially three steps involving bromination of the adenine 
ring, displacement with the azido group and addition of the TNP 
group. 8N3-nucleotides may also be synthesized by 
phosphorylation of commercial 8N3-adenosine. The method we 
chose, however, (Schafer et al., 1978b) has two advantages in 
that it uses a less expensive starting material and also 
generates a good yield of 8N3ATP, 8N3ADP and 8N3AMP in a single 
step. Trinitrophenylation of the 8-substituted nucleotides 
proceeds readily under the same conditions described for ATP 
(Hiratsuka, 1982), although the inclusion of an oxidising agent 
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is essential to prevent reduction of the azido group by the 
released sulfite anion. DTNB is particularly useful in this 
regard as it not only almost completely prevents reduction of the 
azido group, but also increases the yield of trinitrophenylation 
to about 80% compared to published yields of about 50% for ATP 
(Hiratsuka, 1982). 
TNP-8N3-[8-14c]-, and TNP-8N3-[2-3H]-nucleotides were 
synthesized from [8-14c]-, and [2-3H]-ATP using a scaled down 
version of the method used for synthesis of the nonradioactive 
TNP-8N3-nucleotides, with a few modifications. While the yield 
obtained for the [8-14c] derivatives was good, that for the [2-
3H] derivatives was poor. This was on account of the 
exchangeability of the label under conditions leading to 
bromination in the 8-position. An alternative method for the 
synthesis of 8N3-[2-3H]-ATP from [2-3H]-ATP has been published 
(Boos et al., 1978) with overall radiochemical yields of between 
30 and 40%. 
The criteria used for judging purity of the synthesized 
compounds include spectrophotometry, anion exchange TLC and 
reversed phase HPLC. Disruption of the extended azido adenine 
ring structure by photolysis or reduction of the azido group 
results in a shift in the absorption maximum from 281 nm to 273 
nm. Thus any decrease in UV absorbance maximum of a stock 
solution is an indication that a degree of decomposition of the 
azido group has taken place. The anion exchange TLC system 
readily separates TNP-8N3ATP from TNP-8N3ADP and from TNP-8N3AMP 
as well as from the non-trinitrophenylated adenine nucleotides. 
The most powerful technique, however, is reversed phase HPLC 
which separates all the compounds as in the TLC system and, in 
addition, separates out the derivatives with photolyzed or 
reduced azido group. 
Stock solutions of TNP-8N3-nucleotides are stable for at 
least two years when stored frozen in aqueous solution at neutral 
pH, based on the above criteria. With time, some reduction of 
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the azido group does occur as well as loss of the y-phosphate 
group in the case of TNP-8N3ATP. 
4.2 Interaction of TNP-8N3-nucleotides with SR vesicles 
Evidence for binding of the TNP-8N3-nucleotides to the 
catalytic site of the ca2+_ATPase was obtained by several 
methods. The filtration procedure was used to measure directly 
the binding of TNP-8N3-nucleotides to SR vesicles (Fig. 3.12). 
This method revealed a single class of high affinity binding 
sites for all three nucleotides. The ko.s values for binding to 
this site were found to be 0.1 µM for TNP-8N3AMP, and 0.2 µM for 
TNP-8N3ADP and TNP-8N3ATP. This high affinity binding plateaued 
at a value of about 4 nmol/mg protein after which a secondary 
increase was seen which was nonsaturable within the limits used 
here. For this reason, we postulate that this represents 
nonspecific partitioning of the compounds into the SR membrane as 
a result of the increased hydrophobicity conferred on the 
molecule by the azido group. In the presence of EDTA very low 
levels of binding were measured. This could be due to the 
instability of the vesicles under vacuum in the absence of 
divalent cations or, alternatively, the binding sites may not 
exist in EDTA. Binding to the catalytic site was also 
conveniently measured by means of the inhibition of 
intramolecular cross-linking method recently developed in our 
laboratory (Ross and McIntosh, 1987b) (Fig. 3.14). These 
authors have shown that equilibrium nucleotide binding to the 
catalytic site can be measured from the initial rate of formation 
of the species intramolecularly cross-linked with glutaraldehyde 
as determined by SDS PAGE (Ross and McIntosh, 1987a). In this 
study, the usefulness of this technique was extended into the 
nanomolar ligand concentration range by using low protein 
concentrations and large volumes, and collecting the protein on 
glass fiber filters prior to electrophoresis. The Ki values 
obtained with this method are 0.04 µM (TNP-8N3AMP), 0.3 µM (TNP-
8N3ADP) and 0.4 µM (TNP-8N3ATP), and agree closely with the Ka 
values obtained by equilibrium binding measurements. Slightly 
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lower Ka values have been reported for the parent TNP-nucleotides 
(Watanabe and Inesi, 1982; Dupont, 1982, 1985; Nakamoto and 
Inesi, 1984; Davidson, 1986), although, again, the monophosphate 
derivative has the highest affinity (Nakamoto and Inesi, 1984). 
The slightly higher ko values obtained for the TNP-8N3-
nucleotides with respect to their TNP-nucleotide counterparts is 
probably a reflection of the more bulky azido group hindering 
access to the binding site. Lastly, we used the fluorescence 
properties of the TNP group to titrate the catalytic site, both 
in the presence and absence of Mg2+ (Fig. 3.13). In the 
presence of a high concentration of Mg2+, additional binding of 
the TNP-8N3-nucleotides, and particularly TNP-8N3ATP, was 
detected to a fluorescent site and which was not found with TNP-
ATP . Again, this probably represents partitioning of the more 
hydrophobic, chelated TNP-8N3-nucleotides into the SR membrane. 
Evidence for the binding of TNP-8N3ATP to the catalytic site 
of the ca2+_ATPase was also obtained by measuring ATPase activity 
in the presence of increasing concentrations of TNP-8N3ATP (Fig. 
3.11). The results obtained are complicated by the fact that at 
low concentrations, TNP-8N3ATP accelerates activity by binding to 
a regulatori site. Increasing concentrations progressively 
inhibit activity, following competition at the catalytic site. 
The parent TNP-nucleotides have alternately been reported to 
accelerate ATPase activity (Dupont et al., 1985; Champeil et 
al . , 198~), or to block acceleration by ATP (Bishop et al., 
1987). We used a pH-stat procedure to measure acceleration of 
ATPase activity and found that TNP-8N3AMP, TNP-8N3ADP, and TNP-
8N3ATP accelerated activity 1.0-, 1.4-, and 1.5-fold, 
respectively. TNP-nucleotide acceleration of ATPase activity is 
only evident using the pH-stat procedure and not with the coupled 
enzyme method. The reasons for this are not yet understood. 
Binding of TNP-8N3-nucleotides to this regulatory site was 
determined by measuring the increase in fluorescence of the bound 
TNP-8N3-nucleotide upon addition of ATP and ca2+ (Fig. 3.16). 
Similarly to binding to the catalytic site, the TNP-8N3-
nucleotides have a lower apparent affinity (ko.s = 5 - 8 µM) for 
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this site with respect to TNP-ATP and also have a lower yield of 
fluorescence. This may either be an intrinsic property of the 
fluorophore, or it may be a result of the decreased affinity for 
the site. The reason for the increased affinity of the 
monophosphate species may be related to a decrease in the steric 
properties of the probe. It is also interesting that the 
monophosphate does not accelerate ATPase activity. Again, this 
could be a result of the increased affinity for the catalytic 
site which would inhibit ATP binding. The conditions under 
which acceleration is obtained with TNP-8N3ATP and TNP-8N3ADP are 
the same as those for obtaining the high fluorescence state, 
identifying the high fluorescence site with a regulatory site 
responsible for acceleration of turnover ~ A number of studies 
with TNP-ATP have correlated the high fluorescence site with 
binding 
1985; 
to E2-P (Dupont and Pougeois, 1983; Andersen et al., 
Wakabayashi et al., 1986). It has also been postulated 
that the binding of ATP to the phosphorylated enzyme intermediate 
results in acceleration of turnover (McIntosh and Boyer, 1983). 
From these studies we concluded that the TNP-8N3-nucleotides bind 
with high affinity to a moderately fluorescent catalytic site and 
a highly fluorescent regulatory site. Identification of the 
highly fluorescent site with the regulatory site responsible for 
ATP modulation . of turnover, is suggested from the similar 
conditions required for binding to both sites. 
4.3 Photoaffinity labeling 
Nitrenes are capable of a number of reactions including 
addition reactions, insertion into C-H bonds either directly or 
via proton abstraction, rearrangements and nucleophilic attack 
(Knowles, 1972). For an efficient reaction with a protein it is 
necessary that the azido group is in close contact with the amino 
acid side chains, possibly within 2 A (Guillory, 1979). 
Nitrenes react readily with H20, and this reaction could compete 
with that for the protein (Knowles, 1972). In the experiments 
described in this work, we noted a marked pH dependence of 
photoincorporation. This finding may be of more widespread 
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significance in photoaffinity labeling, and has not previously 
been described as a necessary requirement for specific 
photoincorporation; it may, generally, be unnecessary, depending 
on the nucleophile involved. A low degree of labeling is 
obtained at neutral pH which had little effect on ATPase 
activity. 
labeling 
At higher pH, however, highly specific and efficient 
(40 80 %) was obtained. The affinity of the 
catalytic site for the TNP-8N3-nucleotides is approximately the 
same at pH 7 and 8, demonstrating that this effect is due to 
enhanced efficiency of the photoincorporation reaction, rather 
than increased occupancy of the site. Although nitrenes are 
theoretically capable of insertion into C-H bonds they are more 
reactive with nucleophilic centres. A number of studies have 
reported the specific modification of Tyr residues (Garin et al., 
1986; Cross et al., 1987; Wise et al., 1987). A possible 
candidate for labeling from our observed pH dependence would be a 
sulfhydryl residue (usual pK = 7.5), but a Tyr residue with a 
lowered pK for the functional group cannot be ruled out (usual pK 
= 10). The pK values of functional groups are known to depend 
on the protein environment (Barker, 1971). This pH dependence 
of labeling may account for the low level of specific labeling of 
the ca2+_ATPase with 8N3ATP (Campbell and MacLennan, 1983; Cable 
and Briggs, 1984). Both 8-BrATP and 8N3ATP are good substrates 
for the ca2+_ATPase (Champeil _et al., 1988; Seebregts and 
McIntosh, unpublished observations), indicating that the enzyme 
has no difficulty in accomodating the syn structured nucleotides. 
NMR measurements have established that ATP bound to both the high 
and low affinity nucleotide sites of the ca2+_ATPase is in the 
anti conformation (Clore et al., 1982). Our results suggest 
that at neutral pH, water or buffer in the active site represents 
a preferred target for the reactive nitrene radical, while at 
more alkaline pH a reactive nucleophile on the protein becomes 
the target. This would also explain the increased efficiency of 
incorporation obtained under turnover conditions, where it has 
been postulated that water activity in the active site is lower 
(Dupont, 1983). The affinity of this site for TNP-8N3-
nucleotides is slightly lower than the catalytic site as we were 
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able to obtain increased labeling, up to 80% incorporation, at 
higher concentrations of probe (10 µM). Under all three 
conditions, specific modification of the catalytic site was 
confirmed by inhibition of glutaraldehyde cross-linking (Fig. 
3.21). Low glutaraldehyde concentrations and extended reaction 
times were used to obtain almost complete conversion to the 
cross-linked species. Under all conditions, the extent of 
inhibition of the cross-link correlated with the percentage 
inhibition of activity. 
The photoaffinity labeling levels obtained in this study 
may be compared favorably with the recent results obtained 
labeling the tight nucleotide sites of the F1-ATPase 
2N3ATP/ADP, where free nucleotide may be removed prior 





long irradiation times are used (Cross et al., 1987). 
authors typically report values of between 50 and 
These 
70% 
photoincorporation, as assayed by inhibition of ATPase activity, 
with no apparent nonspecific labeling, as judged by extrapolation 
of the inhibition curve to integral values of sites (one in the 
case of the catalytic sites and two in the case of the 
noncatalytic sites) (Cross et al., 1987). It was estimated that 
nearly all the bound nucleotide became incorporated with little 
or no nonspecific labeling (Xue et al., 1987; Melese et al., 
1988). We obtained levels of 50 - 80% photoincorporation under 
steady state conditions at alkaline pH as assayed by inhibition 
of ATPase activity, with little nonspecific labeling. 
We have localized the site of labeling of the ca2+_ATPase 




the region from residues 328-505 
as it occurs in the postulated 
Residues 238-328 are located in 
appears a more 
phosphorylation 
a postulated 
transmembrane region and residues 199-238 are in the so-called 
transduction domain. This section of the A1 fragment contains 
two regions of conserved primary structure, 296-316 and 326-359. 
Neither of these two regions contain Tyr residues and the latter 
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contains two Cys residues, Cys-344 and Cys-349. Cys-344 has 
been identified as the site labeled with NEM and, with Cys-364 is 
one of the 2 sulfhydryl residues making up SHo, in the 
nomenclature of Kawakita et al., (1980). It may represent a 
uniquely reactive residue and thus be more susceptible to 
labeling. 
TNP-8N3-nucleotides, like the parent TNP-nucleotides, 
undergo a large increase in fluorescence upon binding to the 
phosphorylated ca2+_ATPase, in the dark. Similarly, the 
covalently incorporated TNP-8N3-nucleotides, following removal of 
the free nucleotide, undergo an increase in fluorescence. The 
extent of this increase correlates well with the amount of 
photoincorporation and does not depend on whether 
photoincorporation is carried out under nonturnover or turnover 
conditions. In an analogous way to the situation with FITC 
(Pick and Bassilian, 1981), phosphorylation, and the consequent 
fluorescent increase, of the labeled enzyme can only be achieved 
either with AcP as substrate in the presence of ca2+, or with 
as substrate in the presence of Me2SO. These results 
Pi 
are 
consistent with a model in which the covalently incorporated TNP-
8N3-nucleotide blocks ATP binding but allows entry of the smaller 
substrates, AcP and Pi. A similar conclusion was reached for 
FITC. The importance of our results stems from the finding that 
inhibition of ATP binding occurs whether the enzyme is labeled at 
the catalytic site or at the regulatory site. The most simple 
conclusion is that the two sites share the same locus. 
4.4 Location of the Regulatory Nucleotide Site of the C~-
ATPase 
One of the more important goals of this study was to 
determine the relationship of the regulatory nucleotide site, 
responsible for the acceleration of enzyme activity, to the 
catalytic site. The models which have been postulated to 
explain the regulation can be divided into those which invoke a 
second site spatially distinct from the catalytic site to which 
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the accelerating ATP binds and those which require only a single 
site to explain the kinetics. In this latter model, the same 
site is seen to bind both catalytic and regulatory nucleotide but 
at different stages of the catalytic cycle or on a subunit of a 
dimer, i.e. the catalytic and regulatory sites reside on 
different intermediates. This model is the one supported by the 
data presented in this work as the site of labeling under 
conditions of turnover and of nonturnover have a number of 
similar characteristics. (1) The pH dependence of labeling both 
sites is similar, (2) the same tryptic fragment is labeled in 
both cases, (3) TNP-8N3AMP covalently incorporated into both 
sites has indistinguishable fluorescent properties and blocks ATP 
binding and (4) a single labeled tryptic peptide eluting in the 
same place is obtained by HPLC. Furthermore, in both cases we 
were able to titrate only one high affinity TNP-8N3-nucleotide 
binding site. Even though the same site houses both catalytic 
and regulatory nucleotides, the known conformational changes 
during the cycle could lead to a different site of labeling, 
which would not necessarily constitute evidence for another site. 
This possibility appears unlikely, however, as the pH dependence 
of incorporation argues in favor of a single reactive residue 
being labeled. In fact, a more likely criticism is that the 
probe seeks out the reactive residue and thus may not reflect the 
nearest amino acid to the 8 position of the adenine ring, but 
rather the nearest reactive site. Identification of the highly 
fluorescent site with the regulatory site responsible for 
acceleration of activity by TNP-8N3ATP and TNP-8N3ADP has been 
demonstrated in a number of ways. 
It has been postulated that the increase in fluorescence of 
the TNP group is due to an increase in the hydrophobicity of the 
environment surrounding the probe in the active site (Watanabe 
and Inesi, 1982), or due to an interruption of base stacking 
between the TNP and adenine moeities by adenine stacking with the 
aromatic functional group of another amino acid (Hiratsuka, 
1975). In this study, we consistently obtained an increase in 
the extent of incorporation under turnover conditions, i.e. under 
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conditions of binding to the regulatory site. This appears to 
be consistent with the postulate that the increase in 
fluorescence is due to expulsion of water as nitrenes are known 
to be highly reactive towards water and a decrease in water 
activity would lead to an increase in the efficiency of labeling. 
There have been kinetic descriptions of more than two types 
of site as well as more than two types of modulation. With this 
in mind, it must be pointed out that we have not excluded the 
possibility of other sites in addition to the two we have 
labeled. In fact, in the presence of Mg2+ we have detected 
binding to another site, although we have ascribed this to 
nonspecific partitioning into the membrane. 
Our preliminary attempts to identify the amino acid labeled 
by TNP-8N3AMP were hindered by an apparent instability of the 
probe during the isolation procedures. We found that following 
covalent incorporation, the TNP group was lost from the protein 
during the tryptic digestion, as evidenced by a loss of colour 
and absorbance in the visible region. This was not entirely 
paralleled by a loss of radioactivity, although an amount eluting 
in the void volume of the HPLC column was seen. It thus appears 
that the adenine ring remains partially attached to the protein. 
The yields were lower than expected, so some loss does occur. 
We were, however, still able to isolate a single labeled peak 
from both nonturnover and turnover labeled preparations. This 
finding is consistent with a conclusion that the same peptide is 
labeled although it is also possible that the elution of the 
peptide is determined by the presence of the TNP group. Our 
atttempts to sequence the labeled peptide yielded no result even 
though we were able to detect the presence of amino acids 
following total amino acid analysis. Problems with the 
sequencing technique do not appear to be the cause of this as we 
were able to perform a four-cycle analysis of a standard 
synthetic peptide. One possibility is that the peptide has a 
blocked N-terminus, preventing the PITC coupling reaction, or 
that the azido group is situated near the N-terminus and prevents 
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reaction occuring. 
4.5 Nucleotide site structure 
A common nucleotide binding site has been found to exist in 
a number of nucleotide binding proteins including dehydrogenases, 
kinases, and, more recently, F1-ATPases, elongation factors, and 
oncogene products. This common folding pattern is not 
immediately evident from the primary structure as there is little 
similarity apart from a few regions of homology. This gives 
rise to the question as to whether these supersecondary 
structures have arisen as a result of divergent evolution from a 
common ancestor, . or whether they represent a convergence of 
functional evolution from disparate sources. There seems no 
doubt that within families eg. the aspartophosphoryl ATPase 
family, differences repres~nt divergence from a common proto-
enzyme (Fig. 1.2), but is there a common ancestor between 
families? In addition, in view of the structure of the encoding 
genes, in which functional domains appear to be separated by 
intrans, or, in the protein, by trypsin sensitive sites, there is 
the possibility that these enzymes may have arisen by duplication 
of common functional domains and attachment to eg. domains of 
differing ion specificity. Within families, there also appear 
to be differences in the mechanism of nucleotide binding. Apart 
from the low degree of accuracy inherent in the predictive 
method, it has also been claimed that the consensus sequences are 
rather loose and incorporate a large range of possibilities 
(Serrano, 1988). The presence of any homology at all is 
indicative of a common ancestor, however, on account of the 
unlikely event of it appearing fortuitously, especially in a 
number of different enzymes. 
Walker et al., (1982) have presented a model for the 
nucleotide binding site of F1 based on that of adenylate kinase 
(Fig. 1.9). A region of homology has been located between the 
8N3ATP binding site of the F1 a-subunit and the phosphorylation 
site of the P-type ATPases (Modyanov et al., 1985; Ernster et 
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al., 1986). The site of labeling the ca2+_ATPase with AP 3-PL 
occurs in a region homologous to a portion of the myosin heavy 
chain (Yamamoto et al., 1988). Two models has been postulated 
for the nucleotide site of the ca2+_ATPase based primarily on 
that of adenylate kinase (Green et al., 1988) and that of 
phosphofructokinase (Serrano, 1988) (Fig. 4.1). In view of the 
fact that both adenylate kinase and phosphofructokinase share two 
consensus sequences, it follows that, in fact, all these enzymes 
may have a nucleotide site which has arisen from a common 
ancestor. According to this idea, then, the differences have 
arisen as a result of a divergent evolutionary process. It also 
appears that a similar site may also evolve a different mode of 
binding. The mechanism of the different enzymes does not 
necessarily prevent this sort of argument as it has eg. been 
claimed that the phosphorylated aspartic acid of the P-type 
ATPases is analogous to the tightly bound nucleotides of the F-
type ATPases. We have localized the binding of TNP-8N3ATP to 
the A1 tryptic fragment (Fig. 3.23). This fragment has 
previously been identified as the site of labeling with BzATP 
(Cable and Briggs, 1984), although the authors also reported 
substantial labeling of the B fragment and phospholipid. A 
model has been postulated in which the A and B fragments span the 
length of the molecule abutted to one another (Squier et al., 
1987). Our results agree with this model and we conclude that a 
portion of the ~1 fragment must constitute a constant part of the 
nucleotide site of the ca2+_ATPase. More recently, the A2 
fragment has been specifically labeled following irradiation of 
enzyme bound UTP (Ferreira and Verjovski-Almeida, 1988). Thus, 
it appears that the A2 fragment is also involved in making up the 






Figure 4.1 Postulated models of the tertiary structure of two P-
type ATPases in the region of the nucleotide binding 
site 
Two models of the postulated folding patterns in P-type ATPases 
in the region of the nucleotide binding site are shown. The 
one above which refers to the ca2+_ATPase (Green et al., 1988) is 
based on the structure postulated for adenylate kinase (Fry et 
al., 1986), while the one below referring to the fungal plasma 
membrane H+-ATPase(Serrano, 1988) is based on the structure 
postulated for phosphoglycerate kinase (Evans et al., 1981). ---
Shaded areas in the lower figure represent conserved regions. 
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